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ABSTRACT
Two commercially available DNA whole genome Escherichia coli K12 arrays 
were compared to identify a subset of markers for typing. The arrays were 
identical in probe composition but different in substrate (membrane and glass slide 
arrays) and probe preparation (radio- and fluorescent-labelled). Labelled genomic 
E. coli DNA from five strains of the E. coli reference (ECOR) collection 
(ATCT35320 - ATCX35324) and E. coli K12 were hybridised against these 
arrays. A group of 1240 putative markers was identified on the membrane arrays 
and 649 were found on the glass slide arrays. Only a small proportion of these 
sequences (8%) was found through both platforms. Variability in the hybridisation 
signals from duplicate experiments made it difficult to identify useful markers.
In order to investigate whether this technology could be used for characterising or 
typing E. coli strains, an array for the detection of 29 pathogenicity markers in E. 
coli strains was produced. This array was used with eight reference strains, 
including different pathotypes, 72 strains from the ECOR collection, and 49 
clinical isolates. A wide range of E. coli pathogenicity markers was detected. The 
pathogenicity markers that were most common include chuA and iucC, which are 
both involved in iron metabolism. Additionally, the clinical isolates were grouped 
into clusters different from groupings based on biochemical tests. This 
demonstrates that the use of pathogenicity array typing can complement diagnostic 
tests on clinical E. coli isolates.
An extended, second-generation, pathogenicity marker array containing 75 probes 
was made. The extended array successfully distinguished between ten closely 
related isolates from an outbreak of urinary tract infections, while previous tests 
were unable to do so. This array has the potential for providing a rapid and novel 
means of characterising pathogenic isolates.
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Chapter 1 Introduction
1. Introduction
1.1 Escherichia coli
E. coli is a member of the Enterobacteriaceae, and usually defined by the outcome of 
simple biochemical tests. These biochemical characteristics of the Escherichia genus 
include production of indole, the inability to liquefy gelatine, a negative Voges- 
Proskauer test and a positive methyl red reaction. Additionally they do not 
decompose urea and do not utilise ammonium citrate. They are also able to ferment 
carbohydrates, including lactose, glucose and mannitol. For example, rapid lactose 
fermentation is a well known property of E. coli strains (Kauffmann, 1954, Sussman, 
I997a). By definition, the Escherichia genus is Gram-negative and oxidase-negative. 
Bacteria are shaped as small rods and they are between one and eight (im in length.
The intestinal organisms of neonates and breast-fed infants were first described by 
Theodor Escherich (1885) as Bacterium coli commune while studying the 
pathogenesis of enteric infections. Bacterium coli which was found early in his 
studies now bears his name as E. coli and is used by scientists all over the world as a 
model organism for bacterial genetics (Schembri et al., 2004), population genetics 
(Dai and Zimmerly, 2002), evolutionary biology (Grana and Acerenza, 2001) and 
pathogenicity studies (Harel and Martin, 1999). In 1997 the genomic DNA from the 
laboratory strain E. coli K12 MG1655 was one of the first full length genomes to be 
sequenced (Blattner et al., 1997). Although the genome sequence was of great value, 
it by no means provided all the answers to the many questions still remaining about 
E. coli biology. For example, over 38 % of the 4,290 identified open reading frames 
(ORFs) in the E. coli K12 genome sequence were of unknown function (Blattner et 
al., 1997). Although there is much knowledge of the genetics, molecular biology,
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physiology and natural history of E. coli, there is enough still to be found to keep 
researchers intrigued for many years to come. This section describes the classification 
of E. coli strains and the developments in serological and molecular typing that aid 
their identification.
1.1.1 E. coli in the normal population
The genera of Escherichia, Salmonella, Klebsiella, Yersinia and Shigella, belongs to 
the family Enterobacteriaceae and show a high rate of similarity on the basis of 
phenotypic and genotypic characteristics (Ewing, 1953). Whole genome comparisons 
of Enterobacteriaceae have shown a similarity between them of 50 to 86%. For 
example, the similarity between Shigella and Escherichia genomes varies between 80 
and 86%, but is up to 98 % for some individual genes (Fukushima et al., 2002, Jin et 
al., 2002, Zeigler, 2003). This allows genetic recombination to happen between 
Shigella and Escherichia, and therefore they may be considered as a biogroup rather 
than as separate genera.
The principal habitat of E. coli is the lower intestinal tract of birds and mammals, 
where they play an important role in the host metabolism by fermenting nutrient 
metabolites (Cummings and Macfarlane, 1997). E. coli is also present in the 
environment such as soil and surface waters through contamination by faeces 
(McFeters and Stuart, 1972, Ochman and Selander, 1984, Muhldorfer et al., 1996). 
Normally E. coli coexists with the human host without being associated with disease 
in contrast to, for example, Shigella spp. or Salmonella spp. which are invasive 
pathogens in human hosts ( Sansonetti and Egile, 1998, Darwin and Miller, 1999).
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As an aid to understand the biology of E. coli a set of 72 E. coli strains from the 
normal population was selected by Ochman and colleagues from 2,600 natural strains 
(Ochman and Selander, 1984). These 72 strains are referred to as the E. coli reference 
or "ECOR" collection, and they have been used in several typing studies (Miller and 
Hartl, 1986, Arnold et al. , 1999, Clermont et al. , 2001, Johnson et al., 2001). The 
ECOR isolates have come from a variety of hosts and geographical locations, and 
continue to be used to study the variation and genetic structure of E. coli. They 
include strains isolated from healthy individuals as well as from patients suffering 
from urinary tract infections (UTI). The selection of strains for the collection was on 
the basis of three criteria: I) previously used in published studies; II) representative of 
the genotypic diversity based on their multi locus enzyme electrophoresis (MLEE) 
profiles (Herzer et al, 1990); III) isolated from a wide variety of host species and 
geographical locations. On the basis of their MLEE profiles the ECOR collection was 
separated into four phylogenetic groups: A, Bl, B2 and D. These four groups are 
considered to be a representative sample of the natural E. coli population, although 
slight changes in the normal population might have occurred due to clonal drift and 
antimicrobial pressure.
1.1.2 Detection and identification of E. coli
Selective bacterial growth and detection in cell culture
The identification and characterisation tools used for the investigation of E. coli 
isolates can be divided into three categories. Firstly those for detection; secondly 
those for confirmation of identity; and thirdly those for typing. E. coli is usually 
isolated and identified in stool, urine, blood or environmental samples. Detection and
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isolation is the first step towards the identification of any bacterium. For example, the 
presence of bacteria can be revealed by microscopic analysis of a sample. E. coli can 
be isolated easily by growth on selective media at 37°C under aerobic conditions. 
Different agar plates can be used for the selective growth of Enterobacteriuceae. An 
indication of the species is determined by the colour and/or appearance of the 
colonies on a given medium. For example, UTI isolates can be screened on cystine 
lactose electrolyte-deficient (CLED) agar ( Sandys, 1960, Mackey and Sandys, 1966, 
Fallon et al., 2002). Other widely used selective media are MacConkey or methylene- 
blue agar on which they appear as pink and colonies with a green metallic sheen 
respectively.
E. coli pathotypes are strains causing a similar disease pattern in a host. Some of 
these pathotypes can be distinguished by the behaviour of the isolates in cell tissue 
culture, as is described for enteroaggregative E. coli (EAggEC) and 
enterohaemorragic E. coli (EHEC) strains (Konowalchuk et al, 1977, Caprioli et al., 
1983, Nataro et al., 1992). Molecular methods are usually preferred to cell culture 
studies, but they are not always decisive.
Biochemical identification tests
Simple tests for biochemical characteristics, such as the carbohydrate source and 
oxygen use or staining methods are usually sufficient for the confirmation of the 
identity of Enterobacteriaceae. Clinical laboratories often perform these biochemical 
tests using the analytical profile index (API) test manufactured by Biomerieux. The 
API is based on a series of biochemical tests carried out in a strip containing 
dehydrated substrates that initiate an enzymic colour reaction when inoculated with a
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diluted bacterial suspension (Penna et ai, 2002). Each individual test can be assigned 
a positive or negative result on the basis of the colour that develops. The results are 
then separated into groups of three, and the positive reactions give a score. The sum 
of the positive test scores gives a seven digit code which is unique to the subspecies 
level. Final identification is made by entering the data into API software.
Serological identification tests
Normally the biochemical characteristics described above are sufficient to identify the 
species, but strains of E. coli can be subdivided into many serotypes. These serotypes 
are based on surface antigens. In 1947, Kauffmann (1947) designed a scheme based 
on these antigens for the classification of Enterobucteriaceae, making detailed 
serotyping possible for the first time. The scheme was based on the O, H and K 
surface antigens. O antigens or somatic antigens relate to the lipopolysaccharide, H 
antigens are located on the flagella and K antigens correspond with antigenic 
determinants of capsular polysaccharides (see Figure 1.1). These antigens are all 
encoded by chromosomal genes and easily detected using agglutination tests 
(Kauffmann, 1947).
I. Introduction
IPS (O antigen) 
& capsule 
(K-antigen) Flagella (H-antigen)
Figure 1.1 E. coli surface antigens.
Serotyping antigens are detected on the cell wall (O-antigen & K-antigen) or on the flagella (H-antigen). 
Picture courtesy of Dr. Henrik Chart, Laboratory of Enteric Pathogens, HPA.
Many different variants of these antigens are found, and they occur in numerous 
combinations (Kauffmann, 1947, Orskov et al., 1977, Gross and Rowe, 1985). Over 
200 different O antigens, 50 H antigens and 90 K antigens have been described 
(Gross and Rowe, 1985). The O and H combination of antigens defines the serotype 
of the isolate, and the O antigen defines the serogroup. Not all possible combinations 
exist and the combination of O, H and K antigens can relate to E. coli pathotypes, 
which cause similar clinical symptoms (Orskov et al., 1977). Occasionally strains are 
found that cause different clinical symptoms depending on the site of infection. An 
example of that is seen in strains causing UTIs as well as septicaemia, as the latter 
may result as a secondary spread of the first specific infection (Sussman, 1 991 a).
The method of determination of these antigens has changed little since the first 
introduction by Kauffmann. Sera for O antigen determination are produced by the 
immunisation of rabbits, using heat-denatured cultures. A simple agglutination test is 
carried out to determine the O antigen of heated test cultures. The O antigens are
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thermostable, and the bacteria are heated to inactivate capsular antigens that might 
interfere with the agglutination reaction. In a similar way cultures are tested for K and 
H antigens; these are not heated before agglutination. K antigens are confirmed using 
a gel diffusion assay (Orskov et til., 1977, Gross and Rowe, 1985).
Molecular identification tests for differential diagnosis
Molecular tools, such as polymerase chain reaction (PCR), sequencing and DNA 
hybridisation, are nowadays widely used for species identification (Nataro et al., 
1992, Johnson, 2000, Holland et al., 2000). The targeted sequences are considered to 
be species-specific, and the size of the amplified product or the similarity at the 
sequence level determined by hybridisation or sequencing is used as an identifier. 
Ribotyping is also widely used as a molecular tool (Grimont and Grimont, 1986). The 
conserved 16S or 23S ribosomal DNA (rDNA) sequences can be used to identify 
strains accurately as the ribosomal genes are conserved within species but diverge 
between species. Conventional ribotyping is done by the hybridisation of 16S and 
23S rDNA probes to isolated genomic DNA. Recently a new application of rDNA for 
identification was described by Anthony and colleagues (2000). Amplified 23 S rDNA 
genes from the isolates were labelled and hybridised to an array of 23S rDNA targets. 
Species and subspecies identification took place on the basis of hybridisation signals 
to the arrayed targets. Alternative methods of ribotyping involve sequencing of the 
ribosomal genes after amplification with universal 16S or 23 S rDNA primers 
(Drancourte/a/.,2000).
Many variations on standard PCR amplification with gene specific primers in 
conserved chromosomal regions are used for the molecular identification of micro-
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organisms (Bou et ai, 2000, Hopkins and Hilton, 2001, Jinneman et al., 2003). 
Specific genes are targeted for the identification of the bacterial pathotype (Hopkins 
and Hilton, 2001, Jinneman et al., 2003). The problem with this approach is that some 
pathogenicity markers can be horizontally transferred and could occur in more than 
one pathotype. The detection of a gene would therefore not always lead to the correct 
identification of the pathotype. Increased specificity can be obtained by using two 
rounds of amplification (i.e. nested PCR). In nested PCR, a second set of primers for 
a second amplification are located within the sequence of the first round product. The 
products of the second round are then synthesised in high yield and primary products 
lacking the secondary primer annealing sites are excluded.
Molecular identification test for typing
PCR is used in molecular fingerprinting techniques that combine PCR with restriction 
enzyme digestion, sequencing and hybridisation (Smith et al., 2000). These 
techniques are used both for the differential analysis of isolates and for 
epidemiological purposes. Some methods make use of the whole of the genome while 
other methods make use of a small region of the genome. Examples of such methods 
are pulse field gel electrophoresis (PFGE; Gordillo et al., 1992, Noller et al., 2003) 
and amplified fragment length polymorphism (AFLP, Arnold et al., 1999, Velappan 
et al., 2001) for whole genome sampling. In both MLEE (Ochman and Selander, 
1984, Herzer et al., 1990) and multi locus sequence typing (MLST; Adiri et al., 2003, 
Noller et al., 2003) only certain regions of the genome are investigated. In general 
whole genome methods are used for a more detailed investigation into isolates while 
methods using regions of the genome only reveal specific allelic differences.
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For example, in PFGE the whole genome DNA of an isolate is extracted and digested 
with restriction enzymes which cut DNA infrequently. The resulting large DNA 
fragments are separated by agarose gel electrophoresis, giving characteristic patterns. 
The advantage of such methods is that the whole genome is used for testing. Gordillo 
and colleagues (1992) used this method successfully to distinguish between 
enteroinvasive E. coli (EIEC) strains from an outbreak in Houston, USA. The 
outbreak strains were compared to strains of a similar serogroup (O143) and to non- 
EEC strains. All EIEC outbreak strains had a similar restriction fragment length 
polymorphism pattern, and also showed a strong similarity to isolates previously 
associated with EIEC outbreaks. Non-EIEC strains causing diarrhoea and strains with 
the 0143 serogroup that were not causing disease had very different electrophoresis 
patterns. This demonstrates that PFGE is not only useful to identify small differences 
between genomes, but also has the potential to be used on a larger epidemiological 
scale.
A second very precise method for discrimination between genomes on the basis of 
small differences that does not depend on sequencing of large tracts of the genome is 
AFLP (Velappan et ai, 2001). This technology is based on selective amplification of 
restriction enzyme fragments from a digest of genomic DNA. To achieve this, 
genomic DNA is usually digested with enzymes that cut frequently and occasionally 
to obtain suitable sized fragments that can be resolved on a polyacrylamide gel. These 
fragments are amplified using universal primers based on adaptor sequences ligated 
to the ends of the restriction enzyme fragments. With fluorescently labelled primers, 
automated DNA sequencers and laser detection instrumentation can be used for the 
detection of the amplified fragments (Arnold et al, 1999). AFLP has the advantage
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that the whole genome is used and it is also a rapid method with a high throughput 
capacity. AFLP, whether performed with or without fluorescent primers, has been 
used successfully for typing isolates, especially in outbreak situations (Desai et al., 
1998, Arnold et al., 1999, Smith et al., 2000).
MLEE uses the relative electrophoretic mobility of intracellular enzymes to 
characterize and differentiate organisms by generating an electromorph profile. The 
MLEE profiles of all 72 isolates in the ECOR collection were initially prepared using 
11 enzyme loci (Ochman and Selander, 1984). In time, this work was extended to 
include a total of 38 enzyme loci that were included in a cluster analysis, allowing the 
isolates to be placed into groups with identical phenotypic characteristics, which were 
called phenetic groups A, Bl, B2, D (Herzer et al., 1990). This method only samples 
limited loci in the genome and is therefore, like MLST, unsuitable for fine 
discrimination in outbreak investigations. Differences between conserved genes 
appear infrequently in closely related isolates. MLEE and MLST are therefore more 
applicable to understanding the genetics of bacterial populations as a whole (Maiden 
etal., 1998).
MLST has also been used to characterise the ECOR collection. MLST is similar to 
MLEE in that several loci are compared, and in this case housekeeping genes are 
amplified and sequenced (Adiri et al., 2003). For the E. coli MLST identification 
database these genes are: adenylate kinase, fumarate hydratase, DNA gyrase, 
isocitrate/isopropylamate dehydrogenase, malate dehydrogenase, shikimate 
dehydrogenase, adenylosuccinate dehydrogenase and the ATP/GTP binding motif 
(Chan and Aanensen, 2003). A second MLST scheme for pathogenic E. coli strains
__
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has been developed that uses several different housekeeping genes (Whittam, 2004). 
The sequences are then compared to database sequences, and are assigned an 
identification number to each of the loci, based on their nucleotide sequences. The 
identification numbers of all seven loci together form a unique code at the species and 
subspecies level. The limitation of this method is that, like MLEE, only a few loci 
(seven for MLST) are analysed and the epidemiological applications are therefore 
limited. The advantage of MLST over MLEE is that the method does not rely upon 
electrophoretic profiles, but is sequence based, therefore allowing easier comparison 
between different laboratories.
1.1.3 Pathogenic E. coli
E. coli is present in the host intestines as a harmless commensal bacterium. However, 
there are also pathogenic variants i.e. strains that can cause diseases of man or 
animals. These include UTIs, diarrhoea, septicaemia and more severe disorders such 
as haemorrhagic colitis (HC) or haemolytic-uraemic syndrome (HUS). E. coli has 
been associated with gastrointestinal diseases since Escherich first started to 
investigate the gut flora. The infectious intestinal disease (IID) study in England was 
initiated in 1992 (Tompkins et al., 1999). This study indicated that 32.5% of disease 
cases were associated with E. coli, versus 11.9% in the control group (relative 
proportion [case/control] = 2.7). EAggEC was the most common pathotype isolated. 
Besides being responsible for many gastrointestinal infections, E. coli is also the most 
common organism isolated from hospital and community acquired UTIs, and is 
isolated in up to 90% of all cases (Farrell et al., 2003).
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Outbreaks of pathogenic E. coli in which large groups of the population are infected 
with the same E. coli serogroup are often caused by the consumption of contaminated 
foods or by direct or indirect contact with an infected host (O'Brien et al., 2001, 
Brooks et al., 2004). E. coli related infections are being reported with increasing 
frequency. Bacteremia infections caused by E. coli were detected 13,412 times in 
2002 compared to only 7,880 times in 1992 by laboratories in England and Wales 
(Health Protection Agency, 2003a). Also EHEC infections continue to be a concern 
for public health. The Communicable Diseases Surveillance Centre (CDSC) of the 
Health Protection Agency (HPA) reports 595 laboratory confirmed cases of EHEC 
O157:H7 in 2002, but in 1997 and 1999 there were more than a 1,000 cases (Health 
Protection Agency, 2003b).
Pathogenic E. coli have been grouped into six different pathotypes: enteropathogenic 
E. coli (EPEC), enterotoxigenic E. coli (ETEC), EIEC, EAggEC, EHEC and 
extraintestinal pathogenic E. coli (ExPEC). They are distinguished on the basis of 
their mode of pathogenesis. Together they are responsible for a wide variety of 
diseases, including severe and persistent diarrhoea, UTIs and neonatal meningitis. It 
is understood that commensal bacteria may become pathogenic through the 
acquisition of pathogenic characteristics by horizontal gene transfer thereby enabling 
them to cause disease. The acquired genes include those involved in the production of 
adhesins, invasins, flagella, toxins, cell surface molecules, secretins or secretion 
systems.
13
1. Introduction
Enteropathogenic E. coll
The term EPEC was first used to describe a pathotype of E. coli associated with 
epidemic diarrhoea in newborn and young infants (Kauffmann and Dupont, 1950, 
Neter et al., 1955). EPEC are non-invasive pathogens that frequently cause diarrhoea, 
fever and vomiting, often in children under two years old. Individuals at either end of 
the age spectrum are most susceptible to infections, but others may be affected during 
outbreaks (Neter, 1960). Infections are especially common in children and infants in 
the developing world (Trabulsi et al., 2002). The serotyping scheme of Kaufmann 
made it possible to identify links between serogroup and pathotype. Only a limited 
number of serotypes are regularly associated with diarrhoeagenic diseases. In 1997, 
seventeen serogroups were found to be responsible for most of the EPEC outbreaks in 
humans of which 018, O20, O26, O44, O55, Ol 11 and O158 were most frequently 
isolated from infections (Sussman, 1997a). Additional information about 
pathogenicity markers is sometimes required to confirm the pathotype of strains in 
different serogroups.
Multiple pathogenicity factors have been identified in EPEC strains including 
fimbriae, pili and toxins. These are encoded on both chromosomal and plasmid DNA. 
The pathogenic mechanism of EPEC is known as "attaching and effacing". The genes 
responsible for this mechanism are all located on a relatively small region of the 
chromosome known as a pathogenicity island. This island is called the LEE-island, 
which is the abbreviation of the locus of enterocyte effacement. It was McDaniel and 
colleagues (1995) who first discovered that a cloned LEE-island caused 'attaching 
and effacing' in E. coli K12 strains. The LEE is made up of five operons (LEE 1-5) 
involving over 40 genes including genes needed to produce a type III secretion
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system (TTSS). This is an organelle that can transfer bacterial proteins into the host 
cell. Each operon promotor site is activated by a protein known as Ler, resulting in a 
transcription of DNA into mRNA. The structural proteins assemble the basal 
apparatus of the TTSS. Outside the cell the bacteria may use fimbriae to attach to the 
microvilli of gut epithelial cells, causing a signal transduction for the transcription of 
the secretion proteins on LEE4 (EspA/EspD/EspB). EspA polymerises to form a long 
hollow filament through which other proteins can be translocated. EspD and B form a 
pore in the membrane of the host cell through which the bacterial proteins can be 
transported. The translocated intimin receptor protein is phosphorylated and inserted 
into the eukaryotic host cell membrane where it binds intimately to the intimin 
protein in the bacterial outer membrane. The intimate association of the bacterial and 
eukaryotic host cells causes the the re-arrangment of the host cell cytoskeleton and 
the destruction of microvilli. The bacterium becomes partly embedded in the host cell 
membrane, but does not invade the host cell (Ulshen and Rollo, 1980, Rothbaum et 
al., 1982). This process is shown in Figure 1.2.
Typical EPEC strains carry a plasmid of 60MDa called the EPEC adherence factor 
(EAF) plasmid (Nataro et al, 1987b). The initial adherence is mediated by genes 
encoded on this plasmid, and the loss of it has direct implications for the adherence 
and pathogenic characteristics of the isolate. Strains that have lost this plasmid are 
called "atypical" EPEC (Levine et al., 1985). Two loci on this plasmid have been 
identified as important pathogenicity markers: the bfp gene cluster and the per locus. 
The bfp gene cluster is involved in the production of bundle-forming pili. These pili 
are type IV fimbriae and form large bundles of adhesins of 50 - 500 nm able to bind 
other bacteria (Donnenberg et al., 1992). The bfpA gene encodes the subunit of these
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adhesins and is known as bundelin. The per locus encodes a transcriptional activator 
known as the plasmid-encoded regulator. It is essential for the production of bfp, but 
can also be involved in the activation of genes on the LEE-island (Mellies et al., 
1999).
B
Figure 1.2 Intimate adherence of E. coli O157:H7 on the host cell 
surface.
E. coli attaches to the microvilli in the host cell surface (A). This leads to a signal production 
inside the bacterial cell forming a TTSS (B). (C) Host cytoskeletal changes as a result of 
secreted proteins cause intimate adherance of the bacterial cell and form a typical attaching 
and effacing lesion. Illustration based on Quantrell ef a/., 2004.
In 1988 Johnson and Lior described a new heat-labile toxin that was detected in 
EPEC: the cytolethal distending toxin (CLDT; Johnson and Lior, 1988). The mode of 
action has not been defined fully, but the toxin has been detected in patients with 
acute diarrhoea (Pandey et al., 2003). These isolates show very diverse genetic 
profiles when analysed using PFGE.
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Enteroinvasive E, coli
The EIEC are very closely related to Shigella, not only in their pathogenic 
mechanism, but also in the manifestation of mucous and bloody diarrhoea in the host 
coupled with severe inflammation (O'Brien etai, 1982, Gilligan, 1999, Escobar- 
Paramo et al., 2003). EIEC were first distinguished from Shigellci spp. by DuPont et 
al. (1971) when investigating E. coli isolates from American soldiers in Vietnam. The 
guinea-pig eye model, also known as the Sereny test, together with cell and tissue 
culture tests, all showed the invasiveness of these E. coli strains. Shortly after this 
description the first known outbreak of E. coli related dysentery occurred, caused by 
serogroup O124 which is now recognised as EIEC (Tulloch et al., 1973). As well as 
O124, 14 other serogroups have been associated with EIEC including O28, Ol 12, 
O143 and 0152 (Sussman, 1997a).
EIEC are classified as E. coli on the basis of their ability to ferment xylose and to 
produce gas from glucose, but they also resemble Shigella in their non-motility and 
lack of lysine decarboxylase. Strains are often unable to ferment lactose (Silva et al., 
1980). Detection of EIEC using biochemical or serological methods is therefore 
difficult, but specific EIEC DNA probes against plasmid encoded genes have proven 
to be a good approach (Sethabutr et al., 1985).
The pathogenicity markers associated with EIEC, located on an important plasmid, 
are genes encoding for invasion plasmid antigens. These antigens help the bacteria to 
penetrate and multiply within the epithelial cells of the colon, leading to widespread 
cell destruction (Kirn et al., 1998). Without the plasmid, EIEC is unable to invade the
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host cells, but other pathogenicity markers on the bacterial genome may be present 
(Sansonettie/tf/., 1982, 1983).
Enterotoxigenic E. coli
The ETEC are an important cause of diarrhoea in infants and travellers to developing 
countries or to regions of poor sanitation (Jiang etal., 2002). The clinical symptoms 
caused by this non-invasive pathogen vary from physical discomfort to cholera-like 
symptoms, occasionally with fever (Gorbachev a/., 1971, Brunton et al., 1980). The 
effects of ETEC in humans were first described by Taylor and colleagues (1960) and 
were seen in children with diarrhoea. The ETEC toxins cause fluid secretion in 
ligated rabit intestinal loops. Smith et al. (1967) revisited and named the dilating 
substance involved enterotoxin. It was not until a few years later that two separate 
classes of toxins were identified (Sack et al., 1971). ETEC are defined by the 
production of at least one type of enterotoxins. Serogroups associated with ETEC 
include O6, O8, O20, O78, O128, O148.
The enterotoxins are separated into the two classes of heat-labile toxin (LT) and heat- 
stable toxin (ST) (Smith and Gyles, 1970). The LT encoding genes are located on 
plasmids and resemble the toxin isolated from V. cholerae. They are easily 
inactivated by heating to 100°C (Clements et al., 1980). The LT protein contains one 
subunit A of 27kDa and five subunits B of 1 IkDa. The B subunit binds to the gut 
mucosa and after binding the A subunit splits into two parts (Clements and 
Finkelstein, 1979, Clements et al., 1980). Part of subunit A initiates the ADP- 
ribosylation of NAD resulting in increased levels of cAMP. Increased cAMP levels 
result in a net overflow of sodium ions, and a loss of chloride ions and water into the
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gut (Kantor et al., 1974, Chart, 1998). Hence the main clinical symptom of ETEC 
infections is watery diarrhoea.
Two main antigenic variants of this toxin have been identified (Clements and 
Finkelstein, 1979, Holmgren etal., 1982). The sequence encoding the LT-I protein is 
on a plasmid and the protein is neutralised by antibodies raised against the closely 
related cholera toxin. The LT-I I protein is encoded on the chromosome and is 
antigenically distinct from cholera toxin as well as from LT-I (Pickett et al., 1987). 
LT detection was classically performed using the rabbit ligated loop model, and later 
using tissue culture methods (Honda et al., 1981b, 1982, Holmgren et al., 1982). 
Immunological procedures that are easier to implement in the laboratory are the 
Biken test, ELISA and latex agglutination tests. In the Biken test LT producing ETEC 
strains and anti-cholera-toxin or anti-LT sera are placed in separate wells in an agar 
plate. LT positive strains will form a precipitin line in the agar between the wells after 
incubation (Honda et al., 1981 a).
The second class of ETEC enterotoxin genes (ST) encode a low-molecular weight 
secreted protein (2-5kDa) that alters the movement of fluid and electrolytes across the 
intestinal epithelium (Su and Brandt, 1995, Sussman, 1997b). The ST genes are 
encoded on plasm ids. Unlike the LT protein complex, ST does not have different 
subunits, and it is not inactivated by heat. This class of enterotoxins is also divided 
into two subgroups on the basis of structure and function (Burgess et al., 1978). ST-I 
binds to the extracellular domain of guanylate cyclase C, resulting in increased 
intracellular cGMP concentrations, and leading to fluid accumulation in the gut. ST-I I 
has mainly been isolated from pigs, and the mechanism by which it operates is not
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clearly defined. It has been suggested that by binding to the appropriate receptors, 
ST-II leads to the activation of a GTP-binding regulatory protein resulting in 
increased levels of free cytosolic calcium (Okamoto and Yamanaka, 2000). 
Traditionally, ST-I detection was performed by injecting bacterial culture 
supernatants into the stomach of an infant mouse. The weight ratio of intestines to 
mouse carcass, four hours after injection, was used to determine ST-I expression 
(Giannella, 1976). ST-II detection tests using intestinal loops have also been 
developed (Burgess et al., 1978). Currently detection of ETEC (both LT and ST) is 
determined with PCR and molecular probe hybridisation (Moseley et al., 1980, 
Yavzori ?/«/., 1998).
ETEC are also identified by the presence of certain fimbriae called "colonisation 
factor antigens" that are essential for adherence to the host cell. They are filamentous 
structures of between two and seven nm diameter and are composed of one or more 
repeated protein subunit (Dougan and Morrissey, 1985, Gaastra and Svennerholm, 
1996).
Enteroaggregative E. coli
The EAggEC constitute a non-invasive pathotype, and are associated with acute and 
persistent diarrhoea in patients living in both developing and developed countries 
(Bhan et al., 1989, Nataro et al, 1992). The IE) study in England showed that 
EAggEC was the most common isolated pathogenic E. coli group from patients with 
diarrhoea (Tompkins, 1995, Tompkins et al., 1999). The first indication of this 
pathotype was described when certain pathogenic E. coli were found to adhere to 
HEp-2 cells, but did not express known adherence factors (Cravioto et al., 1979).
20
1. Introduction
Other reports soon confirmed this adherence of E. coli to HEp-2 cells, and different 
types of adherence were distinguished: localised, diffuse and aggregative (Scaletsky 
et al., 1984, Nataro et al., 1987a). The diffuse and aggregative adherence types were 
found in strains that did not carry adhesion factors previously identified in EPEC or 
ETEC isolates. EAggEC were named after the pattern of their adherence to HEp-2 
cells, which was in an aggregative "stack-brick" pattern. However, this defines a 
heterogeneous group, and EAggEC have since been divided in two groups, typical 
and atypical (Scaletsky et al., 2002, Zhou et al., 2002).
The typical EAggEC are characterised by the presence of a number of genes whose 
role in pathogenicity is well-defined. EAggEC fimbrial proteins are encoded on a 
60MDa plasmid and can form fimbriae that can extend over a long distance (lOfim) 
(Nataro et al., 1992, Czeczulin et al., 1997, Bernier et al., 2002). Other genes 
encoded on the plasmid are aggR, a transcriptional regulator important for the 
transcription of the fimbrial genes, the aap gene that encodes a protein called 
dispersin, which facilitates the dispersal of EAggEC across the surface of the gut, and 
the aat gene, necessary for the transport of dispersin. Typical EAggEC also produce 
the heat-stable toxin EAST, a homologue of the ETEC ST.
Although typical EAggEC can be detected by cell culture, or by the molecular 
detection of their fimbrial genes using either PCR or DN A-hybridisation, the atypical 
EAggEC are more difficult to define. They do not always adhere the HEp-2 cells in a 
stack-brick formation and the fimbrial genes may not be present. Other characteristic 
pathogenicity markers for this pathotype have not yet been defined, making detection 
and diagnosis difficult (personal communication Dr. C. Jenkins, HPA). Further
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investigation of putative pathogenicity factors will become easier after the completion 
of the current EAggEC genome sequencing project (Chaudhuri and Fallen, 2004). 
The prototype strain used for this project is 042 (serotype O44:H18).
Enterohemorrhagic E. coll
The EHEC is the most recently defined pathotype of E. coli. In 1983, a then rare 
verocytotoxin (VT) producing serotype (O157:H7) was isolated from patients with an 
unusual gastrointestinal disease in Oregon and Michigan, USA. All cases were linked 
to the ingestion of inadequately cooked meat products from fast-food restaurants. The 
symptoms of disease were severe abdominal pain, watery diarrhoea developing into 
haemorrhagic colitis, and little or no fever (Riley et ai, 1983). Since then this EHEC 
serotype has been associated with other outbreaks of severe gastrointestinal disease, 
haemorrhagic colitis, and even the life threatening kidney disorder haemolytic 
uraemic syndrome (Ryan et al., 1986). The resulting disease is characterised by 
haemolytic anaemia, thrombocytopenia, renal failure and central-nervous-system 
manifestations (Riley, 1987). Two isolates from this serotype have been sequenced 
(Hayashi et al., 2001, Pemaetal., 2001)
EHEC are distinguished from EPEC by the production of VT (O'Brien et ai, 1982, 
Levine et a/., 1987). They also carry the LEE region, as described for EPEC strains 
for attachment to host tissues. The first indication of E. coli strains producing a VT 
came from Konowalchuk and colleagues (1977) who reported that certain strains of 
E. coli produced a heat-labile toxin different from the LT detected in ETEC strains 
that was cytotoxic for Vero cells. It is also known as shiga-like toxin (SLT) due to 
structural similarity with this toxin. Antibodies against the known ETEC LT did not
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neutralise the cytotoxic activity. The isolates that produce SLT are mostly associated 
with diarrhoea and belonged to a variety of serogroups. Serogroups most commonly 
associated with EHEC are O26, O55, Ol 11, O103, O128 and O157. Understandably, 
there is a similarity between these compared to the EPEC strains. It is the production 
of SLT that defines these isolates as EHEC, and therefore separation of EPEC and 
EHEC isolates cannot be based on the serogroup alone.
The EHEC SLT are members of a large family of subunit toxins that share a common 
mode of action: they inhibit protein synthesis in the host cells by the removal of an 
adenine residue from the 28S ribosomal subunit, and they function as an enterotoxin 
leading to the induction of fluid secretion, which may eventually lead to death (Endo 
et al., 1988). The toxins have a structure similar to the ETEC LT. They are composed 
of one A subunit of 32 kDa and five B subunits of 7.7 kDa. The B subunit binds to a 
glycolipid receptor on the surface of eukaryotic cells and subsequently part of the A 
subunit binds to the 28S ribosomal subunit (Endo et al., 1988).
Other pathogenicity markers like intimin, enterohemolysin and secreted serine 
proteases, may also be present (Welinder-Olsson et al., 2002). These pathogenicity 
markers also occur in other non-O157 VT producing EHEC (O'Brien etal., 1982, 
Khan et al., 2002).
Extraintestinal pathogenic E. coli
Several non-intestinal diseases are caused by a group of E. coli defined as the ExPEC 
(Johnson and Russo, 2002). There are two main types of illness mediated by ExPEC 
strains: UTI and neonatal meningitis. Although these infections are of great medical
23
/. Introduction
importance, they only occasionally occur in outbreak situations, and have therefore 
not captured public attention like the intestinal strains. ExPEC strains often carry 
multiple antibiotic resistance determinants, complicating treatment (Phillips et al., 
1988). Most ExPEC can be classified into two of the four phylogenetic E. coli groups 
(B2 and D) as described in section 1.1.1 and have been identified with specific 
pathogenicity markers (Clermont et al., 2001, Johnson et al., 2002, 2003). ExPEC are 
one of the principle causes of morbidity and mortality arising from community- and 
hospital-acquired extraintestinal infections in human, of which UTI is most 
commonly observed (Donnenberg and Welch, 1996).
Uropathogenic E. coli
Uropathogenic E. coli (UPEC) are responsible for almost 80% of all UTIs occurring 
in women and the elderly (Farrell et al., 2003). Infections may be asymptomatic, but 
can develop into cystitis or pyelonephritis. Both of these conditions need immediate 
medical attention. Symptoms of cystitis include dysuria, urinary urgency and 
frequency. A more serious UTI results in pyelonephritis caused by organisms 
ascending to the kidneys. Patients suffer fever, flank pain, bacteriuria, abdominal or 
groin pain and vomiting. Infections can spread beyond the urinary tract and enter the 
bloodstream. UTI can lead to the development of bacteremia as a secondary disease 
because of bacteria entering the bloodstream.
The pathogenicity markers found in UPEC strains include a number of different 
fimbriae, among which the P fimbriae was the first to be identified with an important 
role in cell attachment (Svanborg Eden and Hansson, 1978, Hagberg et al., 1981). A 
further understanding of P fimbriae biogenesis and action arrived when Hull and
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colleagues (1981) cloned the genes encoding it. Cells expressing the cloned P fimbria 
showed acquired adherence properties in haemagglutination tests. Other fimbriae 
include F1C, S and Dr and type 1 fimbriae (Johnson and Stell, 2000). Certain 
serogroups like Ol, O2, O4, O6, O7, O18 and O75 have been strongly associated 
with UT1 as have capsule antigens such as Kl and K5 (Mabeck et al., 1971, Glode et 
al., 1977, Kaijsere/a/., 1977, Kaijser and Jodal, 1984, Petit et al., 1995).
Neonatal meningitis E. coli strains
E. coli are responsible for 40% of neonatal meningitis cases, often those that are life 
threatening. Isolates usually carry the Kl antigen as a pathogenicity marker (Glode et 
al., 1977). Serogroups associated with meningitis include Ol, O6, O7 and O18. A 
study carried out in Japan indicates that ExPEC isolates containing this Kl antigen 
are present at a high prevalence in pregnant women (Obata-Yasuoka et al., 2002). It 
was concluded that isolates causing neonatal meningitis could be transmitted during 
natural childbirth.
Nosocomial infections
Enterobacteriaceae, predominantly E. coli, Klehsiella and Enterobacter spp., cause 
over a third of infections acquired during hospitalisation. Infection can be acquired 
during or after operations through the use of medical equipment and through wound 
infections (Vincent et al., 1995). Immunocompromised patients are particularly 
susceptible to infection. Many isolates carry antimicrobial resistance genes on 
chromosomal or plasmid DNA, conferring resistance to one or more antimicrobials 
(Vincent et al., 1995). Multiple resistance, i.e. resistance against four or more 
antimicrobials, can cause severe problems in patient treatment (Livermore et al.,
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2000). The patient may suffer if ineffective antibiotic treatment is given, but on the 
other hand, antibiotic resistance may be encouraged if unnecessary antibiotics are 
used. Consequently, it is helpful to detect the pathogen and its antimicrobial 
resistance profile at an early stage.
1.1.4 E. coli whole genome sequences
The comparison of clinical isolates at the nucleotide level is the most comprehensive 
method for phylogenetic and evolutionary investigations of E. coli. Even with current 
technology, the sequencing of the genome for every isolate is too expensive and 
labour intensive to be realistic. As of early 2005, five complete E. coli genomes have 
been sequenced. These include two E. coli K12 strains (MG1655, W3110), two 
O157:H7 EHEC strains (EDL933 and R1MD 0509952) and the UPEC strain CFT073 
(serotype O6:H 1) (Blattner et al., 1997, Hayashi et al. , 2001, Perna et al. , 2001, 
Welch et al., 2002). Other strains that are in the process of being sequenced are the 
prototype EAggEC strain 042 (serotype O44:H18), an EPEC strain E2348/69 
(serotype 127:H6) and E. coli strain DH10B (Chaudhuri and Fallen, 2004).
The few whole genomes from different pathotypes that have been sequenced to date 
have revealed very useful comparative data, which have led to some interesting 
discoveries. For example, 1,387 novel genes were found in E. coli O157 compared to 
E. coli K12. These are expected to represent functions that E. coliOlSl has acquired. 
It is likely that they will include pathogenicity markers which will be target genes for 
the investigation of pathogenicity in general, and also for studying host-pathogen 
interactions and infection mechanisms (Hayashi et al., 2001).
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A three way comparison of the genomes of E. coli strains MG1655 (K.12), EDL933 
(EHEC) and CFT073 (UPEC) revealed that they only have 39.2% of their predicted 
protein ORFs in common (Welch etal., 2002). This 39.2% may represent an ancestral 
backbone sequence passed on in bacterial duplication. Genes that are only present in 
one or two of the strains may have been either acquired by horizontal gene transfer or 
deleted from a common ancestor. Such genes could have been acquired from closely 
related species in the different ecological niches the strains occupy (Lawrence and 
Ochman, 1998). It is unlikely that all these changes have been obtained through 
horizontal transfer, or the mutation of existing genes. A very high mutation rate 
would have been required in order to generate the level of diversity seen between 
these strains. LeClerc and colleagues discovered defective genes in O157:H7 
involved in repairing DNA mismatches (LeClerc et al., 1996). Defects in these 
mechanisms are also present in non-pathogenic strains and therefore unlikely to be 
the only cause of this genetic diversity. Eisen (2001) has suggested that it is possible 
that genes that are not present in all strains originated in a common ancestor and have 
been deleted over time.
1.2 E. coli pathogenicity
Virulence is defined as "the degree of pathogenicity (capability of causing disease) of 
a micro-organism" (Micropaedia, 1974). Harmless micro-organisms can acquire 
pathogenicity factors through horizontal gene transfer. The acquired sequences 
include toxin, adhesin, capsule and iron acquisition genes (Sussman, I997b). Gene 
acquisition in E. coli occurs by horizontal transfer of DNA through transformation,
conjugation or transduction (Roy, 1999). Transformation of the bacterial cell involves
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naked DNA from the surroundings being taken up into the bacterial cell through the 
cell wall. Chromosomal or plasmid DNA can also be exchanged via pili, in a process 
known as conjugation. Finally, DNA can be transferred through vectors such as 
bacteriophages. All acquired DNA can be integrated into the genome of the infected 
host and replicated through the host's own replication system.
1.2.1 Pathogenicity markers
Pathogenicity markers can be separated into different classes depending on their 
involvement in pathogenesis. Genes that are involved in the attachment of the 
bacterial cell are called adhesins. Pathogenic E. coli can produce several types of 
adhesin genes associated with pathogenesis including fimbriae. Fimbriae are hair-like 
structures of around seven nm and are characterised by their ability to bind to 
surfaces through, for example, D-mannose-containing residues. Fimbriae play an 
important role in pathogenesis by attaching to the host cell and are also involved in 
the evasion of attacking phagocytotic white blood cells (Mattick, 2002). A single E. 
coli isolate can express multiple fimbrial types. Their main function is adherence to 
the host cell and they are generally not involved in movement of the cell. The 
exception to this rule is type IV fimbriae that can twitch slightly and, therefore might 
have a role in the movement of the cell (Mattick, 2002). Type IV fimbriae include 
bundle forming pili produced by EPEC and the longus type IV pilus and colonisation 
factor antigens produced by ETEC (Donnenberg et ai, 1992, Gomez-Duarte et at., 
1999).
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The words fimbriae and pili are now used interchangeably, but pilus was originally 
reserved for specialised adhesins that were involved in DNA transfer in bacterial 
conjugation, also known as the F-factor or sex pilus. Pili are differentiated from 
fimbriae by the formation of a helical tube-like structure and, therefore, typically have 
a slightly wider diameter. Their ability to conjugate may well play a role in the 
assembly of pathogenic markers. The fimbriae of ETEC are called colonisation factor 
antigens as they assist the colonisation process in the host gut or urinary tract, and are 
therefore strongly associated with pathogenesis (Gaastra and Svennerholm, 1996).
Fimbriae are grouped into different types: I-VII. Type I fimbriae are present on many 
bacteria, whilst other fimbriae are associated with specific pathotypes or serogroups 
of E. co//, while others are host related and only appear on strains from a common 
source (Klemm, 1984, Boylan et al., 1988, Nataro et al., 1992, Frydendahl et al, 
2001, Johnson et al., 2002). Colonisation factor antigens are present in ETEC strains 
(Taniguchi etal., 1995). P and S fimbriae are pathogenicity markers that are 
frequently associated with UPEC (Johnson and Stell, 2000, Oelschlaeger et al., 
2002b). EAggEC has specific adherence fimbriae that are involved in the formation 
of the stack-brick adhesion pattern to host cells (Bernier et al., 2002, Elias et al., 
2002). Examples of origin specific fimbriae are K88 in porcine hosts, CS31A in 
bovine hosts and Pap in human hosts.
Another large group of pathogenicity markers codes for bacterial toxins and their 
secretion systems. The toxins are composed of secreted proteins that damage host 
cells through a variety of mechanisms: they can damage surrounding tissue, lyse the 
host cell, block protein synthesis, or interfere with host cell functions. Various toxins
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have been identified in E. coli (AbeetaL, 1990, Bebora, 1997, Call et al., 2001). The 
enterotoxins in ETEC and the SLT in EHEC are the most well known and have been 
described in section 1.1.3.
Other toxins have been found in pathogenic E. coli strains. Haemolysins found in 
EHEC and EPEC strains are capable of destroying the host erythrocytes. It is 
speculated that iron released from the erythrocytes assists in bacterial survival. E. coli 
strains producing haemolysin were first described by Kayser (1903). An association 
between haemolysin producing strains and their pathogenic effects has been 
recognised especially in ExPEC (Welch et al., 1981). The most common haemolysin 
is cc-haemolysin. The importance of a-haemolysin in pathogenesis was shown by 
Welch and colleagues (1981) when a cloned haemolysin gene introduced in a non- 
pathogenic strain resulted in a pathogenic phenotype. The haemolysin toxin is a large 
1 lOkDa protein and its encoding sequences are positioned near other pathogenicity 
markers on the chromosome. Haemolysin is secreted via a type I secretion system and 
binds the host erythrocytes.
The cytotoxic necrotising factor (cnf-1) is commonly found in UPEC strains, but it 
was originally observed in strains isolated from children with enteritis, cnf-1 is 
recognised by its pathogenic ability to cause lesions in rabbits and morphological 
changes in in vitro cell culture (Caprioli et al., 1983). The 1 lOkDa CNF1 protein is 
encoded by a single gene on the chromosome. In ExPEC strains cnf-1 is linked to the 
presence of haemolysin and P-fimbriae that is located on the same pathogenicity 
island.
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EAggEC strains also produce a heat-stable toxin (EAST) which is different in size 
from previously defined heat-stable toxins, but which seems to have a similar mode 
of action (Savarino et al., 1993). It is predicted that EAST1 stimulates the production 
of guanylate cyclase through the same receptor-binding region as ST and guanylin 
leading to increased intracellular cGMP concentrations and fluid accumulation in the 
gut.
The third group of pathogenicity markers are capsules which protect bacteria from 
host defence mechanisms (Schembri et al., 2004). The capsules also help the bacterial 
cell to attach to the surface and support biofilm formation (Danese et al., 2000). 
Approximately 90 different capsule genes have been identified. They consist of acid 
polysaccharides made up from repeating oligosaccharide units. Capsule antigens can 
be classified using specific antisera as described by Kaufmann (1947), and may be 
observed by light microscopy after India ink staining as a "halo", or by 
immunoelectron microscopy. Two groups of capsule genes have been identified. 
Group I antigens are expressed at all temperatures, and group II are only expressed at 
temperatures higher than 25°C (Cieslewicz and Vimr, 1996). Only a few of the 
capsules in group II are frequently associated with pathogens, these include Kl and 
K5. Capsule Kl deactivates the complement system by binding to the components 
resulting in bacteria escaping phagocytosis. Kl is associated with the majority of 
isolates causing neonatal meningitis (Glode et al., 1977). Humans and animals seem 
unable to produce specific antibodies against capsular antigen K5 because of its 
structural identity with desulphoheparin; an intermediate in heparin biosynthesis. 
(Kaijser and Jodal, 1984, Kroncke et al., 1990, Finke et al., 1991). Group II capsules 
are often involved in UTI infections.
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1.2.2 Pathogenicity islands (PAIs) and plasmids
Pathogenicity markers are often located at specific sites in the chromosome (also 
known as pathogenicity islands (PAIs)), or on plasmids. PAIs are large DNA regions 
(10-200 kb) that carry pathogenicity markers and mobility genes. They are absent 
from non-pathogenic members of the same and closely related species. These regions 
are often enclosed by inverted repeats and are characterised by a difference in G+C 
content, an atypical codon usage and are also frequently associated with tRNA genes 
(Dozois and Curtiss, 1999). These characteristics suggest that the genes in this region 
are acquired through horizontal gene transfer, as their characteristics differ strongly 
from DNA on either side of the PAI. For example, as genes representing mobility 
factors such as integrases, transposases or parts of insertion elements are often 
encoded on the PAIs. PAIs have also been detected in Salmonella spp., Helicobacter 
and Yersinia spp. Hacker and colleagues have studied the prototype LJPEC strain 
(536), and have identified five pathogenicity islands (Oelschlaeger et al., 2002a, 
Oelschlaeger et al., 2002b, Hacker et al., 2003). Pathogenicity markers on these 
islands are: cc-haemolysin (PAI I & PAI II); P-fimbriae (PAI II); S-fimbriae (PAI III); 
genes with homology to the iron uptake systems as described for Yersinia species 
(PAI IV); and capsular polysaccharide (PAI V). Mutant strains lacking one or more 
pathogenicity island have a phenotype that not only lacks the function of the genes on 
that island, but also does not produce products encoded on the other islands. Thus the 
pathogenicity islands appear to have a regulatory apparatus for the global control of 
pathogenesis.
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Another pathogenicity island that is found in EPEC and EHEC strains is known as the 
LEE-island, which carries the genes encoding the adherence factor intimin (McDaniel 
et al., 1995). Other pathogenicity markers that have been found on pathogenicity 
islands are type III and type IV secretion systems, toxin genes and capsular 
polysaccharides (Kaper et al., 1997, Boydand Haiti, 1998, Bingen-Bidoise/a/., 
2002). One particular PAI is called the high pathogenicity island (HPI) which was 
originally found in Yersinia spp. and includes yersiniabactin genes; homologues have 
also been detected in many other enterobacterial species pathogenic to humans 
(Koczura and Kaznowski, 2003). HPI-positive strains are also found in non- 
pathogenic E. coli strains isolated from humans but not in environmental strains. 
Therefore, the contribution of the HPI to pathogenesis remains unclear, but it has 
been speculated that the HPI assists in the adaptation to human hosts.
In addition to these chromosomal regions, a number of plasmids that carry 
pathogenicity markers have been identified in pathogenic E. coli (Bebora, 1997). 
Plasmids are easily replicated and transferred, but are often unstable during cell 
division. Pathogenicity-associated genes might therefore be lost during replication. 
Genes identified on plasmids encode for toxins and adherence factors produced by 
ETEC, bundle-forming pili specific to EPEC and EHEC strains, and the heat-stable 
toxin produced by EAggEC (Savarino et al., 1993, Bebora, 1997, Kaper et al., 1997, 
Gomez-Duarte et al., 1999). Certain pathogenicity plasmids, especially those that 
encode an aerobactin-mediated iron uptake system may also contain antibiotic 
resistance genes, which can provide selective advantage (Johnson et al., 1988, 
Phillips et al., 1988). Although these plasmids are very important in pathogenicity, it 
seems unlikely that the acquisition of just one plasmid could cause a microbe to
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become a pathogen as many contributing factors, both chromosomal and 
environmental, are necessary for the expression of plasmid genes.
1.2.3 Pathogenicity marker expression
The expression of pathogenicity markers responds to environmental factors, as well 
as to other expressed pathogenicity markers and internal cell signals (Harel and 
Martin, 1999). Not all pathogenicity markers are produced constitutively as this may 
be disadvantageous; for example, an adhesin can assist the colonisation process in the 
gut, but is a disadvantage whilst the pathogen is being transported through the 
bloodstream to the site of infection.
Although the specific host signals are not yet clearly understood, environmental 
signals that influence pathogenicity marker regulation have been identified. For 
example pH, temperature and iron concentration all affect gene regulation of 
pathogenesis in vivo. The host digestive system is susceptible to large pH changes, 
and E. coli isolates causing infections in this environment need to adjust to conditions 
of low pH. To resist pH stress, bacteria have evolved several mechanisms, including 
regulatory networks that control several genes involved in acid tolerance. For 
example, E. coliO\57:H7 strains have been found to be more acid-resistant than 
generic strains (Conner and Kotrola, 1995). Outbreaks in Canada, spread by 
contaminated apple cider, suggested that this serotype might be more resistant to 
lower pH. Conner (1995) showed that E. coliO\57:H7 is able to survive a range of 
different acid stresses at a variety of temperatures above 10°C. Also, certain flagella 
genes have been shown to be regulated by acid responses (Soutourina et al., 2002). It
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is therefore likely that changes in pH initiate gene responses for the expression of 
other pathogenicity markers that are not directly involved in acid resistance.
Some capsular genes are temperature sensitive and are only expressed at and above 
25°C. The production of these capsules in vitro can be studied by the manipulation of 
the incubation temperature during bacterial growth. Another thermoregulated process 
described by Umanski and colleagues (2002), shows that the regulation of the LEE 
operon is repressed below 27°C and expressed at 37°C. This operon initiates the 
transcription of many genes involved in pathogenesis, including a type III secretion 
system. Hence the activation of this operon increases the virulence of the pathogen.
Hosts are more susceptible to infection by bacteria when iron is freely available as 
iron promotes bacterial growth (Bullen et al., 1991). Neonatal meningitis strains are 
almost always associated with iron associated pathogenesis markers (Negre et al., 
2004). To acquire iron from the host iron-binding proteins, E. coli has developed 
several mechanisms. One of these mechanisms uses a small iron-binding molecule 
called a siderophore which has a higher affinity for iron than host proteins such as 
transferrin and lactoferrin (Crosa, 1989). Two siderophore systems are most 
frequently found in E. coli: I) the enterobactin system and II) the aerobactin system. 
The iron-chelator enterobactin is produced when iron restrictions are present in vitro. 
It can remove iron from other iron-binding proteins due to the extremely high 
formation constant of 1052 . Although highly effective in iron acquisition, enterobactin 
is only used once as after cleavage of the iron ion, the resulting molecule is discarded. 
Aerobactin has a formation constant of 10229 and is therefore less effective in binding 
iron than enterobactin, but still highly compatible with other iron binding proteins.
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Furthermore, after the cleavage of iron from the chelator it can be reused and uses 
therefore less energy in the formation of the chelator compared to the enterobactin 
system. The aerobactin system is often detected in isolates obtained from blood and 
could therefore be associated with septicaemia. The yersiniabactin system located on 
the HPI plays only a very small role in iron uptake in E. coli. Other iron acquisition 
genes widely distributed in pathogenic E. coli also play a role in susceptibility to 
infection (e.g. chuA, iucC andJhuA) (Coulton et al, 1986, Martineze/c//., 1994, 
Torres and Payne, 1997). The genetic locus for the ferric uptake regulation (fur) is 
linked with iron associated cell processes (Schaffer et al., 1985). This locus encodes a 
17kDa protein, which acts as a transcriptional represser of genes involved in the iron 
assimilation pathways. It can bind to specific sequence called the "iron box", which 
can be found in the promoter region of Fur-regulated genes.
One approach to effectively achieve rapid identification and characterisation of E. 
coli pathotypes is the use of DNA arrays. This technology may be able to detect 
multiple potential pathogenicity markers simultaneously, and can also be used to 
monitor their expression.
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1.3 Arrays
In the last decade, arrays have been used to address many biological questions. They 
are now used intensively in virtually all areas of research in the biological sciences 
(Schena et al., 1996, Behr et al., 1999, Alizadeh et al., 2000, Porwollik et al., 2002, 
van Ijperen et al., 2002). The term "microarray" was first used by Schena and 
colleagues (1995) to identify and study a subset ofArabidopsi.s genes. They studied 
plant transcription factors in the early 1990's and adapted the Affymetrix yeast array 
concept to create the first quantitative DNA microarray, using a two-colour 
fluorescence hybridisation method. Also, Southern and colleagues were early 
pioneers in array technology, successfully creating arrays for use in resequencing and 
studying DNA interactions (Maskos and Southern, 1993, Southern et al., 1994). Since 
then, due to the relatively rapid completion of whole genome sequencing projects of 
both prokaryotes and eukaryotes, microarray technology advanced rapidly (Salama et 
al., 2000, Dorrell et al., 2001, Smoot et al., 2002, Wang et al., 2002a). The 
technology has proved not only to be very useful in gene expression patterns, but has 
also been rapidly adapted for genotyping (Behr et al., 1999, Salama et al., 2000) and 
resequencing (Saiki et al., 1989, Cronin et al., 1996). This section will describe in 
more detail various aspects of the arraying process, including methods of data 
analysis.
1.3.1 Array technology overview
The term array is applied to variants of a technology in which the common feature is 
that they all comprise a set of defined nucleic acid sequences (probes), placed at
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specific X, Y co-ordinates on a solid support surface (e.g. coated glass microscope 
slides or nylon membranes). Arrays can differ in the composition, length and density 
of the arrayed probes, the structure of the solid support and the nature of the target 
DNA. The technology is based on hybridisation of labelled target DNA against a 
large number of probes (up to 40,000 per microarray slide) attached to a solid 
support. The most powerful characteristic of array technology is that thousands of 
genes from different samples can relatively easily be analysed, e.g. two different 
samples can be compared in the same experiment by the labelling of the targets with 
different fluorescent dyes (Richter et al., 2002, t Hoen et al., 2003). Understandably, 
the potential for this tool is large in the biosciences, especially in oncology, 
pharmacology and biochemistry.
Rapid developments in technology have lead to the manufacture of equipment to 
assist the practicalities of the arraying process. A variety of robotics, including liquid 
handling and spotting robots, as well as microscope scanners and automated 
hybridisation equipment are now commercially available. Also, software programs 
for the analysis of the hybridisation data are being continually improved and updated, 
including those for standardisation, normalisation and clustering functions of the 
array data.
Figure 1.3 depicts the three separate parts of the arraying process:
a) array printing, including probe preparation, arraying of the probes onto a 
solid support and robotic tools;
b) array hybridisation, including target preparation and pre- and post- 
hybridisation steps;
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c) data acquisition and interpretation, including intensity measurements, 
normalisation and the storage of large amounts of data also known as data 
mining.
Detailed aspects of each of these three processes are described in more detail in the
following sections.
Array technology has developed rapidly since the first successful quantitative arrays 
described by Schena and colleagues (1995). Very quickly scientists realised that this 
tool was not only useful in expression analysis, but also had potential in the field of 
genotyping or "genomotyping" as it was called later by Dorrell (2001). The first 
promising results in this area came from Behr and colleagues (1999), who used 
microarrays to distinguish between different strains of Mycobacterium. Their aim was 
to get a better understanding of the differences between M tuberculosis, M. bovis and 
the BCG vaccine strains developed by Calmette and Guerin (1920). They identified
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16 regions of interest that were deleted from the BCG vaccine strains, of which only 
four had been previously described. They were able to construct a genealogy of the 
different BCG strains. It was around the same time that microarray technology 
became more accessible, and many whole genome sequences became publicly 
available. These two components together led to the production of whole genome 
arrays for many bacterial species composed of either PCR amplified sequences or 
oligonucleotide probes. Some of the genome arrays that have been made are listed in 
Table 1.1.
Table 1.1 Whole genortte arrays
Campylobacterjejuni 
Candida albicans 
Escherichia coli
Haemophilus influenzae 
Helicobacter pylori 
Mycobacterium tuberculosis 
Pseudomonas aeruginosa 
Salmonella Typhimurium
1.3.2 Array printing
Probe preparation
In microarray nomenclature "probes" are the DNA molecules printed onto a solid 
surface. The probes that are spotted onto the array can consist of PCR products or 
oligonucleotides. PCR products are prepared by the amplification of sequences from 
the gene of interest from the chosen organism using gene specific primers (Salama et 
al., 2000, Haas et al, 2003). To amplify all ORFs of an organism in this way can be 
time consuming and expensive as the number of specific primer pairs required is very 
large. Dorrell and colleagues (2001) described an alternative method of ORF
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amplification for array use in which standard plasmid sequencing primers were used 
to amplify cloned, sequence-defined fragments used in the Campylobacterjejuni 
NCTC 11168 genome sequencing project. The advantage of this approach is the low 
cost of the amplification primers, however the drawback is that the PCR products do 
not necessarily represent single ORFs.
The purity and identity of PCR amplified probes needs to be confirmed before 
arraying them onto the solid phase, which is a laborious procedure. The most 
common method is to analyse the products of each PCR by agarose gel 
electrophoresis to check for the presence of a single amplicon of the expected 
molecular size. A representative sample of the products, depending on the resources 
available, is then sequenced to provide a positive identity check prior to arraying 
(Taylor et al, 2001). The PCR products are optimally about 400-1500 base pairs, and 
preferably represent the longest possible specific region of the ORF. In general, 
similar sized probes give a more evenly spread hybridisation signal, which assists in 
the normalisation process.
Oligonucleotides ordered from commercial companies are purified and are ready to 
print as soon as they arrive in the laboratory. This saves the time and resources 
required to run PCR reactions, analyse the products, and redesign any PCRs that do 
not give the expected product. The length of the oligonucleotide probes spotted with a 
printing robot is generally 20 to 70 bases. Short oligonucleotides (20-50mer) are best 
bound to the glass surface via an aminolink group, but this increases the cost of 
synthesis (see also Figure 1.4 . page 45) (Kane et al., 2000). Often, the genes of 
interest on oligoarrays are covered by multiple oligonucleotides to exclude inter-array
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variation, and increase specificity and sensitivity. Oligonucleotides can be designed 
using specific software packages. To find specific oligonucleotides covering an ORF 
the melting temperature, specificity, secondary structure and the length of the 
oligonucleotide are taken into consideration. For a small number of probes this is 
relatively easy as there will be many suitable sequences, but once the required 
number of probes becomes larger there will be less suitable specific sequences that do 
not interact in so many ways. For example, the selection of oligonucleotides for 
printing microarrays might result in unspecific probes that cause cross-hybridisation. 
Either the single most suitable oligonucleotide can be chosen to amplify an ORF, or 
less suitable multiple oligonucleotides with little predicted sequence similarity can be 
used to maximise the detection of the ORF of interest.
Oligonucleotides can also be directly synthesised on the slide through in situ 
synthesis using photolithography (Pease et al., 1994). Arrays manufactured by 
photolithography, as produced by Affymetrix, have a 100 to 200 times higher density 
than arrays produced with a printing robot. Photolithography uses masks to isolate the 
site of activation and elongation of the oligonucleotide, and is initiated by light. 
Microarrays made by photolithography are limited to oligonucleotide probes of 20-25 
bases.
In comparing oligonucleotide arrays with arrays made of longer PCR products it has 
become clear that both can be used for similar applications, but they may not give 
identical results (Li et al., 2002). Furthermore, small differences in sequence can only 
be detected using oligoarrays. A pilot study can confirm whether oligonucleotides or 
PCR products will give the most accurate results. Overall signal variation has been
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found to be less for oligonucleotide arrays as all probes have approximately the same 
length, which may not be the case with PCR products (Kuo et al., 2002). When using 
oligonucleotide arrays it is possible to detect sequence differences at the single base 
level (Cronin et al., 1996). In contrast, arrays made from PCR products can detect 
similar genes with partial sequence similarity to the gene of interest, which may be 
useful for the detection of homologous genes.
Pre-arraying treatment
To make an array, PCR products or oligonucleotides are first redissolved in a volatile 
spotting solution to ensure rapid drying of the gene products (probes), but excessive 
evaporation of the sample during the printing process must be avoided. This is 
influenced by the local temperature and humidity. A common spotting solution is 
50% dimethyl-sulphoxide (DMSO), which is normally used on non-activated surfaces 
with PCR products (Rickman et al., 2003). DMSO can interfere with some active 
groups on the slide surface, and it is therefore less suitable for printing 
oligonucleotides than salt-based spotting buffers. DMSO cannot be used for printing 
on membranes as it causes perforation. Salt-based spotting buffers are better used for 
these applications, but may cause blocking or erosion of the capillary pins used for 
the deposition of probes onto the surface. Changes in the volumes of the probe 
solutions dispensed into microtitre plate wells for arraying inevitably occur over time. 
The probes can be dried down fully and redissolved in the original volume of solvent.
Printing of the arrays
Arrays can be printed either on membranes or glass slides. Nylon membrane arrays 
are generally not used at high densities as the probes are large due to the absorption
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of the probe solution into the membrane (Kuhnert et al., 1997, Anthony et al., 2000). 
One reason for printing probes further apart (greater pitch) on membranes is to 
accommodate variations in the size of the probes formed. When radioactive detection 
methods are used extra space must be allowed between probes to prevent the merging 
of signals from adjacent probes due to the scattering of the radioactive signal. For 
example, on the commercially available Panorama membrane arrays (Sigma- 
Genosys), the probes are printed five millimetres apart.
Glass microscope slides used for the printing of microarrays can be coated with 
reactive groups to allow covalent binding of the DNA probes. Robotics arms 
controlled by stepper motors are used to position the probes micrometers apart (<200 
(im). The density of probes arrayed with printing robots can vary between 20,000 - 
70,000 probes per microarray slide (Wrobel et al., 2003). Slides with different 
coatings are available, and are used depending on the nature of the probes (Taylor et 
al., 2003). There are two classes of slides that are widely used for arraying either 
PCR products or oligonucleotides. Slides for arraying PCR products are usually 
coated with polylysine or aminosilane. These surfaces bind unmodified DNA 
covalently via negatively charged phosphate groups (Figure 1.4a). The second class 
of slides, which are modified with aldehyde (Figure 1.4b) or epoxy groups (Figure 
1.4c), are usually recommended for printing oligonucleotides that have an 
aminolinker. These "active" binding surfaces have the advantage that all of the 
molecules are bound via at the same molecule and have the same orientation on the 
slide e.g. the aminogroup of the modified oligonucleotide binds to the active groups 
on the slide. This is important for relatively short oligonucleotide sequences, where 
steric hindrance can significantly affect the specificity and stability of target
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hybridisation (Shchepinov et al., 1997, Kane etal., 2000). Although non-modified 
oligonucleotides can be covalently linked to epoxy slides, longer probes (>50 mers) 
are recommended (Kane et al., 2000), and care should be taken to obtain good cross- 
linking by UV treatment or baking (Massimi et al., 2003).
A
B
Robotic tools
Robotic instruments are crucial in the preparation of the arrays. Liquid handling 
robots play an important part in the amplification of gene fragments for whole 
genome arrays. They can handle hundreds of PCR products per day and are less
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susceptible than humans to error. Also, because most systems are now fully 
automated, these can save the scientist repetitive and laborious PCR work.
Other robotics are used for the precise placements of the probe onto the solid surface 
(Schena, 1996, Cheung etal., 1999, Thompson etal., 2001). Laboratory arrayers use 
small pins for the deposition of the probes onto glass slides or membranes. There are 
various printing systems, but most arrayers use split-pin technology (Figure 1.5A). 
These pins are capable of producing microarrays comprised of up to 40,000 probes on 
a single microscope slide. The split-pin is a tiny capillary with a total volume of 
several nanolitres. Picolitres of probe are deposited each time the pin touches the 
surface of the array.
Alternative technologies like the ring and pin system and inkjets are available for 
producing arrays. Ring and pin technology uses multiple (usually eight) pin/ring 
pairs; the pin and ring of each pair can be moved up and down separately but are kept 
constant in relation to one another with respect to the XY plane. The ring is immersed 
in a sample well so that an aliquot is held in the ring's centre via surface tension. A 
spring-loaded pin is then driven through the ring effecting probe deposition (see 
Figure 1.5B). The system can probe fluids with significantly different viscosities on a 
variety of flat-surface substrates (Sinclair, 1999, Hollo way et al., 2002). The arrays 
are composed of probes with a small diameter and a good morphology. Arrayers 
using piezoelectric (inkjet) technology are non-contact printers and can therefore be 
used on any microarray surface. Nanolitres of probe solution are "fired" onto the 
surface from a very small distance. Arrays created using this method do not have
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problems associated with mismatched or damaged pins as seen in contact arrayers 
and have a low variability between probes (Cortese, 2000).
Splitpin technology
Ruig-piu technology
V
1.3.3 Array hybridisation
Target preparation
In microarray nomenclature, the "target" is the nucleic acid that is hybridised to the 
array. Depending on the application of the array, the nature of the target DNA differs. 
The well-known application of microarrays for gene expression studies uses labelled 
cDNA made from mRNA by reverse transcription (Watson et al., 1998). Other 
applications use a variety of DNA targets prepared using PCR amplification of 
specific genes (Chizhikov et al, 2001). Genomic DNA may be used for typing or 
screening for the presence or absence of genes (van Ijperen et al., 2002, Anjum et al., 
2003, Bekal et al., 2003, Dobrindt et al., 2003).
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Target labelling is done by the direct or indirect incorporation of suitable labels (i.e. 
fluorescent, radioactive or biochemical). The label that is most suitable is determined 
by the nature and characteristics of the surface on which the array is printed. Targets 
used for hybridisation on membrane arrays are not usually labelled with fluorescent 
markers, because the auto-fluorescent characteristics of the membrane make the 
detection of a fluorescent probe problematic (see also section 3.2.2, page 97). Instead, 
targets used for hybridisation against membranes are more commonly labelled using 
radioactive tracers (e.g. radioactive phosphor) or hapten labels (e.g. digoxigenin) 
(Kuhnert et al., 1997, Amon and Ivanov, 2003). Target nucleic acids for glass slide 
hybridisation are produced using fluorescently labelled nucleotides. The fluorescent 
labels attached to these nucleotides are usually members of the cyanine series that are 
large aromatic molecules. Two of these fluors that are intensively used in array 
technology are l-ethyl-2-[(l£',3£)-5-(l-{6-[(2,5-dioxo-l-pyrrolidmyl)oxy]-6- 
oxohexyl}-3,3-dimethyl-5-sulfo-l,3-dihydro-2//-indol-2-ylidene]-l,3-propadienyl}- 
3,3-dimethyl-5-sulfo-3//-indolium (Cy3) and l-ethyl-2-[(l£,3£)-5-(l-{6-[(2,5-dioxo- 
l-pyrrolidinyl)oxy]-6-oxohexyl}-3,3-dimethyl-5-sulfo-l,3-dihydro-2//-indol-2- 
ylidene]-l,3-pentadienyl}-3,3-dimethyl-5-sulfo-3//-indolium (Cy5). The differences 
in the trade names (Cy3 and Cy5) refer to the number of C-atoms in the single/double 
bond chain between the large aromatic groups. The emission maxima of these two 
fluors are well separated so that interference of signal during data acquisition is 
avoided, and these fluors can therefore be used in the same hybridisation experiment 
to compare results from two individual samples (Richter et al., 2002, t Hoen et al., 
2003).
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Direct labelling methods use transcription or replication to incorporate nucleotides 
with a label attached directly into the amplified DNA. The large Cy dyes which are 
attached to one of the nucleotide bases can cause problems for efficient incorporation, 
as steric hindrance impairs the activity of some polymerases. Indirect labelling 
methods firstly incorporate nucleotides carrying a small reactive group, to which a 
label is attached in a subsequent chemical reaction. The advantage of this approach 
for the labelling of target DNA is that the modified and natural nucleotides used in 
the amplification are incorporated with approximately equal efficiency by a wide 
range of polymerases. The most widely used method for labelling targets indirectly 
for microarray hybridisation uses amino-allyl-modified dNTPs. The small amino-allyl 
dNTPs are incorporated into the target nucleic acid at a similar rate to unmodified 
nucleotides (Richter et al., 2002). The Cy dye is then bound to the amino-allyl dNTPs 
in the target by ester bonding. This approach gives good yields of highly labelled 
target, and so minimises experimental variation.
After purification, the labelled targets are redissolved in buffered solutions. Some 
array applications require the presence of competitor DNA during the hybridisation 
reaction. For example, addition of CoM DNA to the hybridisation solution reduces 
the reannealing of repetitive elements by binding to the target sequences. Similarly, 
tRNA acts as a blocker of non-specific hybridisation (Pollack, 2003). The use of 
formamide in the hybridisation solution has the advantage that the DNA is denatured 
at lower temperatures (Ideker et al., 2003). Hybridisation at a lower temperature 
reduces evaporation, which avoids the high background signals associated with 
drying and excessive probe concentrations.
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Pre hybridisation treatment
Most membranes and slides are pre-treated before hybridisation to prevent non- 
specific binding of target DNA to the array surface. Membranes are blocked by 
incubation in blocking buffer containing bovine serum albumin (BSA) (Taylor et al., 
2003). When glass slides are used, blocking can be done either with blocking buffers 
similar to the ones used for membrane blocking, or by incubation in humidity 
chambers causing the active binding groups on the slide surface to be deactivated (see 
section 1.3.2) (Chiuetal., 2003).
Hybridisation
Membranes are treated as traditional Southern blots during hybridisation. Incubation 
at the desired hybridisation temperature is done in roller bottles, plastic bags or 
containers in a hybridisation oven or waterbath. For microarray slides a similar 
approach is possible. Special water tight chambers (Corning or Genetix Limited) that 
fit single or multiple microarray slides are used for hybridisation (see also Figure 2.6, 
page 67). The chambers prevent the slide from drying out and can be used for 
incubation in either a hybridisation oven or water bath. The target is incubated under 
a coverslip so that several microlitres (ul) of target are evenly spread over the array. 
Automatic hybridisation stations are also commercially available (Cortese, 2000, 
Holloway et al., 2002). In these systems, hybridisation takes place in a low-volume 
chamber with access ports for the addition of buffers. An advantage of this equipment 
is that the hybridisation process is dynamic, as a pump moves the target solution 
around over the surface of the slide. This increases signal intensities and ensures that 
all positions on the array are equally exposed to the target (Holloway et al. , 2002). 
The disadvantages are that the automated systems require a larger target volume than
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used in coverslip hybridisations, and they are less suitable for large numbers of 
probes as the ring sealing of the hybridisation area restricts the surface area on which 
probes can be printed.
Post-hybridisation
Washes of increasing stringency follow the hybridisation procedure to remove any 
non-specifically bound target. The stringency of the post-hybridisation washes affects 
the strength of the hydrogen bonding between the probe and target and can be 
adjusted by changing the washing temperature, salt concentration and by adding 
denaturing agents. A higher stringency is obtained at higher wash temperatures and 
lower salt concentrations (Sambrook et al, 2001). For the post-hybridisation of glass 
slides arrays, sodium dodecyl sulphate (SDS) should be avoided in the last wash as 
this can cause interference with data acquisition because of its auto-fluorescent nature 
(Massimi et al, 2003).
1.3.4 Data acquisition and interpretation
The third and final part of the arraying process is depicted in Figure 1.3C. It includes 
the data acquisition and analysis and is by far the longest part of the arraying process. 
When whole genome arrays are used, one experiment often results in thousands of 
data points, which may require individual analysis. Data analysis software assists this 
process, but it is still labour intensive. Interaction between scientists, computer 
analysts and statisticians are important for the correct interpretation of the data.
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Data acquisition
The results of membrane experiments can be visualised using either X-ray film or a 
variable mode imager. Membranes can be exposed to X-ray films in the dark and 
hybridisation signals revealed after photographic development. Variable mode 
imagers can be used to detect the signals on the hybridised membrane by laser 
scanning. Unlike exposure to X-ray film, this data acquisition is direct and not 
cumulative. Therefore hybridisation signals need to be very strong for the imager to 
be able to detect them (Bertucci et al., 1999).
A variety of fluorescent scanners are now commercially available for data acquisition 
from glass slide microarrays. The Affymetrix 428, the Axon Genepix 4000 and the 
Perkin Elmer ScanArray scanners are most commonly used, but others are listed by 
Holloway and colleagues (2002). All of these employ a similar technology for data 
acquisition. High resolution scanners contain one or more lasers for excitation of the 
dyes most commonly used for target labelling. For example, Cy3 is excited at 532 nm 
and fluoresces maximally at 570 nm while Cy5 is excited at 635 nm and fluoresces 
maximally at 670 nm. The detector device measures the signal intensity every 10 to 4 
urn depending on the scanner. The overall hybridisation signal from each probe is 
visualised through the sum of all the pixels for that probe in a digital image. A 
function known as pseudocolouring is often used to aid visual assessment of scans. 
The faintest probes are usually shown in blue and the stronger probes are shown in 
increasingly hot colours towards red and finally in white. Monocolour images, 
usually red for Cy5 and green for Cy3 signal, are used for easy visual comparison of 
overlaid images. This results in images of the array with either green, red or yellow 
probes indicating the hybridisation of Cy3, Cy5 or both targets respectively.
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Intensity measurement
A variety of software packages are available for microarray data analysis. Although 
there are differences, most programs have basic functions to allow the measurement 
of signal intensities and to present the data in convenient formats (e.g. histograms, 
scatterplots etc). The available programs are under continual development, and 
upgrades of them often include improved tools for normalisation and statistical 
analysis.
The array analysis process is a multi-step process. A customised grid is positioned on 
top of the digital image by software manipulation, whether the image is derived from 
a membrane or a glass slide array. This grid includes information about gene 
identification, size of the probe, background substraction, reference probes etc. For 
the identified probe size a measurement of the signal intensity is taken. These data are 
used for the interpretation of the results. Microarray experiments on a whole genome 
array result in thousands of data probes that are complicated to interpret because of 
the influence of the many experimental parameters. The data have to be adjusted in 
such a way that only biological differences contribute to changes in signal intensity 
(Kroll and Wolfl, 2002, Quackenbush, 2002). This process is called normalisation, 
and it is one of the most discussed and important aspects of microarraying.
Normalisation
Array experiments are susceptible to manual and experimental variation, caused by, 
for example, unequal quantities of starting material, and differences in labelling and 
detection efficiencies. It is necessary to exclude any variation arising during the 
arraying process for the correct interpretation of any biologically significant results.
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This is most important in gene expression analysis studies as quantitative differences 
are measured, however, all data obtained from array experiments need to be carefully 
adjusted. Many different approaches to data normalisation are currently used and 
there is debate about which method is best. Two reviews have described and 
compared the different methods (Kroll and Wolfl, 2002, Quackenbush, 2002).
Background correction is the first normalisation step. By subtracting the background 
from the signal intensities the first variable between arrays is excluded. After 
background correction, total intensity or 'global' normalisation methods are used. 
These methods rely on two assumptions. Firstly, that equal amounts of template DNA 
have been labelled and, secondly, that the arrayed elements include only genes that 
give a representative range of signal intensities (Quackenbush, 2002). Normalisation 
factors are calculated by summing the overall signal intensities from both scans 
separately, then assuming that the sum values should be identical, each individual 
data point is transformed using this factor. Variations on this 'total intensity' 
approach use mean or median value of all or a selected subset of probes to achieve 
global normalisation. All these methods are designed to minimise experimental 
variation. However, each method will be more or less suitable for normalisation of 
particular data sets as discussed by Kroll and Wolfl (2002). To summarise, all total 
intensity normalisation approaches are applicable to a wide variety of gene sets and 
are easily computed and applied. All are good for noise reduction in the data. Mean 
normalisations are influenced strongly by non-linear behaviour of high intensity 
genes and strong signals from single genes. Median normalisation is less often 
applicable when many genes have low signal intensities, as it skews the data. 
Additionally, other more complicated normalisation algorithms have been designed
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for array data and these are mostly used in expression analysis. One example is 
locally weighted linear regression (Lowess) normalisation which is used to remove 
intensity dependent effects in the ratio value (Cleveland, 1979, Yang et al, 2002). In 
contrast to global normalisation methods, this is a non-linear adjustment of the data. 
The relative error increases for probes with a lower intensity, and therefore the signal 
intensity is adjusted differently for low and high signal intensities. In general these 
algorithms are more difficult to compute and apply, but are sometimes more precise 
in filtering out experimental differences.
An acceptable standard needs to be determined for the interpretation of microarray 
data, whether it concerns the presence or absence of the genes on the array, or 
measurement of over/under expressed genes. For genotyping applications, this can be 
done by the hybridisation of strains with a previously defined hybridisation pattern. 
The minimal signal for known positive probes is used as a threshold to score all other 
genes on the array. For gene expression experiments a ratio value is set to determine 
over and under expressed genes. Data are usually transposed to log-ratio format for 
statistical purposes (Quackenbush, 2002). When looking at expression data a minimal 
log-ratio fold change of two is seen as an up-regulation and in the same way down- 
regulation of a gene is indicated by probes with a log-ratio lower than 0.5 (Schena, 
1996).
Normalisation will continue to be a much discussed topic in microarray technology. 
Standardisation of normalisation methods and the close collaboration between 
biologists, computer scientists and statisticians will hopefully allow a better 
understanding of the normalisation of array data, and establish easy-to-apply
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algorithms for all types of microarray data as comparing different data sets currently 
proves rather difficult.
Data mining
Microarray experiments generate a large amount of data even before normalisation 
and transformation of the results. Not only the scanned digital microarray image of 
several 100 Mb but also the intensity measurements have to be stored. Additionally, 
the raw data are normalised and, when appropriate, further transformed using other 
algorithms, causing at least a doubling in size of the data file. Guidelines have now 
been established for the additional information that needs to be stored together with 
the data, so that microarray data can be exchanged between different laboratories 
(Brazma et al., 2001, Spellman et al., 2002). The most appropriate method for storing 
this type of data is in databases. Although any database software can be amended 
with scripts for the handling and filtering of the data, specialised microarray packages 
are more suitable (e.g. Genespring, Silicon genetics; GeneTraffic, lobion; 
BioNumerics & GeneMaths, Applied Maths).
56
1. Introduction
1.4 Aims
The main hypothesis behind this work is that a subset of genes derived from the 
genome of a bacterium can be used to assess whether or not a strain of E. coli carries 
these genes and can characterise the strain. A general hypothesis was that DNA arrays 
can also be used for typing organisms without the need for whole genome 
sequencing.
In order to achieve this, specific objectives of the work described in this thesis were:
  To determine which type of commercial whole genome arrays would produce the 
most accurate results for genotyping bacterial strains. The two types of whole 
genome arrays that were available were composed of PCR amplicons printed on 
membranes or oligonucleotide probes on glass slides.
  To determine whether it is possible to identify candidate genes characteristic for 
the individual E. coli strains that could be used as sub-typing markers for DNA 
'fingerprinting' of strains. The work was designed to test the hypothesis that 
interpretation of array data would lead to the identification of suitable of marker 
genes of E. coli that could be used on a subtyping array.
  To determine whether a custom made pathogenicity marker array would show the 
distribution of pathogenicity markers in E. coli isolates. The work was designed 
to test the hypothesis that certain pathogenicity markers are widely distributed in 
all isolates. Such an array was produced and then used to investigate selected E. 
coli strains.
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To determine whether custom made pathogenicity marker arrays could be used 
for the identification of different pathotypes in individual clinical specimens. 
To determine whether an extended array could be used to distinguish between 
closely related isolates from outbreak situations. The work was designed to test 
the hypothesis that an array including a wider selection of pathogenicity markers 
and sequences could characterise clinical isolates in greater detail.
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2. Materials and methods
All water, chemicals and solutions used were of the most appropriate grade for their 
intended use. Water, buffers and solutions are listed in Appendix I.
2.1 Bacterial strains and growth conditions
Eight individual bacterial strains with different predetermined pathotypes, as well as 
isolates from three strain collections were investigated and are listed in Table 2.1.
Two strain collections were used: the ECOR collection (Ochman and Selander, 1984) 
and the BMEG collection (Fallon et al., 2002). Also a group often isolates obtained 
at Shrewsbury Public Health Laboratory during an outbreak of UTI were 
investigated.
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The BMEG collection was established at the Shrewsbury Public Health Laboratory 
over a period of two weeks in January and February 2000. All incoming urine 
samples with a white blood cell count higher than 100 x 106/litre were selected for the 
evaluation of different types of agar for rapid bacterial identification (Fallen et «/., 
2002). E. coli isolates from this collection, identified by API, comprise a unique 
collection for the investigation of the distribution of pathogenicity markers and the 
relationship between strains collected in the same geographical area.
Ten UPEC isolates with multiple antimicrobial resistance patterns were isolated from 
individuals infected with an outbreak of urinary tract infection. These strains were 
previously indistiguisable using API and PFGE and were challenged against the 
pathogenicity marker array to find any differences between them.
All isolates were grown first on agar plates (Luria Broth (LB) or Cystine Lactose 
Electrolyte-Deficient (CLED)) overnight at 37°C, and where necessary single 
colonies were grown in LB cultures overnight at 37°C. Cultures were stored on beads 
(Technical Service Consultants Ltd.) at -70°C.
2.2 Antimicrobial susceptibility testing
Antimicrobial susceptibility testing of the E. coli isolates in the BMEG collection was 
carried out using Oxoid antibiotic disks. Isosensitest agar plates (Chester Media 
Service) were inoculated with bacterial cultures of low cell density (McFarland scale 
0.5). Antimicrobial resistance disks for trimethoprim, ampicillin, cephalexin, 
norfloxacin, augmentin and nitrofurantoin were then placed firmly on the plates.
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Zones of inhibition were measured after overnight incubation at 37°C. The area 
around the disk where no growth appeared was measured and zones bigger than those 
of reference cultures for that antimicrobial substance indicated susceptibility. Where 
no inhibition appeared or if the zones were smaller than the reference, the strains 
were called resistant. This is illustrated in Figure 2.1.
E. coli 
E. coli on 
2.3 Genomic DNA extraction 
2.3.1 QIAquick DNeasy Tissue Kit
Genomic DNA was extracted from single colonies grown overnight in 1 ml 
suspension in LidBac culture tubes (Eppendorf). The QIAquick DNeasy extraction 
protocol is based on an ion-exchange principle (Qiagen). Genomic DNA binds to a 
silica gel filter at an alkaline pH, and elution of the washed DNA from the filter is at 
pH7.
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Cells were harvested from plates with a 1 (0.1 culture loop or from suspensions by 1 
minute centrifugation at 10,000 x g and resuspended in 180 |il Qiagen ATL buffer. 
Cells were incubated at 55°C after addition of 20 (il proteinase K (20 mg/ml) and 
vortexed occasionally until lysis was complete. Two hundred (j.1 Qiagen AL buffer 
were added and the sample was immediately mixed thoroughly before incubation at 
70°C for 10 min. After addition of 200 |il 96-100% ethanol (Sigma) homogeneous 
solutions were transferred into the DNeasy column. DNA was bound to the column 
by a 1 minute centrifugation at 10,000 x g. The column was washed twice by 
centrifugation with 500 |il wash buffers Qiagen AW1 and AW2 respectively. The dry 
column was placed in a clean 2 ml collection tube and the DNA was eluted in 400 ul 
nuclease-free dH2O (Promega). DNA was stored at -20°C.
2.3.2 MagNA Pure Automated DNA extraction
The MagNA Pure automated extraction robot (Roche) also uses proteinase K to lyse 
the cells and then captures the extracted DNA on magnetic beads. Genomic DNA was 
extracted from single colonies grown overnight in 1 ml suspension in LidBac culture 
tubes (Eppendorf). Cells were washed and resuspended in 100 (il PBS and together 
with the necessary solutions loaded onto the machine. Genomic DNA was extracted 
using the DNA I high performance protocol. The robot is able to extract 32 samples 
in one extraction run in approximately 1.5 hours. After extraction of the genomic 
DNA, all samples were treated with RNase A (10 mg/ml, Sigma) for 1 hour at 37°C. 
DNA was stored at -20°C.
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2.4 Quantification and Qualification ofDNA 
2.4.1 Spectrophotometrical analysis
The quantity of genomic DNA extracted was spectrophotometrically determined by 
measuring the UV absorbance. Extracted genomic DNA was diluted in nuclease free 
and read in an Eppendorf Biophotometer (Eppendorf) against nuclease free 
. DNA dilutions were adjusted if the reading taken at 260 nm (A26o) was not 
within the 0.1 - 1 linear range. A clean DNA solution with an A2 6o of 1.0 has a 
concentration of 50 (ig/ml. The concentration of an unknown sample is calculated by:
DNA cone (|Llg/ml) = [A260 ] [50] [dilution factor]
The UV absorbance at 280 nm (A2go) was also measured to determine the purity of 
the DNA. A clean DNA sample of good quality will have an Aaso/Aaso ratio of 1.8. 
Impurities such as proteins will decrease this value as their absorption will cause an 
increase in A2so, indicating a less pure sample and leading to an incorrect 
quantification.
2.4.2 Agarose gel electrophoresis
DNA in extracts was separated by electrophoresis on 1 % w/v agarose gels to check 
their integrity. Agarose gels (SeaKem* LE Agarose, Cambrex) were prepared in 1 x 
THE buffer (Invitrogen) and heated in a microwave oven until dissolved. Gels were
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cooled and allowed to set for at least 30 minutes at room temperature before 3 |o.l of 
sample, mixed with 2 |il Orange G loading buffer (Severn Biotech) and 5 (il dH2O, 
were loaded onto the gel. Samples were electrophoresed at 8 V/cm until the orange 
loading dye migrated to the bottom of the gel. Gels were stained in ethidium bromide 
(5 |ig/ml) in distilled water. Visualisation of the gel was with UV light (312 nm), and 
images were captured on Polaroid film or with the use of a CCD camera in Geldoc 
system (Biorad).
2.5 DNA digestion
Genomic DNA samples with an A260/A280 ratio between 1.77-1.83, were digested 
before labelling. Only the labelling with Cy dyes was done directly on heat denatured 
genomic DNA extracts. For the digestion approximately 1.5 (ig of DNA was mixed 
with 10 |j,l 10 x digestion buffer and one unit restriction enzyme (EcoRl and Msel; 
New England Biolabs). The total volume of the reaction was adjusted to 100 (il with 
nuclease free water. Digests were incubated for at least one hour at 37°C and samples 
were analysed by electrophoresis on a 1% w/v agarose gel as described in section 
2.4.2 to determine digestion efficiency.
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2.6 DNA labelling
2.6.1 Digoxigenin labelling
To generate hybridisation probes the smaller Mvel digested DNA fragments were 
labelled with digoxigenin using the DIG High Prime DNA Labelling kit (Roche). 
DNA was heat denatured by a 5 minutes incubation at 95°C followed immediately by 
5 minutes on ice. Each labelling reaction contained 1 ug heat denatured DNA and 4 
ul DIG-High Prime mixture containing random hexamer primers, nucleotides, DIG- 
dUTP, Klenow enzyme and buffer components in a total volume of 20 ul. The 
reaction tube was incubated at 37°C for 1 hour and the reaction was stopped by the 
addition of 2 pi 0.2 M EDTA pH 8.0 (Invitrogen). The labelled DNA preparations 
were used as hybridisation probes, and were cleaned from unincorporated nucleotides 
and enzyme using Microcon spin columns (YM-100, Millipore). The signals from a 
dot-blot experiment of labelled and control DNA were compared to define the 
incorporation efficiency. Seven serial dilutions were made ranging fromlO pg/fil to 
0.01 pg/|il and spotted onto Hydrobond-N+ membrane (Amersham Biosciences), 
crosslinked and washed for 2 minutes in 20 ml maleic acid buffer (Roche). 
Membranes were incubated for 30 minutes in 10 ml blocking solution followed by 30 
minutes in 10 ml antibody solution, and washed 2 times for 15 minutes in 10 ml 
washing buffer. Membranes were equilibrated in 10 ml detection buffer for 2 minutes 
before visualisation with the chemiluminescence substrate 'CSPD ready-to-use' 
(Amersham Biosciences) that was applied to the membrane and incubated for 5 
minutes at room temperature. The excess liquid was removed and the membranes 
were exposed to ECL-Hyperfilm (Amersham Biosciences) for 15-25 minutes in the
dark (details of development in 2.7). Signal intensities were compared to the control
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material to calculate the amount of DIG-labelled DNA. Probes for membrane 
hybridisation were heat denatured for 5 minutes at 95°C and cooled on ice for 5 
minutes before overnight hybridisation.
2.6.2. Fluorescent labelling
Genomic DNA was fluorescently labelled using an enhancement chemifluorescence 
(ECF) random prime labelling kit. (Amersham Biosciences). Up to 2 ug of Mse\ 
digested, heat denatured DNA in a maximum volume of 34 ^il was mixed with 10 ul 
nucleotide mix, 5 ul primer solution and 1 ul enzyme solution supplied by the 
manufacturer to make a total reaction volume of 50 ul. Reactions were incubated 
between 1 to 3 hours at 37°C and terminated by the addition of 2 ul 0.2 M EDTA (pH 
8.0). Hybridisation probes were cleaned from unincorporated nucleotides and enzyme 
using Microcon spin columns (YM-100, Millipore) and semi-quantified before use as 
described below.
The signals from a dot-blot experiment of labelled and control DNA were compared 
to define the incorporation efficiency. Seven serial dilutions in TE buffer of the 5 x 
nucleotide mix, ranging from 1:5 to 1:500, were sported onto Hydrobond-N+ 
membrane (Amersham Biosciences). A second filter was made with the 5 ul labelled 
probe and a negative control. Both filters were placed on filter paper moistened with 
TE buffer. Signals were viewed using UV light. Labelled DNA with a comparable 
intensity to the 1/100 control dilution was considered to be sufficiently labelled for
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hybridisation experiments. Probes were heat denatured for 5 minutes at 95°C and 
cooled on ice for 5 minutes before use.
2.6.3 33P labelling
For the labelling of probe DNA with 33 P, a commercial random prime kit was used 
(Rediprime II, Amersham Biosciences). Up to 1 (ig of Msel digested DNA in 45 ul 
TE buffer was denatured for 5 minutes at 95°C and cooled on ice for 5 minutes. The 
denatured DNA was transferred to a ready made reaction tube containing a buffered 
solution of dATP, dGTP, dTTP, exonuclease-free Klenow enzyme and random 
primers in a dried stabilised form with a light blue colour. Five |il of radioactive 
labelled dCTP (Redivue 33 P dCTP, Amersham Biosciences) were added and the 
contents of the tube were mixed until the solution appeared purple (following mixing 
of the pink coloured Redivue 33P dCTP with the blue stabilised pellet of reaction 
mix). The reaction was incubated at 37°C between 1 and 3 hours and stopped by the 
addition of 5 ul 0.2 M EDTA. For the use in hybridisation experiments the DNA was 
heat denatured for 5 minutes at 95°C and cooled on ice before use. The specific 
activity was estimated by the theoretical incorporation as described by the 
manufacturer, or measured using a scintillation counter; both described below.
The specific activity of the probe was calculated using the manufacturer handbook. 
Firstly, the total amount of DNA at the end of the reaction has to be determined using 
the following formula:
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Mass of DNA (ng) = luCiaddedl|13.2||%incorporation| + starting template (ng)
Specific activity of [ 33P]dCTP
Secondly the amount of radioactivity incorporated in disintegrations per minute 
(dpm) can be calculated using the following formula:
Activity incorporated (dpm) = [u i added] [2.2 x 104][%incorporation]
The specific activity is calculated by a division of these two:
Specific activity dpm/ug = |dpm incorporated||103 |
Mass of DNA (ng)
Radioactive probes were also measured for the incorporation of radioactive phosphor 
with a scintillation counter. One p.1 of labelled DNA, radioactive label and a negative 
control were spotted onto individual pieces of DE81 filter paper (Whatman) and 
washed 3 times for 5 minutes in 10 ml 5 % Na2HPO4-12H2 O, 5 minutes in deionised 
water and 2 minutes in industrial methylated spirit. Filters were dried on filter paper 
and placed into a scintillation vial. Three ml scintillation fluid was added (Ecoscint A, 
National Diagnostics) to the vials and they were counted in a Beckman LS 1801 
scintillation counter (Beckman Instruments). Unwashed and blank filters were 
included for baseline measurement.
Probes that were not used immediately were purified using N AP -5 columns 
(Amersham Biosciences). The excess liquid was poured off the top of the column and 
after removal of the bottom seal the column was equilibrated using 10 ml TE buffer
pH 7.0. The sample in a maximum volume of 50 (il was applied to the column and
_
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absorbed in the gel bed. DNA was eluted in 1 ml TE buffer. The purified probes were 
stored at -20°C.
2.6.4 Fluorescent Cy labelling
Fluorescent probes for hybridisation to the glass arrays were made using a 
modification of a random labelling kit (Bio-Prime, Invitrogen). Heat denatured 
genomic DNA (1.5 - 2 \\.g) was used as template. Each reaction contained 20 fil 
random primers (750 ug/ml), 5 u,l dNTPs (1.2 mM each of dATP, dCTP, dGTP and 
0.6 mM dTTP), 1 \a\ Klenow enzyme (40 units/ill) and 1 (il Cy labelled dUTP (25 
ng/|il) in a total volume of 50 |il. The reaction was incubated at 37°C in the dark for at 
least 3 hours. After labelling, QIAquick PCR purification columns were used to 
remove unincorporated dyes. Samples were mixed with 5 volumes buffer PB and 
applied to a QIAquick spin column. DNA was bound to the column by centrifugation 
for 1 minute at 10,000 x g. Filters were washed with 700 |il buffer PE. The flow- 
through liquid was discarded and the column was dried by an additional spin for 1 
minute at 10,000 x g. Targets were eluted in 50 (il nuclease free water. A sample of 1 
to 2 (il was run on a 1 % w/v agarose gel and scanned with the Typhoon scanner to 
investigate incorporation of the Cy dye.
The specific activity of the incorporation of the fluorescent probes was determined as 
described by Murray et al. (2001). The formula given below calculates the total 
number of nucleotides divided by the Cy5 dye labelled nucleotides i.e. the lower 
value the more fluorescent dye is incorporated.
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Specific Activity (ng/pmol) = [Labelled target (ng)l 110001
[Incorporated Cy5 (pmol)| [324.5]
in which:
Labelled target (ng) = [A26«] [50[ [volume (ul)[[ 1000]
Incorporated CyS (pmol) = |A6sol [volume (ul)|
[0.25]
For Cy3 labelled targets the following formulas apply.
Specific Activity (ng/pmol) = [Labelled target (ng)l [10001
[Incorporated Cy3 (pmol)] [324.5]
in which:
Labelled target (ng) = [A26ol [50] [volume (ul)][ 1000]
Incorporated Cy3 (pmol) = [A^nl [volume (ill) I
[0.15]
After spectrophotometrical analysis of the targets these were dried under vacuum in a 
Speed Vac (Savant) and redissolved in 30 |il 1 x hybridisation buffer (see Appendix 
I).
2.7 Southern blotting and hybridisation
Genomic DNA and restriction digests were separated by agarose gel electrophoresis 
on 1 % w/v gels and were transferred onto Hydrobond-N+ membrane (Amersham 
Biosciences). The gel was depurinated for 30 minutes in 0.25M HC1. This step 
partially depurinates DNA into smaller fragments that are more easily transferred to 
the membrane. This was followed by denaturation in 1.5M NaCl/0.5M NaOH twice
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for 20 minutes causing the double stranded DNA to denature. Finally, the gel was 
neutralised in 1.5M NaCl/0.5M Tris HCI twice for 20 minutes. This final step raises 
the pH of the gel as DNA will bind less efficient to the membrane at a lower pH. The 
gel was very fragile after these washes and had to be handled with great care while 
building the blotting stack tower. The transfer buffer (20 x saline sodium citrate 
(SSC), Invitrogen) in the reservoir transferred the DNA to the membrane by upwards 
capillary action through the filter wick. The gel was placed on top of the wick and a 
plastic seal was placed around the gel. The pre-wetted membrane was placed on top 
of the gel. Filter paper and tissues were used to absorb the transfer buffer. The tower 
was completed with a glass plate to distribute the pressure of a heavy weight. After 
overnight blotting, the blotting tower was disassembled and the reduced gel was 
checked by UV light for adequate transfer, i.e. when no significant ethidium bromide 
stained DNA was detectable in the gel, the transfer had been completed. Positions of 
the lanes were indicated on the membrane by pencil marks for orientation purposes. 
Membranes were UV-crosslinked for one min on a UV light source (wavelength 312 
run) for covalent binding of the DNA to the membrane as shown in Figure 2.2. 
Membranes were used directly for hybridisation or wrapped in plastic and kept at 
4°C.
DNA binding
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Prehybridisation was performed using blocking buffers provided by the 
manufacturers of the commercial kits that were used. Membranes were prehybridised 
for at least one hour. Probes were heat-denatured for five min at 95°C and rapidly 
cooled on ice. The concentration of labelled probe per ml hybridisation buffer was 
adjusted as shown in Table 2.2.
Hybridisation took place overnight in roller bottles in a hybridisation oven (Hybaid) 
at temperatures shown in Table 2.2, dependent on whether the supplied hybridisation 
buffer contained formamide or not. Formamide in the buffer keeps the DN A 
denatured at lower temperatures and therefore hybridisations are performed at lower 
temperatures while the stringency is not affected. After hybridisation, blots were 
washed following the recommended washing protocol, details of which are shown in 
Table 2.2.
For DIG and ECF labelled hybridisation reactions the signal was detected by an 
antibody based method. Membranes were washed in detection buffer followed by 
incubation in blocking solution for 30 minutes (supplied by the kit manufacturer, 
listed in Appendix I). The antibody conjugate was diluted in blocking solution (see 
Appendix I). Membranes were incubated in antibody solution for 30 minutes and
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washed. A chemiluminescent substrate to the antibody conjugate was added before 
exposure and visualisation of the membrane.
Hybridisation signals were detected by phosphor imaging on a Typhoon 8600 
variable mode imager (see Figure 2.10) or on film. Blots were exposed to ECL 
Hyperlink film (Amersham Biosciences) for 25 min to 1 hour and then developed and 
fixed using Kodak solutions. One in 4 dilutions of X-ray developer and fixer were 
prepared in tap water. The film was immersed in developer and agitated until signal 
became visible. Films were immersed in the fixing solution for twice the clearing 
time and air-dried. Radioactive labelled probes hybridised to Southern blots were 
visualised on X-ray film or phosphor storage screens (see section 2.10.1)
2.8 Whole genome membrane arrays
Commercial membrane arrays were used for full genome analysis of radioactive 
probes derived from Msel digested DNA as described in 2.5.2. Each of the 
membranes (Sigma-Genosys) contains 4,290 PCR amplified ORFs of E. coli K12. 
The majority of ORFs had been amplified from start to stop codon. All 4,290 ORFs 
were printed in duplicate at 10 ng per probe onto positively charged nylon 
membranes. DNA was bound covalently onto the membranes by cross-linking using 
UV-light. The array consists of three fields, each field has a primary grid composed 
of 16 rows (A-P) and 24 columns (1-24) and a secondary grid with four genes printed 
in duplicate in a staggered formation. The corners of each field (Al, A24, PI, P24) 
contain genomic E. coli K12 DNA. These probes act as positive control orientation 
probes and can be used to normalise data between replicate arrays. A layout of the
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array can be seen in Figure 2.3. A gene identification file of all probes is included on 
the enclosed CD-rom under Panorama Array gene ID.
"Wo
E. coli 
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Before first use the arrays were washed in 50 ml 2 x saline sodium phosphate-EDTA 
(SSPE) for 5 min. Prehybridisation buffer consisting of hybridisation solution 
(Sigma-Aldrich) supplemented with salmon testes DNA (Sigma) to a final 
concentration of 100 (J.g/ml was prewarmed to 65°C. Incubation in 5 ml buffer was 
performed in a hybridisation oven in roller bottles at 65°C between 1 to 2 hours. 
Radioactive labelled probe was heat denatured at 95°C for 10 min in 3 ml 
hybridisation solution and cooled on ice. The prehybridisation buffer was replaced by 
the denatured labelled target DNA in fresh hybridisation buffer before overnight 
hybridisation at 65°C. Post hybridisation membranes were washed 3 times for 2 
minutes at room temperature in 50 ml wash buffer (0.5x SSPE and 0.2% SDS) and 3 
times 20 min at 65°C in 80-100 ml wash buffer. Arrays were sealed in plastic and 
exposed to a Kodak Low Energy Storage Phosphor screen for 24 hours before 
visualisation using a Typhoon 8600 scanner (see Figure 2.10).
To remove the radioactive label from the membranes they were incubated in 
preboiled stripping buffer for 20 minutes. After draining the excess solution the 
membranes were again exposed to the storage phosphor screens to confirm that no 
signal residue was still present, before reusing the arrays. During hybridisation, 
stripping and storage the membranes were not allowed to dry completely as this 
makes stripping and reprobing less efficient.
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2.9 Glass slide arrays
2.9.1 MWG whole genome arrays
Commercial glass slide arrays were used for full genome analysis of fluorescent!y 
labelled genomic DNA as described in section 2.5.4. Every E. coli K12 Pan Array 
(MWG) contains 4,416 50-mer oligonucleotides representing all E. coliK\2 ORFs 
and controls. There are 32 positive control probes, 47 replicated control probes and 
48 Arubidopsis thaliana oligomers. The 48 A. thaliana oligonucleotides have no 
homology with any of the E. coli ORFs, and are used as negative controls. The 32 
oligonucleotides used as positive controls represent a flagellar E .coli gene (JliO). The 
oligonucleotides are printed on epoxy slides and are covalently bound to the slides by 
an active binding of the free amino group attached to the oligonucleotide and the slide 
surface as shown in Figure 2.4.
The array, of which the layout is shown in Figure 2.5, consists of a primary grid with 
two rows and two columns and a secondary grid with 32 rows and 36 columns. The
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majority of oligonucleotides on the slide are present only once. Forty-seven probes 
are spotted twice to look at inter-array variability. These replicates are shown in 
yellow in Figure 2.5. Positive controls are shown in red and negative controls are 
shown in blue. Probes indicated in green are empty positions on the array. A gene 
identification file of all probes is included on the enclosed CD-rom under Pan Array 
gene ID.
E.coli 
E.coli. 
Slides were prehybridised at 42°C in a BSA-based buffer for at least one hour. BSA 
was first dissolved in sterilised water at 4 °C before SSC and SDS were added. The 
buffer was preheated at 42°C until all precipitate had disappeared. After 
prehybridisation, slides were rinsed three times in 50 ml sterilised water and dried 
through centrifugation. Fluorescent hybridisation targets were denatured at 95°C for 5
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minutes but not cooled on ice as the large incorporated Cy molecules might have 
precipitated. After applying the target, the slide was covered with a hydrophobic 
coverslip (hybrid-slips, Sigma) and each slide was incubated in an individual 
hybridisation chamber shown in Figure 2.6 overnight at 42°C.
The chambers were wrapped in foil to protect the light sensitive Cy dyes from 
photobleaching. After hybridisation, arrays were washed once for 2 minutes in wash 
buffer A (see Appendix I) and twice for 2 minutes in wash buffer B (see Appendix I) 
and dried in 50 ml centrifuge tubes by centrifugation for four minutes at 1,500 x g. 
Slides were then ready for scanning with an Affymetrix 428 array confocal 
microscope scanner. Slides could not be reused as stripping was not possible once 
they have dried.
79
2. Materials and methods
2.9.2 First generation pathogenicity marker array
A subset of PCR amplified pathogenicity markers was spotted onto aminosilane 
coated glass slides (CMT-GAPII, VWR) for the screening of pathogenicity markers 
in E. coli. Probes for arraying were prepared from clones by Kuhnert and colleagues 
(1997, 2000) The genes were selected on the basis of involvement in pathogenesis of 
UTI strains and also included several well known pathogenicity markers from other 
pathotypes. Pathogenicity markers were previously cloned into pBluescript plasmids 
after amplification from pathogenic E. coli strains using gene specific primers that are 
listed in Appendix II.
Plasmid extraction
For probe preparation, plasmids containing pathogenicity marker genes were 
extracted from 100 ml broth cultures using a plasmid extraction kit (HiSpeed Plasmid 
Midi Kit, Qiagen) following the manufacturer's instructions. Clones were grown in 
250 ml flasks in 100 ml LB medium at 37°C overnight under continuous agitation at 
225 rpm (imMedia Amp; Invitrogen). Cells were harvested by centrifugation for 15 
minutes at 6000 x g. Cell pellets were resuspended in 6 ml buffer PI containing 
RNase A and lysed by the addition of 6 ml of buffer P2. Samples were incubated at 
room temperature for 5 minutes. After addition of 6 ml buffer P3 and mixing by 
inverting the tube several times, the lysate was directly transferred to the QIAfilter 
Cartridge and incubated for 10 minutes. During this incubation the Hi Speed Midi Tip 
was equilibrated, allowing 4 ml QBT buffer to pass through the tip by gravity flow. 
The lysate was passed through the QIAfilter cartridge into the Hi Speed Midi Tip by 
gentle pressure from the plunger and allowed to pass through the tip by gravity. The 
tip was washed with 20 ml buffer QC. Plasmid DNA was eluted in 5 ml buffer QF
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and precipitated using the QIAPrecipitator Midi module. After addition of 3.5 ml 
isopropanol (Sigma) and 5 minutes incubation at room temperature the 
eluate/isopropanol mixture was filtered through the QIAprecipitator. The filter was 
washed twice with 2 ml 70% v/v ethanol and dried. Plasmid DNA was eluted in 1 ml 
nuclease free water (Promega).
DNA fragments were digested from the plasmids with restriction enzymes selected 
during the primer design (shown in Appendix II), using the method described in 
section 2.5. Products were gel-purified before amplification for the complete removal 
of vector sequences using the electrophoresis method described in section 2.4.2. 
Further purification was performed using the Qiagen gel extraction kit. In brief, the 
DNA bands were excised from the agarose gel and weighed. Twice the volume of the 
excised agarose gel was added in resuspension buffer and tubes were incubated at 
50°C until all agarose was dissolved. DNA was purified through silica columns as 
described for the PCR purification method (section 2.6.4).
DNA fragment amplification
Genes encoding pathogenicity markers were amplified from purified plasmid inserts. 
One |il of purified fragment was added to 10 |il 10 x PCR buffer, 10 u.1 2 mM dNTPs, 
3 (il of each primer (20 pmol/^1), one unit Taq in a total volume of 100 ul. 
Amplification was carried out in GeneAmp PCR system 9700 thermal cycler 
(Applied Biosiences) using the following PCR cycling program. An initial denaturing 
step for 4 minutes at 95°C was followed by a three step cycle of 30 sec at 95°C, 30 
sec at the annealing temperature (TA), 30 sec at 72°C for 30 cycles and a final 
elongation 7 minutes at 72°C. Products were held at 4°C after completion of the
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programme. TA values used for amplification are given in Appendix II. PCR products 
were cleaned using the QIAquick PCR purification kit (see section 2.5.4) and 
quantified using spectrophotometrometrical and agarose gel electrophoreisis analysis 
(see section 2.4).
Equal amounts of amplified product (1.5 ^g) were dried and resuspended in 20 ^il 
50% v/v DMSO and allocated a position in a 384-well plate before arraying.
Microarray construction
Arrays were made on a Microgrid II arrayer (Biorobotics) at 25°C and 40 % relative 
humidity. An image of the instrument is shown in Figure 2.7A. A program was 
designed for the allocation of the probes on the slide. Four capillary pins, shown in 
Figure 2.7B, were used for the arraying process. These small pins, 100 nm in 
diameter, print probes of 180 jim only millimetres apart. The reservoir contained up 
to 55 nl of PCR product and deposited 50 pi per target visit. Array patterns were 
designed in such a way that positive and negative controls were used on easy 
identifiable places for orientation purposes (Figure 2.7C). Products were put on the 
CMT-GAPII slide (Corning) in random positions to cut out inter-slide variability. 
Pins were washed before each new 384 well source visit in distilled water, once in 
both circulating water baths for 2 sec and once in the main wash station for 4 sec, 
followed by drying of the pins under vacuum. Each slide contained two identical 
arrays. Each pathogenicity marker array contained 144 probes representing PCR 
products from E. coli pathogenicity marker genes and controls. All probes were 
printed at least in triplicate. In total there were 30 positive control probes, and 15 
negative control probes. The positive controls included a 16S rDNA dilution series 
and genomic DNA probes. Negative control probes were water and spotting solution.
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The probes on the slide were covalently bound to the CMT-GAPII slides by 
crosslinking at 2000 x 100 uJ in an UV Stratalinker (Stratagene).
The array consisted of a primary grid with two rows and two columns and a 
secondary grid with six rows and six columns. A layout of the array is shown in 
Figure 2.7C.
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Slides were prehybridised and hybridised as described in 2.9.1. Post hybridisation 
washes were once for 5 minutes in wash buffer A (see Appendix I) followed by a 
rinse and a 10 minutes wash in buffer B (see Appendix I). Slides were dried in 50 ml 
centrifuge tubes by centrifugation for 4 minutes at 1500 x g. Slides were scanned in 
an Affymetrix 428 array confocal microscope scanner at laser power 40 dB.
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2.9.3 Second generation pathogenicity marker array
In collaboration with Dr. Henry Smith's group at the Central Public Health 
Laboratory in Colindale a second-generation pathogenicity marker array was made. 
This array was made to characterise typical and atypical EAggEC and to develop new 
detection methods targeting genes characteristic of both groups of EAggEC. It 
included all sequences from the first generation array described in section 2.9.2 and 
gene sequences amplified directly from EAggEC strains (listed in Appendix III) that 
could potentially be involved in pathogenesis. This last group of genes was identified 
by sequence comparison of the genome and plasmid sequence of EAggEC strain 042 
to the Genbank database by Dr. Dudley, Baltimore. PCR products were resuspended 
at a concentration of 75 ng/jil in 50 % v/v DMSO and printed from a 384-well plate 
onto CMT-GAPII slides. All products were printed in triplicate on each array, which 
contained a total of 81 probes representing pathogenicity sequences and controls. The 
probes on the slides were covalently bound to the slides by crosslinking at 2000 x 100 
mJ in a U V Stratalinker. The array consists of a primary grid with 2 rows and 2 
columns and a secondary grid with 10 columns and 11 rows. A layout is shown in 
Figure 2.8.
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2.10 Array visualisation and analysis 
2.10.1 Array visualisation
Membrane arrays were scanned on a Typhoon 8600 variable-mode imager as shown 
in Figure 2.9. The Typhoon instrument produces digital images of radioactive, 
chemiluminescent and fluorescent gels and processed blots by laser scanning. 
Radioactive samples need to be exposed to a storage phosphor screen coated with 
BaFBr:Eu+2 . The molecules on the screen surface were excited on the exposure of 
radioactive samples; Eu2+ was oxidised to Eu3+ and BaFBr was reduced to BaFBr". 
The screen was scanned using the red laser (633 nm) in the Typhoon scanner for the 
visualisation of stored information. Signals are detected by the scanner as the 
emission of light from electrons falling back to their ground state.
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Chemiluminescence and fluorescent samples were scanned directly using the laser 
settings. Acquired images were analysed in Arrayvision 6.0 (Imaging Research Inc.), 
a specialist array analysis program for measurement and comparison of signal 
intensities.
] 2 3 4 S 6 ? 8 9 10 11 1213 14 15 16 1? 18 19 20 21 22 ;
Genomic DNA labelled with Cy dyes and hybridised to glass arrays were visualised 
on an Affymetrix 428 array scanner as shown in Figure 2.10, which has a higher 
resolution than the Typhoon. This is a digital confocal laser scanning epifluorescent 
microscope for viewing Cy3 and Cy5 fluorescent-dye labelled samples on the slides. 
The microscope detects the emitted light and creates a false coloured image to be 
used in downstream analysis with Imagene 4.0 (Biodiscovery).
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2.10.2 Array analysis
The analysis programs ArrayVision 6.0 (Imaging) and Imagene 4.0 (Biodiscovery) 
were designed especially for the analysis of array images. The major steps in the 
analysis process were the identification of all array elements by the creation of a 
template, and the quantification of the array elements, hi the template, all information 
about the printed array was incorporated, including the size of the probes, the 
structure of the array, gene identification, reference probes, background and the 
measurements required. Although some downstream analysis features were available 
in the software, further processing was done in MicroSoft (MS) Excel software. The 
background value was subtracted from the total signal intensity and a normalisation 
factor was applied. Values were compared to intensity signals of E. coli K.12 with use 
of the commercial arrays. Probes with ratios higher than 3 or lower than 0.3 were
identified as different between control and test strain when raw intensity data of at
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least one of the genes was above the minimum detection value. Genes were filtered 
using the following MSExcel software function: 
=IF(AND(OR(A>50000,B>50000),O3),"pos in strain
l",IF(AND(OR(A>50000,B>50000),C<0.3333),"pos in K12","neg")) in which A = 
raw intensity data for the probe in strain 1, B = raw intensity data for the probe in 
K12 , C = ratio of the normalised intensity values.
For the pathogenicity marker arrays, a threshold was calculated by analysing 
hybridisation patterns of strains with a known pathotype. Probes with a normalised 
intensity higher than the threshold were called present and probes with an intensity 
lower than the threshold were called absent. An MSExcel software macro was used to 
assist in this analysis and is included on the enclosed CD-rom.
2.11 Data mining
Data was stored in a Bionumerics database (Applied Maths). Experiments (e.g. 
numerical values or assay results) were linked to the entries (e.g. bacterial strains) by 
a unique key. The three major experiment types in Bionumerics are fingerprint type 
(e.g. a densitometric result), character type (e.g. an array of well determined values 
including binary data) and sequence type (e.g. sequence data). The character type was 
used for the storage and analysis of the array data.
Chapter 3 Investigation of extraction, 
[abetting and hybridisation techniques
using bacterial genomic *2)fA^L as array 
hybridisation target
3. DNA extraction, labelling and hybridisation
3.1 Genomic DNA extraction
To determine the most appropriate method for recovering intact high molecular 
weight genomic DNA from bacterial cultures, semi-manual and automated extraction 
procedures were compared (see section 2.3, page 64). The semi-manual method using 
silica gel membrane technology in which DNA from a lysate is bound to a filter and 
eluted after several wash steps (Qiagen method), whereas the automated method used 
magnetic beads to capture the genomic DNA from a lysate (MagNA pure method; see 
section 2.3.2). Both methods gave similar yields of genomic E. coli DNA (40 (J.g/ml) 
from overnight cultures prepared as decribed in section 2.1. When the integrity of the 
DNA was checked by electrophoresis on agarose gels, the manual extracts showed 
smears of DNA (see Figure 3.1), whereas the automated extracts showed clear single 
bands of high molecular DNA (see Figure 3.2). The automated extraction method 
also recovered rRNA, whereas the manual extraction method had an RNase treatment 
step incorporated in the extraction procedure. Therefore, DNA recovered by the 
automated method had to be treated with RNase after extraction to remove RNA 
which would interfere with subsequent labelling and hybridisation of the DNA. The 
manual extraction method was done on individual samples and was relatively 
laborious. In comparison, the MagNA pure instrument could be used to extract 32 
samples simultaneously, and was fully automated. DNA was extracted rapidly and 
there was minimal hands-on time involved in setting up the robot.
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3.2 Optimisation of labelling techniques and hybridisation
To determine which DNA labelling method was most suitable for the hybridisation of 
genomic DNA against the Panorama membrane arrays, three different labelling 
methods were compared. For these optimisation experiments genomic DNA extracts 
were first digested using the restriction enzymes Msel, a restriction enzyme that 
digests DNA frequent, or EcoRl, a restriction enzyme that digests DNA infrequent 
(see section 2.5). A sample of the digest was run on an agarose gel as shown in Figure
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3.3. Whole genomic DNA and restricted fragments were run on agarose gels that 
were subsequently used for the preparation of membranes by Southern blotting for 
hybridisation experiments with various probes, as described in section 2.6.
HB101 K12 ECOR 1 ECOR 2 ECOR 3
E. coli 
E. coli 
Mse\ 
The DNA fragments produced by digestion with Msel were smaller in size than the 
EcoRI fragments when incubated for the same time. The Msel fragments were 
labelled with digoxigenin, 33P or fluorescent dUTP (see section 2.6). These three 
labels were compared because of their different properties as reporter molecules in 
membrane hybridisation reactions. Genomic DNA, rather than PCR products, was 
labelled to simulate the hybridisation of an identical target DNA to the microarrays. 
Digoxigenin-labelled dUTP was used because it is relatively cheap, non-radioactive 
and compatible with Southern blotting. Fluorescent dye labelling of DNA is fast and 
efficient, but DNA prepared in this way is less suitable for Southern blot membrane 
hybridisation, as the auto-fluorescence of the nylon membrane interferes with specific 
data acquisition. Radioactive tracers were used for labelling genomic DNA upon 
recommendation of the manufacturer. Radioactive labeling was a quick, sensitive and
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efficient method, but hazardous waste is produced. 33 P, which was used in this study, 
has a shorter half-life than the more widely used 32P isotope (Amersham Biosciences, 
2004). By testing DNA labelled in different ways on similar membranes, the 
methodologies involved and the specificity of the hybridisation were investigated.
3.2.1 Digoxigenin labelling of the hybridisation target
DNA was labelled with digoxigenin by random hexamer amplification of Msel 
digested genomic DNA. The incorporation efficiency of the digoxigenin labelled 
dUTP into the genomic DNA was assessed by comparison of the labelled probe and a 
control probe (provided by manufacturer) on the same membrane. After development 
of the exposed film, the signals were compared and the concentration of the labelled 
product calculated. Typical signal intensities are shown in Figure 3.4. By comparing 
the signal intensity of the labelled DNA probe with a dilution series of labelled 
control DNA of known concentration, an estimation of the probe concentration was 
made. In this example, the control DNA and the labelled E. coli DNA showed 
identical signal intensities. The signal of the 1:330 E. coli DNA probe that was 
prepared, was equivalent to the signal of the control probe with a concentration 5 
pg/|ul (See Figure 3.4). Therefore the approximate concentration of the labelled probe 
was estimated at 5 pg/|il x 330 = 1650 pg/pil = 1.7 ng/(j.l.
93
3. DNA extraction, labelling and hybridisation
coli 
E. coli 
Digoxigenin-labelled DNA was used for the hybridisation of membranes produced by 
Southern blotting of both undigested and digested genomic DNA electrophoresed on 
agarose gels, as shown in Figure 3.3. Hybridisation signals were undetectable (results 
not shown) when the manufacturer's recommended concentration of digoxigenin 
labelled product was used as listed in Table 2.2. When the concentration of probe 
DNA used during hybridisation was increased, most of the undigested DNA bands 
with high concentration became visible, as shown in Figure 3.5. Both of the added 
control standards were detected clearly, confirming that the hybridisation probe was 
indeed labelled, and also that the labelled DNA was annealing to the genomic DNA 
bound on the membrane.
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K12 ECOR1 ECOR2 ECOR 3
3.2.2 Fluorescein dUTP labelling of the hybridisation target
Genomic DNA extracted from E. coli strains was labelled with fluorescein-dUTP by 
random prime amplification (see section 2.6.2) using an ECF labelling kit. When the 
signal intensities from the labelled DNA were compared to a dilution series of 
fluorescent standards, supplied in the kit, they were observed to be equivalent to the 
highest concentration as shown in Figure 3.6. This shows that the E. coli DNA 
digested with Mse\ restriction enzyme was labelled sufficiently well for use as a 
hybridisation probe. The signal intensities of the labelled E. coli DNA were higher 
than the expected minimal labelling efficiency compared to dilutions of the control 
labelled probe. The fluorescently labelled probes were used for hybridisation with
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Southern blot membranes prepared from agarose gels as shown in Figure 3.3. The 
fluorescent signal from the membrane after overnight hybridisation was too low to be 
directly detected by phosphor imaging using a Typhoon instrument. Autoradiographs 
of the membranes also gave weak signals, and had a low signal to noise ratio as the 
auto-fluorescence of the membrane interfered with the probe signal (data not shown).
Mse\ \ 
:500 1:250 1:100 1:50 1:25 1:10
E. coli 
Mse\ 
3.2.3 Radioactive labelling of the hybridisation target
Genomic DNA extracted from E. coli cultures was labelled with 33 P by random prime 
labelling, as described in section 2.5.3. Before use in hybridisation reactions, the 
specific activity of the radioactive probes was calculated using the manufacturer's 
guidelines. An example of a calculation (using the formula given in 2.6.3) is given 
below for the incorporation of 33 P into SOOng of template DNA. [33P]-dCTP with a 
specific activity of 2500 Ci/mmol and at 50 |j.Ci/ml was used, which gave 93%
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incorporation after 30 minutes. Therefore the mass of DNA after the incorporation 
was:
Mass of DNA (ng) = [uCi addedlf 13.21[%incorporation1 + starting template (ng)
Specific activity of [33P]dCTP
= 50x 13.2x93 + 500 = 524.5 ng 
2500
The activity incorporated into the DNA was expressed as: 
Activity incorporated (dpm) = [|J.Ci added][2.2 x 104][%incorporation]
= 50 x 2.2 x 104 x 93% = 1.02 x 10* dpm 
The specific activity of the probe was calculated by:
Specific activity dpm/flg = [dpm incorporated][103]
Mass of DNA (ng)
= n.02xl08U03 = 2.0 x 108 dpm/^ig
524.5
To determine the specific activity directly, the incorporation of 33 P into labelled 
genomic DNA was measured by scintillation counting. The measurements used in the 
example calculation below are in Table 3.1.
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The average of the duplicate measurements of probe readings was compared to the 
unwashed sample to determinate the incorporation efficiency (%):
% efficiency = average sample reading x 100% 
unwashed reading
= (1.35x 107 + 1.40 x 107 V2 x 100% =93% 
1.48x 107
The specific activity was calculated by:
Specific activity = (CPM incorporated - back ground Vefficiency
Mass DNA (jig)
(d.35x 107 +1.40x 107 V2-152)70.93 = 1.6 x 107 dpm/^g
Both methods showed that the probes were efficiently labelled. The manufacturer's 
manual gives a formula that allows an estimation of the specific activity, but for an 
accurate measurement a scintillation counter is necessary. Only labelled probes with a 
specific activity higher than 1 x 107 dpm/u,g were considered to be labelled 
sufficiently for use in hybridisation reactions.
Membranes prepared from agarose gels by Southern blotting were hybridised 
overnight, processed and then visualised by autoradiography using X-ray film, or by 
phosphor imaging after exposure to a storage screen. Examples of these are shown in 
Figure 3.7 (autoradiography) and Figure 3.8 (phosphor imaging). The use of the 
Typhoon instrument for detection clearly shows an improvement in the detection of 
the hybridisation signal. Both undigested and digested DNA targets on the 
membranes were strong and clearly detectable after hybridisation with the radio- 
labelled probe.
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HB101 K12 ECOR 1 ECOR2 ECOR 3
Mse\ 
HB101 K12 ECOR1 EC OR 2 ECOR 3
Mse\ 
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3.2.4 Fluorescent Cy labelling of the hybridisation target
Genomic DNA was labelled with fluorescent Cy labelled dUTPs by random prime 
amplification for the use of hybridising glass slide arrays. A small sample of the 
labelled product was electrophoresed on agarose gels to determine the level of 
incorporation. An example is shown in Figure 3.9.
1 234 5678 1 234 5678
Using gel electrophoresis and visual estimation to determine the efficiency of 
incorporation of the Cy dyes was not very precise. A second method, described by 
Murray et ai, (2001) was therefore used to determine the level of incorporation. This 
method measures the amount of DNA remaining unlabelled after the incorporation of 
Cy dye, and therefore the lower the calculated figure, the higher the Cy dye 
incorporation in the DNA. The specific activity is defined as the number of 
nucleotides divided by the dye labelled nucleotides. This could be considered to be 
the reciprocal of the way specific activity is usually expressed for radioactively
100
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labelled probes. The measurements used in an example calculation are given in Table
3.2.
The specific activity for the Cy5 labelled DNA was calculated as follows:
Specific Activity for Cy5 = [Labelled target (ng)1 [10001
[Incorporated Cy5 (pmol)] [324.5]
in which: Labelled DNA (ng) = [A26o] [50] [volume (ul)]
= 0.63 x 50 x 100 = 3.12xl03 ng
and: Incorporated Cy5 (pmol) = [A&5o] [volume (fil)]
[0.25]
= 0.15x100 = 61 pmol 
[0.25]
Specific activity for Cy5 = (3.12 x 103 )1000 =158 ng/pmol
61 x 324.5
and for Cy3 labelled DNA:
Specific Activity for Cy3 = [Labelled target (ng)] [1000]
[Incorporated Cy3 (pmol)] [324.5]
in which: Labelled DNA (ng) = [A260 ] [50] [volume (\i\)]
= 0.48 x 50 xlOO = 2.39 x 103 ng
and: Incorporated Cy3 (pmol) = [AW| [volume (p.!)]
[0.15]
= Q.09x 100 = 61 pmol 
[0.15]
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Specific activity for Cy3 = (2.39 x 103 )x 1000 = 120 ng/pmol
61*324.5
For Cy5 as well as Cy3 hybridisation DNA targets with a "specific activity" below 
175 ng/pmol were used for hybridisation.
3.3 Discussion DNA extraction and labelling procedures
Molecular characterisation methods used for bacterial typing generally require good 
quality, pure DNA. The extraction procedures used to obtain such DNA range from 
manual phenol-chloroform methods and commercial extraction kits (often based on 
binding DNA to a resin) to automated systems for (semi-) high-throughput screening 
(Schmidt et al., 1995b, Sambrook et ai, 2001, Mygind et al., 2003, Smith et al., 
2003). For example, Sambrook and colleagues (2001) describe a phenol-chloroform 
method for extracting DNA from micro-organisms for use in standard molecular 
techniques. Smith et al. (2003) compared five high throughput extraction kits using 
DNA binding, DNA filter plates, or metallic beads, and found 96-well plate methods, 
such as the Montage plasmid Miniprep96 kit (Millipore), easiest to use. Mygind and 
colleagues (2003) also evaluated kits for bacterial DNA extraction, including the 
Qiagen DNeasy Tissue and the MagNA Pure extraction kit, which were also used in 
this study. They concluded that DNA extracted with the MagNA Pure was of the 
highest concentration and purity. Automated methods are increasingly favoured for 
their consistency of DNA quality and purity, and for their ease of use (Mygind et al., 
2003). Manual extractions are more laborious, and RNA and inhibitors of PCR need 
to be removed before the extracted nucleic acid can be used in downstream
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applications. DNA extraction kits generally shorten labour time, and may increase the 
purity of the DNA compared to manual extractions using standard molecular 
techniques. DNA prepared by automated systems can often be used directly in 
downstream applications and, may give more reproducible results.
The Qiagen extraction kit and the Roche MagNA Pure automated extraction robot 
were compared as part of this study. Genomic DNA extracted with the MagNA Pure 
instrument was visible as a strong clear band following gel electrophoresis. The 
Qiagen extraction kit showed smears of DNA (see Figure 3.1 and 3.2). This may be 
because the DNA was not forced through a filter during the MagNA Pure process 
unlike the Qiagen extraction method. DNA sample variation, in terms of yield and 
A260/A280 ratio, was better for DNA prepared with the MagNA Pure than with the 
Qiagen extraction method. Similar results were found in other studies (personal 
communication, Dr. J. Logan and Dr. K Edwards, HPA) and are also acknowledged 
by Roche.
The DNA obtained by any extraction method has to be labelled in a uniform, efficient 
and reproducible manner if it is to be suitable for hybridisation against whole genome 
arrays. The labelling of DNA is a well established technique and can be performed 
either directly, incorporating the labelled nucleotide into the DNA, or indirectly, by 
incorporating a modified nucleotide into the DNA and then attaching a label in a 
second reaction (Richter et al., 2002). Various procedures, including fluorescence, 
digoxigenin and radioactive tracers, efficiently incorporate the tracer into the DNA, 
and the differing characteristics of the incorporated molecular structures make them 
more or less useful for different applications (Wang et al, 2002c). Genomic DNA
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hybridisations were used to identity a suitable way for the hybridisation and detection 
of targets with the Panorama membrane microarrays. Colourimetric labelling 
methods are often used for membrane hybridisations (Bertucci et al., 1999). These are 
easy to use and do not have the drawbacks of stability and safety associated with 
radioactive probes. The experiments described in section 3.2.1 show that digoxigenin 
labelled DNA gave only weak hybridisation signals for the detection of digested and 
undigested genomic DNA on Southern blots (see Figure 3.5). A hybridisation signal 
was only observed after increasing the probe concentration from the advised 25 [ig/ml 
to 100 |ig/ml of hybridisation solution. These observations may have been because 
the structure of the DNA did not allow efficient labelling, or they may have been due 
to impurities in the template DNA. The specific activity of the labelled DNA was 
determined before hybridisation, and it was considered to be sufficient for 
hybridisation. Impurities in the DNA preparations were not observed in either gel or 
spectrophotometric analyses.
The use of fluorescent molecules for labelling DNA was investigated to determine if 
this approach would improve the sensitivity of the signal obtained following 
hybridisation of the DNA to the arrays. Fluorescent labels are widely used in 
biological applications (e.g. sequencing or fluorescent electron microscopy or 
fluorescent-activated cell sorting) (Kaiser etal., 1989, Knutton et al., 1997, Tung et 
al., 2004). The advantage of using a laser scanner for the detection of the fluorescent 
labels is that more than one label can be detected in each experiment. Although 
fluorescent labelled DNA is a good for hybridisations against glass slides, using such 
DNA for membrane hybridisations leads to problems of detection, such as auto- 
fluorescence of the nylon membrane, which interferes with data acquisition. Indeed,
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the Typhoon variable mode imager used in this study was unable to detect the 
hybridisation signals directly from membrane arrays probed with fluorescently 
labelled DNA. The signal was amplified by the use of an antifluorescein, bound to 
alkaline phosphatase. Even after amplification the chemiluminescent signal was 
barely detectable after exposure of these membranes to film (results not shown). 
Fluorescent labelling, therefore, was not used for the hybridisation experiments with 
the membrane arrays.
During the initial hybridisation experiments it was found that when 33 P labelled DNA 
gave a good signal when visualised with auto radiography (e.g. Figure 3.7). Following 
overnight exposure of the hybridised blots to a storage phosphor screen the sensitivity 
of detection increased (e.g. Figure 3.8). The disadvantages of radio-labelling and the 
longer exposure of the blots to the storage phosphor screens were negligible 
compared to the increase in sensitivity. The drawback of using radio-labelled probes 
and the storage phosphor screen was that the detection process was time consuming 
and would not be applicable for high throughput screening. The membrane arrays 
would be hybridised with radioactively labelled targets and the glass slides would be 
hybridised with Cy3/Cy5 labelled targets. Both methods would use random prime 
amplification for the incorporation of the label. The membrane arrays would be 
visualised using the storage phosphor screens and the Typhoon instrument. The glass 
slides would be scanned directly in the Affymetrix 428 microarray scanner.
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4. Comparison of whole genome arrays for characterisation ofE. coli 
4.1 Introduction
This chapter describes a comparison of two commercial whole genome DNA arrays 
for typing and comparing Escherichia coli (E. coli) strains. A whole genome array 
prepared from all PCR amplified ORFs on nylon membranes (Panorama Array, 
Sigma-Genosys) was compared with a whole genome array prepared from ORF 
specific 70-mer oligonucleotides on glass slides (Pan Array, MWG). Both arrays 
were designed to cover all ORFs in the E. coli K12 gene sequence. To determine 
which array would produce the most accurate results, each type of array was 
hybridised with the same strains from the ECOR collection. The array data were 
interpreted to identify possible candidate genes characteristic for individual E. coli 
strains that could be used as sub-typing markers for DNA 'fingerprinting 7 of the 
strains.
It was anticipated that the commercial arrays would display strain-specific 
hybridisation patterns when hybridised with DNA prepared from different E. coli 
strains. This is illustrated in Figure 4.1, which shows how two hypothetical ECOR 
strains might compare with E. coli K.12. Some ECOR strains might have multiple 
copies of genes present in E. coli K12 (e.g. the blue gene for ECOR x and the green 
gene for ECOR y in Figure 4.1 A). Therefore the hybridisation signal for these genes 
would be stronger for those isolates compared to the signal intensity of the same gene 
in E. coli Kl 2. Other genes might be deleted or replaced with a completely new gene 
(the "yellow" genes in Figure 4.1 A) and a hybridisation signal for the original gene in 
E. coli K12 would not be detected. Interestingly, the replacement genes might have 
been acquired through horizontal transfer and could potentially be genes involved in
I07
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pathogenesis. Other genes might have less than 100% sequence similarity with the 
equivalent in the reference strain, and therefore the hybridisation signal from these 
would be weaker (the genes represented with dotted lines in Figure 4.1 A). Finally, 
some genes might be highly conserved and give a similar signal in both genome 
hybridisations (the genes represented with solid lines in Figure 4.1 A). Figure 4.IB 
shows the hypothetical results these gene changes would have on the hybridisation 
signals, showing a unique pattern for each of the strains.
r.nli POOR F mli 
E. 
E. 
E. coli 
E. coli 
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4.2 Panorama Arrays 
4.2.1 Whole genome Panorama membrane hybridisations
Initially, the applicability of the Panorama whole-genome membranes (Sigma- 
Genosys) for a detailed characterisation of E. coli strains was investigated. Radio- 
labelled probes were prepared from genomic DNA isolated from E. coli K12 and five 
strains from the ECOR collection (in the data tables these ECOR strains are labelled 
ECOR1-ECOR5). Hybridisations against E. coli K12 were carried out in duplicate to 
test reproducibility (in the data tables these two hybridisations are labelled K12_l and 
K12_2). Typical results of just one field of the array are shown in Figure 4.2, Every 
membrane had three of these fields all with different probes. The signal intensities of 
the probes on the membranes were measured using the specialised microarray 
software Arrayvision 6.0 (Imaging Research Inc.). A defined grid template was 
positioned over the digital image and measurements were returned in a large data 
table including gene identities, raw data and background measurements. This process 
is illustrated in Figure 4.3. MS Excel software was used for the calculation and 
interpretation of the data. All raw data can be found on the enclosed CD-rom under 
Chapter 4/Raw data/Panorama Arrays.
109
4. Comparison of whole genome arrays for characterisation ofE. coli
33 P
coll 
E. coll 
110
4. Comparison of whole genome arrays for characterisation ofE. coli 
4.2.2 Array normalisation
Normalisation is the computational process by which data from different arrays are 
equalised before analysis (Schena, 2003c). The most appropriate normalisation factor 
to use was investigated with the data acquired from the membrane arrays. Data were 
normalised separately using: (a) the average signal of the genomic DNA reference 
probes; (b) the median value of all probes on the membrane; and (c) the mean value 
of all probes on the membrane. The appropriate normalisation factors were calculated 
and all measurements of the probe intensities for that hybridisation were adjusted 
using these factors. Part of a complete datasheet for the normalisation of one 
experiment is given in Table 4.1. The full datasheets for normalisation of all 
hybridisations can be found on the enclosed CD-rom under Chapter 4/Normalised 
data/Panorama Arrays.
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= raw data ' 
gen DNA norm factor
raw data ' 
median norm factor
raw data ' 
mean norm factor
gen is genomic, norm is normalisation
The effect of normalisation of the data can be seen in Figure 4.4 A-D. After 
normalisation, the normal distribution of the data is comparable for different arrays as 
the frequency distribution has a similar range on the x-axis. This makes it possible to 
compare data from different arrays once the data are normalised.
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E. coli 
Mean normalisation was used as standard for the normalisation of data for two 
reasons. Firstly, it would not be possible to compare the two types of arrays using the 
genomic DNA probes as the Pan arrays do not have any genomic reference probes. 
Secondly, low intensity hybridisation signals that are detected in Panorama array 
hybridisation data could affect data interpretation if median normalisation was 
applied (Kroll and Wolfl, 2002).
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4.2.3 Reproducibility of hybridisation
To investigate array reproducibility, E. coli K.12 DNA was hybridised in duplicate 
against two membrane arrays. In both cases, the hybridisation probes were made from 
the same genomic DNA extraction, but the labelling reactions were performed 
separately. The scatterplot of mean normalised data obtained in a duplicate 
experiment of E. coli K12 target DNA hybridised against the membrane arrays is 
shown in Figure 4.5. For duplicate microarray experiments the scatterplot data points 
are expected to form a straight line at 45° to the axes. Although the mean 
normalisation process has placed the data around the 45° line on the plot, there is a 
wide distribution of probes.
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Another way to visualise the duplicated data is to use a Bland-Airman plot (Bland and 
Altman, 1986, Bland and Altman, 1999). In this plot the average of two data points is 
set out versus the difference between two data points. In an experiment with a high 
reproducibility, the probes are expected to be present on or around the x-axis. The 
Bland-Altman plot of the repeated E. coli K.12 hybridisation experiment is shown in 
Figure 4.6 and shows that probes are not present on the x-axes. The standard 
deviation lines included in the graph show that probes are widely spread and do not 
fall between the 1 or 2 standard deviation lines. The duplicated hybridisations have a 
wider variability than expected for a same versus same plot.
14
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One advantage of membrane arrays compared to glass slides is that the hybridisation 
probes can be removed from the membrane and the membrane can be reused in a 
second hybridisation reaction. To investigate whether all detectable signal was 
removed from the membranes, a "stripping" protocol using SDS buffer was used (see 
section 2.8). Most of the signal was removed to satisfactory levels as over 4200 
probes were stripped of more than 99% of their signal. This included all the genomic 
DNA positive control probes. The difficulty was that even after stripping, the 
intensity of the brightest probes was still significantly higher than the background. 
Therefore, in subsequent experiments, when an unknown sample was to be hybridised 
with these membranes, probes absent in the tested strain might still give a signal 
higher than the background. Because of this membranes often had to be stripped more 
than once to leave intensities well under the background levels. Stripping of the 
membrane caused unwanted loss of membrane bound DNA that resulted in decreased 
signal values.
E. 
Although the results obtained from probing the membranes with E. coli K12 DNA 
were not reproducible, further experiments to shed more light on this, using the 
ECOR strains, were performed. For example, to investigate the ECOR strains, their 
hybridisation patterns were compared to the equivalent pattern obtained with the 
reference strain E. coli K12. Ratios of the signal intensities of the tested strain versus 
the reference strain were calculated after mean normalisation. On the basis of the ratio
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values probes were divided into three groups. Probes with a high ratio were 
those with a higher intensity in the test strain compared with E. coli K12. These 
probes were called positive in the test strain. 2: Probes with a low ratio were 
those with a higher intensity in the E. coli K12 strain compared with the test strain. 
These were called positive in K12. 3: Probes with ratios close to one were 
considered to be for genes that were either both present or both absent in the 
reference and test strains.
The cut-off value of interest was set for probes with a ratio higher than three or lower 
than one third, meaning that the intensity in one strain must be three times the 
intensity level in the other strain for it to be called a positive in the strain where it was 
brightest. Probes that had a low intensity value in both arrays were filtered out of the 
list of potential informative genes, as these were likely to cause unreliable high or low 
ratios that could skew the data and lead to misinterpretation of the analysis. The 
analysis described above was performed using MS Excel software using the function 
described in section 2.10.2. Venn diagrams, shown in Figure 4.7, were used to get an 
initial overview of the size of the three different groups.
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K12 1 vs K12 2 ECOR3 vs K12
259 3797 237
ECOR2 vs K12 p ECOR5 vs K12
E. coli 
E. coli 
Data are presented for the five ECOR strains and a duplicate E. coli K12 experiment 
(Figure 4.7 A). The self versus self comparison of E. coli K12 shows that the use of 
membrane arrays with DNA labelled by random priming did not give reproducible 
patterns of hybridisation, since 258 and 290 probes differed in intensity levels. 
Many of the probes did not differ in intensity when the ECOR strains were compared 
against the E. coli K12 strain (i.e. the blue values in Figure 4.7). These were expected 
to represent conserved genes. However, the Venn diagrams also show groups of 
probes that had a higher intensity in the ECOR strains (i.e. the red values in Figure 
4.7) or a lower intensity in the tested strain (i.e. the green values in Figure 4.7) 
compared to the reference strain of E. coli K12. These were expected to represent
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variable genes. These genes can be classified into their functional groups as shown in 
Table 4.2 (numbers are colour coded as shown in the Venn diagrams above). By far 
the largest group was those of hypothetical, unclassified and unknown gene function, 
which was the largest category of genes on the array.
Amino acid biosynthesis and 
metabolism
Biosynthesis of cofactors, 
prosthetic groups and carriers
Carbon compound catabolism
Cell processes (incl. adaptation, 
protection)
Cell structure
Central intermediary 
metabolism
DNA replication, recombination, 
modification and repair
Energy metabolism
Fatty acid and phospholipid 
metabolism
Genomic DNA
Hypothetical, unclassified, 
unknown
Membrane proteins
Nucleotide biosynthesis and 
metabolism
Other known genes
Phage, transposon, or plasmid
Putative chaperones
Putative enzymes
Putative regulatory proteins
Putative transport proteins
Regulatory function
Structural proteins
Transcription, RNA processing 
and degradation
Translation, post-translational 
modification
Transport and binding proteins
13
14
12
1 
12
13
1257
12
21 
31 
71 7
41 4
12
14
16
14
21 
3 
31 
21 
21 
31 
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To investigate genes that appeared to be different for the test strains it was necessary 
to consider them individually. In total there were 722 ORFs missing from any of the 
tested strains (i.e. an intensity three times lower compared to the E. coli K12 strain). 
Two hundred and twenty eight of these genes were previously found to hybridise 
irreproducibly between duplicate K12 experiments and therefore the reliability of 
these 228 probes must be questioned. The positions on the chromosome represented 
by these genes might be lost or replaced with another gene through horizontal gene 
acquisition. The graph in Figure 4.8 depicts the 722 genes in groups in relation to 
how often they were detected in the five data sets. A total of 401 probes (55%) were 
missing in just one of the tested ECOR strains and could therefore be a unique 
characterisation marker for that strain. Thirty three genes (5%) were missing from all 
five data sets. Upon further examination most of these genes (88%) were classified as 
unknown genes.
13%
55%
18%
E. coli 
E. coli 
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Although these missing genes can assist in the characterisation of the strains 
(especially the ones unique to one strain), they also display one of the biggest 
limitations of experiments using microarray as described in this chapter. Microarrays 
can only confirm information about the genes that are on the array and therefore 
known and are less applicable for the investigation of newly acquired or mutated 
genes.
In total there were 535 probes that were brighter in any of the ECOR strains 
compared to K12, but 268 genes from mis list had previously been detected in the 
K12 versus K12 comparison. The graph in Figure 4.9 depicts the 535 genes in groups 
in relation to how often they were detected in the five data sets. Almost half of the 
genes (41%) detected as more intense in an ECOR strain are unique to that strain and 
only appear once (i.e. 222 genes). About one in ten genes (11%) were present in all 
data sets (i.e. 60 genes).
11%
19% 41%
13%
16%
coli 
E. coli 
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All of the 722 and 535 genes that were identified have been pooled in Table 4.3 to 
identify the individual genes classified by their unique b-number. Part of this gene list 
is displayed, but the whole list of these potentially informative genes and their 
presence or absence in the tested strains can be found on the enclosed CD-rom under 
Chapter 4/Genes of interest Panorama Arrays. The genes and their functional group 
are listed in the first two columns. The next columns show the data obtained from the 
hybridisation of the five ECOR strains. A numerical value of 1 indicates a probe with 
a higher signal intensity in the ECOR stain (e.g. probes previously labelled in red). A 
numerical value of-1 indicates a probe that had a lower signal intensity in the ECOR 
strain (e.g. previously labelled in green). Probes with a numerical value of 0 have a 
similar hybridisation intensity in both strains (e.g. previously labelled in blue).
ECOR1 ECOR2 ECOR3 ECOR4
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Two dendrograms were obtained from this data The first one was drawn from the 
data obtained while focussing on the absent genes in the ECOR strains (Figure 4.11) 
while the second one looked at genes present in the ECOR strains (Figure 4.12). Both 
of these dendograms were than compared to the dendogram obtained by Herzer and 
colleagues using MLEE to characterise the strains in the ECOR collection (Figure 
4.10). A categorical clustering method and the UPGMA algorithm were used for the 
composition of all dendrograms shown.
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Normalisation of the signal intensities obtained from array experiments is crucial to 
the correct interpretation of microarray data (Quackenbush, 2002, Yang et al., 2002, 
Park et al., 2003). Any type of experimental variation in the signal intensity values 
caused by changes in labelling or hybridisation efficiency, the post hybridisation 
washes, the scanning process or other aspects of the microarray process can lead to 
differences in the raw data that are not representative of differences in the DNA 
sequences being compared. To correct for these discrepancies as far as possible, a 
normalisation factor is used to equalise data from different channels or arrays before 
analysis. Global normalisation factors calculated from the total signal intensity (e.g. 
mean and median values) are widely used as standard methods (Kroll and Wolfl, 
2002), and are described in more detail in section 1.3.4. Also reference probes, 
whether housekeeping genes or genomic DNA probes, are used for the normalisation 
of microarray data (Hegde et al., 2000, Quackenbush, 2002). Using the data acquired 
from the whole genome membrane arrays, three different global normalisations were 
compared. Data was normalised against the mean of genomic DNA reference probes,
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the mean intensity of all ORF representing probes or the median intensity of all ORF 
representing probes.
Normalisation against the average signal intensity value of the genomic DNA 
reference probes led to two problems. Firstly, the signal intensities of the genomic 
DNA probes were very different in value across the membrane. It would not have 
been appropriate to simply average these values and use the mean for normalisation 
since the use of this value would have introduced systematic errors. The membrane 
arrays were normalised per field using the average value of the signal intensity of the 
genomic DNA reference probe in that field. Analysis of the data in this way may have 
lead to misleading interpretations. Secondly, normalisation against the genomic DNA 
reference probes was not possible for the Pan arrays used later in this project, as these 
did not contain comparable reference probes. The median of the overall intensity 
values can easily be influenced by extremely low hybridisation signals (Kroll and 
Wolfl, 2002), which appeared in the Panorama arrays. The gene representation 
printed on the Panorama and Pan array was identical, with the exception of the 
positive and negative control genes. It was therefore concluded that using the mean 
normalisation factor method was most appropriate to compare normalised data from 
the Panorama and Pan arrays.
Microarray gene expression experiments require a high number of replicates for the 
data to be reliable (Churchill, 2002). There is a high level of variability that can occur 
during the experiment, and the large number of probes on microarrays cause normally 
acceptable levels of false positives or negatives to lead to misidentification of many 
genes (Lee et al., 2000). The work described using membrane arrays gave results that
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were not satisfactory from the point of view of reliability and reproducibility. It may 
not be completely unexpected to find a poor reproducibility in the membrane 
hybridisations from just one replication experiment. One solution would be to repeat 
the experiments multiple times and thereby remove outliers and average the 
reproducible data. The variation in signal intensities of a repeated experiment can be 
the result of many aspects of the labelling and hybridisation process. In the 
experiments described in section 4.2.3, Figures 4.5 and 4.6, labelled target DNA was 
made from one genomic DNA extract but labelled in separate reactions. It is possible 
that the lack of reproducibility observed was because incorporation of the label into 
the DNA was not comparable for the different targets. When the incorporation of 
label was measured the specific activities were similar. If targets were not labelled 
with the same efficiency there should not be a great effect on the reproducibility after 
normalisation has taken place. Possible variability introduced during the (post) 
hybridisation reaction should have been eliminated by the normalisation of the signal 
intensities.
Another possible reason for the lack of reproducibility in probe signal intensities is 
the random nature of the labelling reaction. Radio-labelled nucleotides may have 
incorporated into different regions of the genome with different efficiencies leading 
to variation in hybridisation signal. This might explain the results of the membrane 
hybridisation with labelled genomic E. coli K12 DNA shown in Figure 4.2. All the 
genes on the array are amplified from the E. coli K12 strain and should give probes 
with constant signal intensities significantly above background after hybridisation 
with the E. coli Kl 2 labelled genomic DNA target. When an array hybridised in this 
way was examined it was noticed that the signal intensities were inconsistent. Some
4. Comparison of whole genome arrays for characterisation ofE. coli
probes were very intense while others were only just detectable. Although the random 
nature of the labelling reaction is a possible explanation of why replicated 
experiments were not reproducible when membranes were used, similar problems 
were not observed with the fluorescently labelled targets hybridised against the glass 
slide arrays, which were also labelled using a random amplification. Another 
explanation is that the inconsistency in the signal intensity of the probes is caused by 
differences in concentration of spotted PCR product during the production of the 
membranes by the manufacturer. For example, there could be variability in either the 
quantity of probe delivered to the membrane or in the efficiency of binding to the 
membrane surface. Although this remains the most likely explanation for the poor 
quality of the results obtained on the membranes no further information is available to 
support this hypothesis.
Even though the membrane hybridisation data lacked reproducibility, the results 
derived from the hybridisations were analysed. It was anticipated that the number of 
probes giving a different hybridisation signal for E. coliK\2 and the ECOR test 
strains would differ to a greater extent than when replicate K12 target preparations 
were compared. There were 548 variable probes (258 and 290; see Figure 4.7A) 
identified from the E. coli K.12 hybridisation experiments.
After normalisation of the signal intensity against the mean value, ratios of the tested 
ECOR strain versus E. coli K12 were calculated as described in section 2.9.2. On the 
basis of the value of that ratio, genes were divided into the three groups described in 
section 4.2.5. Most genes were part of the third group (i.e. their signal intensity did 
not differ significantly between the ECOR and E. coli K12 strain). Probes in group 3
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can be described as core genes of E. coli (Welch et al, 2002, Anjum et al., 2003, 
Smalley et al., 2003). Genes with very different hybridisation patterns were also 
detected. Genes identified in the second group, with a lower signal intensity than 
found in the hybridisation of E. coli K12 DNA, can be explained in three ways. 
Firstly, the genes may be absent from the ECOR strain. Secondly, fewer copies of the 
gene may be present in the ECOR strain compared to the E. coli K12 strain. Thirdly, 
the gene may have a sequence similarity less than 100% with the gene in E. coli K12, 
and therefore the hybridisation of genomic DNA from ECOR strain is less efficient 
compared to the signal obtained from the hybridisation with E. coli K12 genomic 
DNA. The genes in the first group, with a higher intensity in the tested ECOR strain 
can be explained by genes that are present in multiple copies in the ECOR strain 
compared to the E. coli K12 reference strain. Some of these genes were unique to just 
one of the ECOR strains and could therefore be probes with potential to be used for 
the characterisation of the individual strains. These should only be considered in 
combination with the missing genes as these genes were amplified from the E. coli 
K12 genome and can therefore not be characteristic for just that ECOR strain.
The E. coli K12 self-hybridisation experiments on the membrane arrays showed 258 
and 290 differences (see Figure 4.7). A student t-test revealed that the two data sets 
were significantly different. When assuming that both data sets obtained in the K12 
duplicate experiment are normally distributed, a paired t-test showed a probability of 
P - 0.0001 for the comparison of the mean of the replicated data. The variance of 
both distributions was also significantly different (P = 0.0026). It was expected that a 
strain different from K12 would have an increase in genes with a different 
hybridisation pattern. Therefore, it was expected that the investigation of the
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hybridisation patterns of the ECOR strains against K.12 would indicate more than 290 
differences. However, analysis of the results of the hybridisation patterns of five 
ECOR strains showed that this is not the case (see section 4.2.5). Only the ECOR1 
strain gave slightly more than 290 gene differences. In total, 313 genes gave a more 
intense signal in this strain compared to the signals from the E. coli K12 
hybridisarion. Statistical tests of the tested strains and the E. coli K12 on the different 
groups as presented in Figure 4.7 show a significant difference between the expected 
values for E. coli K12 as detected through the replication experiment and observed 
values in the tested strains. The Chi-square probabilities for the tested strains in 
comparison to the duplicated E. coli K12 experiment are all lower than 0.04. The 
groups of present and absent probes contain significantly different numbers from 
what was expected on the basis of the reproducibility experiment. Also the 
probabilities of the tested strains mean are significantly different compared to the 
duplicated K12 experiment (P«0.0001). So although the distributions are different, 
this has not reflected in an increase of possible markers. It is therefore challenging to 
identify the genes that are truly different between K12 and other E. coli by this 
membrane-based, whole genome array hybridisation approach.
The genes belonging to group 1 and 2 were analysed according to their function. All 
groups had at least one difference in probe hybridisation signal. Some of the 
functional group (i.e. fatty acid and phospholipids metabolism and membrane 
proteins) had only few differences suggesting that these functional groups are very 
well conserved in E. coli. Many of the potentially interesting genes are included in 
the group of hypothetical, unclassified and unknown genes, which are by far the 
largest category of genes on the array (see Table 4.2). The genome sequences of more
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E. coli isolates and other closely related species arising from whole-genome 
sequencing projects will most likely shed more light on the function of these genes. It 
needs to be taken into account that only genomic DNA was hybridised, and that no 
conclusions can be drawn from these experiments as to whether this results in an 
alteration of expression levels. However, genes that appear to be absent in the tested 
strains cannot be expressed.
In total, 1240 genes had different probe intensities in the ECOR strains compared to 
E. coli K12. From these 1240 genes, 535 were identified as being more intense and 
722 were identified being less intense in any of the ECOR strains. These numbers 
may appear to be misleading but some genes were more intense in one strain while 
less intense in another. So there is a small overlap between the two categories. From 
the 290 and 258 probes that gave irreproducible results in the E. coli K12 
reproducibility experiment (see Figure 4.7), almost all (494) appeared in the list of 
candidate genes. The reliability of these 494 genes should therefore be questioned and 
not be the focus of further investigations to use these genes as typing markers.
For example, one of the genes with high probe intensity in all strains was entB 
(b0595), which plays a role in enterobactin assembly which is an important mediator 
for iron transport in E. coli, and is detected in the majority of strains. Other genes 
include gatY (b2096) as well as its operon (b2087), giving confidence that the genes 
are not just different by chance, but that closely related probes appear on the list of 
potential informative genes. The genes for galactitol and ribitol utilisation are are 
mutually exclusive although their sequence is not similar. Previous reports show that 
a positive Gat phenotype is easily lost at the transduction of genes for ribitol
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utilisation (Woodward and Charles, 1983). The ECOR strains could have lost the gat 
genes but still be able to metabolise galactitol via the alternative pathway.
Genes with a low probe intensity in all ECOR strains include a large group ORF 
defined as phage, plasmid or transposons and hypothetical unclassified and unknown. 
ORFs that were well characterised in this group of genes missing from all five ECOR 
stains include a cluster of genes involved in lipopolysaccharide biosynthesis (b3624, 
b3627, b3629, b3630). The difference in hybridisation signal of these genes cannot be 
caused by a membrane effect as these genes are widely spread over the membrane. 
This region in the chromosome could therefore be interesting for further investigation 
to see whether these genes are replaced with other genes or are lost completely. It 
could also indicate a region that might be of interest for molecular serotyping. 
Although E. coli K-12 does not express LPS these genes were still identified on the 
chromosome. The ECOR strains might have different LPS and therefore not give a 
hybridisation signal for these particular probes. These probes could still be of interest 
as missing a gene could be just as characteristic for a strain as genes that are present.
The protocol provided by the manufacturer of the Panorama array (Sigma-Genosys) 
gives a method for stripping the membranes (up to ten times) so that they can be re- 
used, but warns that the signal might be reduced. This method decreased signal 
intensities of most probes by over 99% after stripping, however, some of the 
remaining signals were still more intense than the background measurement of the 
previous hybridisation. Therefore, if these stripped membranes were to be re-used 
immediately, erroneous conclusions might be drawn. Although great care was taken 
during the stripping of the membranes, and the stripped membranes were re-exposed
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to the storage phosphor screens before re-hybridisation, re-use may have affected the 
reproducibility of the results. High-throughput screening would not be achieved using 
this methodology because of the time-consuming characteristic of stripping and data 
acquisition. Reusing membrane arrays for the high-throughput testing of isolates was 
therefore not considered acceptable for fingerprinting analyses and it was anticipated 
that non-reusable glass slide microarrays would give more reliable results.
The Panorama membrane arrays were large and not easy to handle. Radio-labelling of 
the hybridisation target made data acquisition time consuming. Stripping the 
membrane was possible, but complications arose for probes with a high intensity 
level in relation to the background. The reproducibility of the repeated experiments 
on the stripped membranes was poor. The genes showing a difference in signal 
intensity levels were abundant, but did not exceed the number of genes observed to be 
different in the E. coli K12 duplication experiment. The Panorama arrays were 
therefore not considered to be suitable for the development of a fingerprinting or 
typing method. Glass slide arrays and fluorescent labelling of the target were 
therefore investigated to determine if they would be free of the problems encountered 
when using the Panorama membrane arrays.
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4.3 Pan Arrays 
To investigate the application of the Pan whole-genome glass arrays (MWG-Biotech) 
for genomic typing of E. coli, glass slides were hybridised with fluorescently labelled 
probes prepared from E. coli Kl 2 and five ECOR strains. These were identical to the 
strains used in the Panorama array experiments and are numbered ECOR1-ECOR5 in 
this results section. Six whole genome glass slide arrays were simultaneously 
hybridised with E. coli K12 DNA labelled with Cy3 and DNA extracted from one of 
the bacterial strains in the ECOR collection labelled with Cy5. Hybridisations for the 
ECOR1 strains and E. coliK\2 were carried out in duplicate to test reproducibility. 
This replicated data are labelled ECORla and ECORlb. Data were acquired by 
scanning the hybridised slides using an Affymetrix 428 microarray scanner (see 
Figure 4.13). Signal intensities of the probes on the glass slides were measured using 
Imagene 4.0 (Biodiscovery) microarray software. A defined grid template was 
positioned over the digital image and measurements were returned in a large data 
table including gene identities, raw data and background measurements. This process 
is illustrated in Figure 4.14. MS Excel software was used for the calculation and 
interpretation of the data. All raw data can be found on the enclosed CD-rom under 
Chapter 4/Raw data/Pan Arrays.
133
4. Comparison oj whole genome arrays for characterisation ofE. coli
E. coli 
E. coli 
coli 
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The data from glass slide hybridisation were normalised against the mean of the total 
signal intensity, as was performed for the Panorama arrays (see section 4.2.2). Part of 
a complete datasheet for the normalisation of one experiment is given in Table 4.4. 
The full datasheets for normalisation can be found on the enclosed CD-rom under 
Chapter 4/Normalised data/Pan Arrays.
raw data x 
mean norm factor
To investigate the reproducibility of the hybridisations, genomic E. coli K12 DNA 
and ECOR1 DNA were labelled with two different Cy-dyes and hybridised against
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the same array in a competitive hybridisation experiment. This experiment was done 
in duplicate with strain ECOR1 and therefore the data are labelled as ECORla or 
ECORlb. In both cases the genomic DNA used was from one extraction, but the 
labelling reactions were separate. For duplicate microarray experiments a straight line 
at 45° to the axes on a scatterplot was expected. In the scatterplot of this duplicate 
experiment of the hybridisation E. coli K12 and ECOR1 labelled DNA shown in 
Figure 4.15, there was a wide distribution of probes.
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The Bland-Altaian plot as described in section 4.2.3 is shown in Figure 4.16. hi this 
graph, the data of the repeated E. coli K12 hybridisation experiments show that 
probes were not present on the X-axes. Also, the standard deviation lines included in 
the graph show that the probes were widely spread and did not all fall between the 
one or two standard deviations.
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The duplicated hybridisations have a wider variability than expected for a same 
versus same plot in both the scatterplot and the Bland-Altman plot. Although the 
standard deviation was slightly bigger than for the Panorama array hybridisations, 
there were fewer extreme outliers detected, indicating that the variation between 
reproduced data probes was smaller and therefore more reliable. This was probably 
due to the fact that glass slide array data were compared with the internal E. coli Kl 2 
reference standard.
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Similar to the analysis for the Panorama arrays the hybridisation patterns of the 
ECOR DNA were compared with the patterns of the reference strains E. coli K12. 
Ratios of the signal intensities from the tested strain versus the reference strain were 
calculated after mean normalisation of the signal intensities. On the basis of those 
ratio values, probes were divided into three groups similar to those described 
previously (see section 4.2.5). Probes with a low raw intensity value were filtered out 
of the data set using the same MS Excel software filtering function as was used for 
the Panorama Arrays (see also section 2.10.2). Venn diagrams, shown in Figure 4.17, 
were used to get an initial overview of the size of the three different groups.
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ECORla vs K12_la ECOR3 vs K12_3
E.coli 
E.coli 
In duplicate experiments shown in Figure 4.14 A and B, more genes were of similar 
signal intensity compared to the Panorama array experiments (i.e. the blue values in 
Figure 4.17. Importantly, the Venn diagrams also revealled some probes that had a 
higher intensity (i.e. the red values in Figure 4.17) or a much lower intensity (i.e. me 
green values in Figure 4.17) in the ECOR strains compared to the reference E. coli 
K12. The number of genes with a higher intensity in the tested strain was much lower 
than previously detected in the Panorama array experiments. In contrast, the genes 
with a lower signal intensity in the ECOR strains contained a similar number of 
probes. The functional groups of all the different genes, in both categories are shown 
in Table 4.5 (numbers are colour coded as shown in the Venn diagrams above). Most
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of them were of hypothetical, unclassified and unknown function. Other genes were 
distributed over the functional groups without any obvious trend.
Amino acid biosynthesis and 
metabolism
Biosynthesis of cofactors, 
prosthetic groups and carriers
Carbon compound catabolism
Cell processes (incl. 
adaptation, protection)
Cell structure
Central intermediary 
metabolism
DNA replication, 
recombination, modification 
and repair
Energy metabolism
Fatty acid and phospholipid 
metabolism
Hypothetical, unclassified, 
unknown
Membrane proteins
Genomic DNA
Nucleotide biosynthesis and 
metabolism
Other known genes
Phage, transposon, or 
plasmid
Putative chaperones
Putative enzymes
Putative regulatory proteins
Putative transport proteins
Regulatory function
Structural proteins
Transcription, RNA 
processing and degradation
Translation, post-translational 
modification
Transport and binding 
proteins
01 
21 
18
10
10
12
12
122
12
21 
01 
21 
01 
21 5
01 2
01 
12
01 
01 
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To investigate genes that appeared to be informative for the test strains it was 
necessary to consider them individually. In total there were 586 ORFs missing from 
any of the six hybridisations of which one is a replicated experiment with the ECOR1 
strain (i.e. an intensity three times lower compared to the E. coli K12 strain). Only 15 
of these genes were previously found to hybridise irreproducibly between duplicate 
K12 experiments and therefore the reliability of these 15 probes must be questioned. 
The graph in Figure 4.18 depicts the 586 genes in groups in relation to how often they 
were detected in the six data sets. A total of 282 probes (48%) were missing in just 
one of the tested ECOR strains and could therefore be a unique characterisation probe 
for that strain. Forty-eight genes (8%) were missing from all five data sets. Upon 
further examination of these genes two functional categories had a high number of 
probes. Twenty-seven percent belonged to the functional category of "Phage, 
transposon or plasmid". This is understandable and expected if these genes were 
missing from the ECOR strain. Another 46% belonged to the category of 
"Hypothetical, unclassified and unknown".
E. coli 
coli 
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In total there were 70 probes that appeared to give a higher intensity signal in the 
EC OR strains compared to K12. Six of these were present in more than one of the 
tested strains. The graph in Figure 4.19 shows the appearance of the genes in groups 
in relation to how often they were detected in the six data sets. Sixty-four of the 70 
(91%) genes appeared only once in any of the strains. Nine percent of the probes were 
common to two strains. There were no genes that appeared in more than two strains, 
as was previously seen in the Panorama array experiments (see Figure 4.8).
91%
E. 
E. coli 
All of the 586 and 70 genes that were identified have been pooled in Table 4.6 to 
identify the individual genes classified by their unique b-number. Part of this gene list 
is displayed, but the whole list of these potentially informative genes and their 
presence or absence in the tested strains can be found on the enclosed CD- rom under 
Chapter 4/Genes of interest Pan Arrays. The genes and their functional group are 
listed in the first two columns. The next columns show the data obtained from the
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hybridisation of the six data sets including a replicate experiment for the ECOR1 
strain. A numerical value of 1 indicates a probe with a higher signal intensity in the 
ECOR stain (e.g. probes previously labelled in red) A numerical value of-1 indicates 
a probe that had a lower signal intensity in the ECOR strain (e.g. previously labelled 
in green). Probes with a numerical value of 0 have not changed (e.g. previously 
labelled in blue).
Two dendrograms were obtained from this data. The first one was drawn from the 
data obtained while focussing on the absent genes in the ECOR strains (Figure 4.19) 
while the second one looked at genes present in the ECOR strains (Figure 4.20). Both 
of these dendograms were than compared to the dendogram obtained by Herzer and 
colleagues (1990, Figure 4.10). A categorical clustering method and the UPGMA 
algorithm was used for the composition of both dendograms.
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E. coli 
There has been a rapid increase in commercial availability of E. coli arrays which are 
available from Operon, Affymetrix, Clonetech and MWG. The first generation of a 
MWG oligonucleotide glass slide microarray for E. coliK\2 was available shortly 
after the start of this thesis project. This array comprised of 70-mer oligonucleotides 
and was used to compare to the results and experiences obtained with the membrane
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based array of amplified PCR products of E. coli K12 ORFs. One aim was to 
determine if glass slide technology would overcome any of the disadvantages seen in 
the Panorama array experiments.
Hybridisation targets for microarrays are often labelled indirectly as the Cy dyes are 
large and are difficult to incorporate directly. Although labelling DNA indirectly is 
more time consuming, it might give a more effectively labelled DNA product 
(Richter et al, 2002). Because random prime labelling with direct incorporation of 
the radioactive tracers was used in target preparation for the membrane hybridisation, 
a similar approach was used for Pan arrays hybridisation. While testing glass slide 
substrates for hybridisation with targets labelled in a direct manner with Cy dyes, 
hybridisation signals were easily detected using a confocal laser microscope scanner. 
The reproducibility of the glass slide array hybridisations was better than for the 
membrane arrays. The Bland-Altaian plot shows that more than 96% of the probes 
fell within two standard deviations of the mean. One general advantage of using glass 
slides for arraying experiments is that competitive hybridisation with two differently 
labelled DNA preparations is possible. In this work, arrays were hybridised with 
genomic DNA from the strain of interest labelled with Cy5, and with E. coli K12 
genomic DNA labelled with Cy3. Using the E. coli K12 signals as a hybridisation 
reference on each array gave the ratios a higher reliability, as inter array variation and 
variability in the hybridisation reaction were excluded.
Re-using glass slides arrays after stripping the signal from them was not possible as 
the slides need to be dried before data acquisition could take place, and the target 
binding was irreversible after it had dried onto the slide. Therefore, each experiment
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required a separate microarray. For reproducibility purposes, the arrays for a 
complete experiment were all printed in the same print run to minimise variation.
The mean normalised signal intensities were converted into ratios and classified in 
the three different groups previously described above for the membrane arrays 
(section 4.2.5). Compared to the membrane arrays, fewer genes differed for the E. 
coli K12 hybridisation signals (e.g. the blue numbers in Figure 4.17), suggesting that 
the variability with the glass slide arrays is less than with the membrane 
hybridisations. Also the means of the data distributions of the replicated experiment 
was only just significantly different (T-test: P = 0.05), and their variance was very 
different (F-test: P = 0). From the 290 and 258 probes that gave irrepreducible results 
in the E. coli K12 reproducibility experiment using the Panorama arrays (see Figure 
4.7) only 70 probes were also detected in duplicated Pan array hybridisations. A total 
of 509 genes were shown to give an irreproducible result in a duplicated Pan array 
experiment.
After the competitive hybridisation of Cy3 labelled E. coli K12 and Cy5 labelled 
ECOR DNA, a large number of genes had different probe signal intensities. The 
genes belonging to group 1 and 2 were analysed according to their function. Most of 
the functional groups had only few differences suggesting that these functional 
groups are very well conserved in E. coli. By far most differences were detected in 
the category of "hypothetical, unclassified and unknown genes", which are by far the 
largest category of genes on the array.
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In total, 649 genes had different probe intensities in the ECOR strains. From these, 70 
were identified as being more intense and 586 as less intense in any of the ECOR 
strains. There is a small overlap between these two categories, which explains the 
small discrepancy when numbers are added. The number of probes that appear less 
intense (586) is similar to those detected in the Panorama array experiment. This 
might indicate that the data for the less intense probes is more reliable than data for 
probes that had a higher intensity in the ECOR strains compared to the E. coliK\2 
data.
Two of the genes that appeared more than once in the list of present probes were 
b2001 and b3913. Both these ORFs belong to the hypothetical, unclassified and 
unknown genes category and the reason why these genes have a higher signal 
intensity remains uncertain. There were no genes that had a high intensity in all of the 
ECOR strains, as seen in the membrane array experiments.
Genes with a low probe intensity in all ECOR strains include a large group of genes 
classified as Phage, transposon or plasmid (13) and as Hypothetical, unclassified and 
unknown (22). Similar to the Panorama arrays, probes involved in lipopolysaccharide 
biosynthesis included on this array also show a low hybridisation signal (b2031 and 
b2033). Other genes areperR (b0254) a gene involved in peroxidase resistance in the 
stationary phase and another putative gene involved in iron-uptake (b0263).
Dendrograms from all membrane experiments were compared. A dendrogram was 
obtained from the hybridisation results on the membrane arrays (see Figure 4.11 & 
4.12), but it does not show any similarity with the dendrogram of the ECOR strains
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determined by MLEE (Herzer et al., 1990). The dendrogram drawn from the Pan 
array results shows a different relationship among the ECOR strains compared to that 
seen with the Panorama arrays (compare Figures 4.11 and 4.19 and Figures 4.12 and 
4.20). The grouping of the five isolates as seen in clustering of the present probes 
identified in the Pan array array experiments show the best similarity to the 
dendrogram of the MLEE (shown in Figure 4.10) (Herzer et al., 1990). This may 
indicate that the reduction of noise in the Pan arrays increases the reliability of the 
array results.
Compared to the membrane arrays, the glass slide arrays were relatively easy to 
handle. The characteristics of the fluorescent labelling mean that the target DNA had 
to be protected from light; hence target preparation and hybridisation were carried out 
under limited lighting. Each experiment was done on a single printed glass slide array 
so stripping complications did not arise. The hybridisation signals from the Pan array 
were all of a similar lower intensity, compared to the Panorama membranes. This is 
likely to be due to the probes being of constant length (70-mers oligonucleotides), 
giving a smaller standard deviation. Overall fainter signals resulted in the easier 
detection of high background signals, and oversaturated probes were not observed. 
The reproducibility was better with the glass slide arrays compared to the membrane 
arrays due to the co-hybridisation of E. coli K12 DNA as an internal control. Only a 
few genes had a higher signal intensity in an ECOR strain than in the E. coli K12 
control.
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Of the two objectives regarding this part of the project the first one, to determine 
which type of commercial whole genome array would produce the most accurate 
results for genotyping bacterial strains has revealed that glass slide arrays are 
preferred. The slides are easier to handle and give more accurate hybridisation results 
because of the advantage of an internal control labelled with a different Cy dye, that 
can be co-hybridised in every experiment. Also data acquisition is more rapid and 
allows high throughput testing. The second objective, to identify candidate genes for 
individual E. coli strains that could be used as sub-typing markers for DNA 
'fingerprinting' has identified 1240 genes through the membrane hybridisation 
experiments and 649 genes through the glass slide hybridisation experiments. In the 
group of present genes only 15 probes were found that were identified in both 
Panorama and Pan array hybridisation experiments. Only 6 of those did not appear in 
the list of irreproducible genes found in a replicated experiment. In the group of 
absent genes 198 probes were found in both Panorama and Pan array hybridisation 
experiments. Only 98 of these did not appear in the list of irreproducible genes. These 
98 and 6 probes probably contain the most valuable information for the 
characterisation of strains.
Further research on these genes identified using whole genome arrays would be time 
consuming and would involve cloning, sequencing and mapping of these candidates. 
Perhaps this would not be very informative because of the low reproducibility of the 
experiments. Before deciding whether it was worthwhile undertaking such studies, 
the use of arrays bearing specific genes coding for pathogenicity markers was 
investigated. The experiments described in this chapter have indicated how arrays 
might be used for fingerprinting, once several technical problems associated with
149
4. Comparison of whole genome arrays for characterisation ofE, coli
reproducibility are overcome. Further increase in reproducibility through the 
optimisation of DNA labelling, adjustment of the hybridisation conditions, and 
consequent improvement of the signal to noise ratio would be advantageous. This 
would allow potentially interesting genes to be identified more precisely. On the 
positive side, these experiments gave insight into array technology and data analysis, 
and allowed efficient design and use of the custom made pathogenicity marker array 
described in the next chapter.
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5. Custom pathogenicity marker array for typing E. coli
This chapter describes the preparation, validation and use of a custom made 
pathogenicity marker array containing a small number of E. coli pathogenicity 
sequences obtained from several E. coli pathotypes. The pathogenicity sequences on 
the array included adhesin, capsule, toxin, invasion and iron acquisition genes, some 
of which were specific for certain E. coli pathotypes. It was expected that the genes 
on the array would make it possible to distinguish between different pathotypes and 
so allow characterisation of the E. coli strains, as illustrated in Figure 5.1. 
Fluorescently labelled genomic DNA from E. coli strains of known pathotype were 
hybridised against the custom-made array to determine the presence of genes 
associated with pathogenicity after hybridisation. Subsequently, all the E. coli isolates 
in the ECOR collection were screened for the presence or absence of these 
pathogenicity sequences, to investigate the distribution of pathogenicity markers 
within the collection of isolates. The array results were displayed as a dendrogram of 
E. coli pathotypes to identify groups of strains with similar characteristics. Finally, a 
group of clinical E. coli isolates was tested on the same array to examine the clonality 
and classify which pathotype.
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coli 
The first stage of constructing the pathogenicity marker array was to identify and 
amplify the pathogenicity-associated sequences that were to be probes on the array. 
The aim was to compile a subset of genes that included markers associated with 
different E. coli pathotypes. For an initial proof of concept, a set of suitable E. coli 
strains was obtained from Professor J. Prey's group at the Institute of Bacteriology at 
the University of Bern. These strains carried plasmids bearing cloned pathogenicity 
markers, previously identified as pathogenicity sequences from various pathotypes of 
E. coli (i.e. UPEC, EPEC, ETEC, EHEC, EEC and EAggEC), listed in Table 5.1. 
The pathogenicity marker sequences were selected because they were sufficiently 
diverse and represented the various E. coli pathotypes compatible with the planned
testing of clinical isolates.
__
5. Custom pathogenic ity marker array for typing E. coli
The bacterial strains harbouring the cloned pathogenicity genes were grown on LB 
agar plates containing ampicillin. Single bacterial colonies were grown in overnight 
cultures and purified plasmid DNA was produced using the Qiagen HiSpeed Plasmid 
Midi Kit isolation method as described in section 2.8.2. A small sample of the 
plasmid DNA was analysed by agarose gel electrophoresis as shown in Figure 5.2 in 
order to check the quality of the yield. The size and the mobility of the plasmid 
depend on the target genes cloned into it.
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Restriction enzyme digestion sites were incorporated in the gene specific primers for 
the initial cloning of the pathogenicity sequences and are listed in Appendix II. These 
restriction sites were used for the digestion of the plasmid DNA and isolation of the 
gene fragments. A small sample of the digested DNA was electrophoresed on an 
agarose gel (Figure 5.3) to ensure the sizes of the fragments (ranging from 250-1500 
bases; listed in Appendix II) were as expected. Differences in the length of the PCR 
fragments are likely to result in variations in the hybridisation signal. Longer probes 
can bind more labelled target DNA and therefore show a stronger signal. Although
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there were differences in probe length, this could not be correlated directly to the 
observed variation in signal intensities on the array.
Genes associated with pathogenicity were amplified from the plasmid inserts 
encoding the selected genes before they were arrayed onto the glass slides, (see 
section 2.9.2). The pathogenicity marker fragments were separated from the
remainder of the plasmid DN A to avoid cross hybridisation between the E. coli vector
__
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sequences and the E. coli sequences on the array. Pre-purification of the target 
sequence was necessary since previous experiments had shown that amplification 
directly from the plasmid preparation resulted in the generation of non-specific 
hybridisation signals (Kuhnert etal., 1997). The enzyme-restricted fragments were 
purified by gel electrophoresis to remove PCR inhibitors (e.g. restriction enzymes and 
high salt buffer) and to isolate the PCR template. The pathogenicity marker sequences 
were amplified using gene specific primers, and a small amount of the PCR product 
was electrophorised to verify the size of the product (Fig 5.4).
Initially, all fragments were amplified at the same TA (58°C), but this did not give 
equal amounts of PCR product. For example, the yield of PCR product amplified 
from the aafA sequence, in Figure 5.4 lane 6 was much lower than that of the product 
amplified from the eltlA sequence in lane 4. To increase the yield of the weaker PCR 
products, amplifications were repeated with an adjusted TA as listed in Appendix II. 
The new TA values were re-calculated on the basis of the sequence of the primers, 
using a world wide web based tool for the calculation of the properties of the 
oligonucleotide (Kibbe et al., 2000). The sequences that required re-amplification 
were then grouped by similar TA to reduce the number of PCR reactions that were 
needed. The amount of PCR product was measured as described in section 2.3.1. One 
and a half (ig of purified DNA was dried and redissolved in 20 jal 50 % DMSO. The 
PCR amplicons were stored frozen in a 384-well plate and used for printing 
microarray glass slides with the Microgridll arrayer.
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5 
Lane 1, 20, 21 and 32 are 1 kb ladder. Lane 3-19 and 22- 
29 are virulence fragments amplified from digested 
plasmids by PCR. lane 2 stxl, lane 3 stxll, lane 4 eltlA, lane 
5 e/tf£4, lane 6 aafA, lane 777i^, lane 8 bfpA, lane 9 </a/, 
lane 10 cnfl, lane 11 c/o//, lane 12 <M«, lane 13 F1C gene, 
lane '\4fimA, lane 15 ipaH, lane 16 iucC, lane 17 neuA/neuC, 
lane 18 /t#£, lane 19/*/M lane 22 sfaS, lane 23 stIAMB, 
lane 24 .s/o/l, lane 25 f/>v4, lane 26 /j/y-4, lane 27 astA, lane 
28 cofA, lane 29 /«g/l, lane 30 chuA. lane 31 16S rDNA.
158
5. Custom pathogenicity marker array for typing E. coli
The labelled genomic DNA prepared from eight E. coli strains were used as 
hybridisation targets to validate the first generation pathogenicity marker array. These 
eight strains included five reference strains (UPEC, EPEC, ETEC, EHEC, EAggEC; 
see table 2.1) used for the amplification of some of the pathogenicity sequences, and 
two clinical isolates previously tested for the presence of the same pathogenicity 
markers by dot blotting. E. coli K12 DNA was used as a negative control. Genomic 
DNA of these strains was labelled by random amplification incorporation of 
fluorescent Cy labelled dUTPs as described in section 2.5.4. The arrays were 
incubated overnight in individual hybridisation chambers with two DNA targets 
labelled with different fluorescent dyes. The test strains were labelled with Cy5 and 
the E. coli K12 DNA was labelled with Cy3. To investigate reproducibility, three 
probes were prepared from DNA isolated from the UPEC strain and three identical 
hybridisations were done using this DNA. (Data from the three separate 
hybridisations can be recognised in the data tables as UPEC_1, UPEC_2 and 
UPEC_3). Wash buffer containing SSC and SDS was used for post-hybridisation 
washes as described in section 2.9.2. One array was used per hybridisation for each of 
the test strains.
Arrays were scanned using a confocal microscope laser array scanner. The resulting 
images were imported into Arrayvision software and signal intensities were measured
using a grid overlay that compensated for background signals. Further data
__
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processing was done using MS Excel software. All raw data can be found on the 
enclosed CD-rom under Chapter 5/Raw data pathogenicity marker array/Validation. 
The signal intensities of the probes were corrected for background, and were mean 
normalised (see also section 1.3.4). The normalisation datasheet is given in Table 5.2, 
and can also be found on the enclosed CD-rom under Chapter 5/Normalised data 
pathogenicity marker array/Validation.
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Table 5.2 Normalisation of the pathogenicity marker array for validation strains lilf!
aafl
bfpA
cfal
cfall
cofA
(.'ae
FIC gen?
IngA
pcipA
sfiiA
sfaS
kfiB
neitA, neuc
ipaH
chuA
iucC
ax/A
cnfl
MA
eltllA
MyA
ehxA
stIA.stIB
stxl
stxll
16S
16S_2
fhitA
fimA
blank
spotting 
solution
water
0.00
0.00
0.00
0.14
0.01
0.05
3.61
0.01
4.50
3.49
2.52
0.06
0.01
0.04
5.12
0.02
0.01
2.80
0.00
0.00
3.35
0.01
0.00
0.00
0.00
22.63
16.74
1.49
3.71
0.01
0.01
0.01
0.06
0.01
0.00
0.10
0.00
0.10
3.07
0.01
4.24
2.57
1.47
0.10
0.10
0.03
7.13
0.06
0.00
3.28
0.01
0.01
3.17
0.02
0.29
0.00
0.00
31.44
25.57
2.10
3.01
0.00
0.01
0.01
0.00
0.00
0.02
0.01
0.01
0.01
4.01
0.00
4.24
3.34
2.07
0.12
0.01
0.01
3.75
0.06
0.00
3.66
0.00
0.00
3.71
0.01
0.00
0.00
0.00
29.88
22.79
1.92
4.00
0.01
0.00
0.01
0.00
0.50
0.00
0.00
0.00
11.52
0.00
0.07
0.03
0.01
0.00
0.01
0.00
0.01
0.06
0.04
0.03
0.00
0.09
0.00
0.00
0.00
0.04
0.00
0.00
23.46
25.90
14.71
3.42
0.13
0.01
0.12
0.15
0.01
0.00
4.78
0.01
0.00
0.00
1.14
0.00
0.08
0.00
0.02
0.01
0.01
0.03
0.04
1.71
0.00
4.26
0.00
0.04
0.00
2.11
0.00
0.00
55.90
52.48
16.08
0.01
0.02
0.08
0.21
0.00
0.01
0.00
0.02
0.00
7.38
0.01
0.01
0.00
0.00
0.00
0.00
0.01
0.03
1.44
0.03
0.43
0.01
0.03
0.03
0.00
1.17
0.03
5.09
5.30
6.83
8.28
4.23
6.18
0.02
0.03
0.04
7.14
0.06
0.00
0.54
0.07
0.20
0.23
0.31
0.00
0.03
0.00
0.02
0.19
0.13
11.82
0.36
1.57
0.10
0.00
0.02
0.01
0.06
0.39
0.00
0.00
80.14
79.98
6.20
0.17
0.10
0.18
0.60
0.01
0.00
0.02
0.00
0.07
0.01
0.26
0.09
0.00
0.53
0.80
0.01
11.28
0.01
7.70
0.03
0.01
0.00
0.00
0.01
0.01
0.02
0.01
0.00
0.00
25.16
23.36
6.89
2.64
0.20
0.22
0.16
0.01
0.00
8.05
0.00
0.00
0.01
0.00
0.01
0.00
0.00
0.00
0.00
0.05
0.00
0.01
0.01
6.52
0.01
8.75
0.00
0.00
0.00
3.74
0.00
0.00
11.78
11.87
3.12
0.62
0.03
0.01
0.04
0.03
0.06
0.06
0.10
0.32
0.09
0.17
0.18
0.02
0.15
0.05
0.22
0.04
0.07
0.27
0.13
0.19
0.28
0.07
0.07
0.11
0.07
0.10
0.62
0.07
37.28
16.88
6.19
4.86
0.08
0.20
0.12
1 Genes are in the same order as Table 5.1
To calculate a threshold value for the determination of the presence of genes, 
intensity signals from the three datasets obtained from hybridisations with UPEC 
genomic DNA to the custom-made pathogenicity marker array were used (Figure
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5.5). The pathogenicity markers of this strain had been previously characterised at the 
University of Bern (Kuhnert et al., 1997).
The background signal of the arrays was very low, and it was therefore relatively easy 
to observe the binding of the labelled target to the positive probes. The threshold was 
calculated so that only genes known to be present in the UPEC strain gave a positive 
signal. On the basis of these results all probes with normalised intensities higher than 
1 were called positive. The frequency distribution of the mean normalised values of 
three independent hybridisations of labelled UPEC genomic DNA (Figure 5.6) 
showed a clear separation between positive and negative signals. After consultation 
with a statistician (CDSC Statistics Unit) a threshold was estimated at 1 to optimise
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sensitivity (74%) and specificity (100%) of the test. In the example shown in Figure 
5.6, 33% of the signals (11 probes) were positive and were located on the right hand 
side of the cut-off value, in contrast to the 66% of negative signals (22 probes) on the 
left hand side.
To investigate the reproducibility of the hybridisation procedure, the UPEC strain J96 
was hybridised in triplicate against three glass arrays, hi all cases the hybridisation 
probes were made from the same genomic DNA extract, but were labelled separately. 
The frequency distribution in Figure 5.6 shows that there is a high degree of 
reproducibility. All the expected probes were positive in all three arrays. The 
scatterplot shown in Figure 5.7 shows a good correlation of the two data sets with 
only some slight discordance at high intensity values.
5. Custom pathogenicity marker array for typing E. coli
The second method used to visualise the reproducibility of the data was the Bland- 
Altman plot (Bland and Altaian, 1986, Bland and Airman, 1999). Data from two of 
the three hybridisation experiments with genomic DNA extracted from the UPEC 
strain J96 performed on the custom made pathogenicity marker array were compared 
(Figure 5.8). Figure 5.8A shows all data points including the high intensity signals 
from the 16S rDNA that skews the data trend. Probes with an average normalised 
probe intensity lower than seven were reproducible and within two standard 
deviations from the mean. When high signal intensities from the normalised data 
from the 16S rDNA gene sequences were taken out of the graph, the standard 
deviation decreased significantly leading to a narrower distribution, as shown in 
Figure 5.8B. This Figure shows that 93% of all data are within two standard deviation 
of the mean value of the calculated data points. Moreover, when the normalised data 
were interpreted with respect to the presence or absence of a gene after hybridisation 
of DNA extracted from UPEC strain J96, there was 100% reproducibility. Although 
there was some variation in signal intensity in the raw data, the interpreted data
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confirm that all genes that were expected to be present in the strains were found in all 
three hybridisation experiments.
E. coli 
A collection of pathogenic E. coli strains of known pathotype was used to investigate 
the genes that were present in the different pathotypes. The normalised gene intensity 
values obtained from all but one of the genes that were expected to be positive were 
above the threshold. However, the bfpA gene gave only a weak signal and its 
normalised intensity value was just below the threshold, although clearly visible on
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the array scan. This is most likely an effect of the high signals from the positive genes 
in the EPEC reference strain. All but one of the positive pathogenicity markers 
detected in this strain had larger PCR fragments representing the gene, which may 
have caused variability in signal. This affected the normalisation factor and therefore 
the normalised data. The image of the actual array can in these cases confirm the 
presence of the gene. All pathogenicity sequences that were identified as positive in 
any of the strains are listed in Table 5.3. Pathogenicity markers unique to one of the 
pathotypes are indicated in red, while those positive in more than one of the reference 
strains are indicated in black.
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Five genes representing pathogenicity markers did not give a hybridisation signal 
from any of the reference strains. These were cofA, eltllA ipaH, iucC and kfiB. The 
ipaH gene is found in EIEC and no isolates with this pathotype were tested. eltllA 
encodes the LTII protein and is mainly found in animal strains; in this study animal 
strains were not used in the validation. Surprisingly, the UPEC isolate did not reveal 
the presence of iucC or kfiB, nor did the ETEC strain hybridise to cofA. These last 
three genes (i.e. iucC, kfiB and cofA) were previously amplified and cloned using 
gene specific primers from strains that were tested positive for these pathogenicity
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markers. Also, previous membrane studies showed that a wider variety of strains did 
give a hybridisation signal for all gene products (Kuhnert ct al., 1997). All the genes 
expected to be present in the reference strains were detected and no additional ones 
were found. It was therefore concluded that genes without showing a positive signal 
in the validation of this array would hybridise if they were present in the test strains.
Data were stored in the program Bionumerics, and a dendrogram calculated using 
categorical clustering with the UPGMA algorithm. Results of the clustering of the 
different pathotypes are displayed in Figure 5.9
The hybridisation results obtained using the pathogenicity marker array were 
compared to the hybridisation results previously obtained using membrane 
hybridisations, which included a similar set of genes (Kuhnert et al., 1997). Genes 
were more easily detected on the glass slides because of a lower signal to noise ratio.
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5.3.5 
The E. coli pathogenicity marker array was made with PCR amplified probes, which 
were spotted onto aminosilane coated glass slides. Only gel purified plasmid DNA 
inserts were used for the amplification of the pathogenicity marker sequences to 
prevent cross contamination with E. coli K12 vector sequences. This is a complex 
method for obtaining the fragments, and in theory it would have been quicker to 
amplify the pathogenicity markers directly from genomic DNA using the gene 
specific primers, as was done when the sequences were originally cloned. The 
advantage of having strains that carry the pathogenicity markers in cloned plasmids 
was that they were non-pathogenic themselves and can be precessed and transported 
safely. Also, amplification from the isolated plasmid DNA decreased the chance of 
non-specific amplification.
The array was validated using labelled genomic DNA from seven strains with known 
pathogenic marker profiles, as confirmed by membrane hybridisation or PCR 
amplification (Kuhnert et al, 1997). Probes covering the same gene sequence were 
present on the pathogenicity marker array and the original membrane arrays. This 
made validation of the array easier as positive signals previously seen by membrane 
hybridisation were expected to appear on the glass slide microarrays. False positives 
were not detected after hybridisation of the labelled genomic DNA from these 
reference strains and less than 1 % were false negative results. The results of the two 
assays were therefore in good agreement.
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Fluorescent dyes were incorporated into the target DNA by random amplification. 
Together with the use of glass slides, this improved the sensitivity of the method by 
giving a lower background compared to that observed in membrane hybridisation 
experiments. For example, five E. coli strains were tested on membranes as well as 
glass slides. Some of the strains gave a high background signal on the membrane 
system, making observation of the positive probes difficult. In contrast, all of the 
strains were relatively easy to analyse using the glass slide system (e.g. see Figure 
5.5). There was a clear separation between the signal intensity of present and absent 
genes using the glass slides. Additionally, the time spent processing samples was 
significantly less than for experiments involving membrane arrays, mainly due to the 
shorter post-hybridisation washes and antibody incubation times. The confocal 
microscope scanner was sensitive enough to detect the emission signal directly, and 
there was therefore no need for the amplification of the signal.
Multiplex PCR has previously been used for the detection of E. coli pathogenicity 
markers (Pass et a/., 2000, Call et al., 2001, Chizhikov et al., 2001, Wang et a/., 
2002b). In these studies the multiplex PCR products were analysed on gels or 
hybridised to microarrays. The number of genes that could be detected in one 
multiplex PCR was limited. Also sequence variation in the primer region could lead 
to false negative results for some of the pathogenicity markers. In contrast, random 
amplification of genomic DNA, as described here, was a more rapid way of creating a 
broad-range hybridisation target. The results (see Figure 5.5) showed that the use of 
genomic DNA and rapid random amplification did not affect the sensitivity of the 
method, and that individual genes were still detectable. The positive signals were
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strong and there was no background hybridisation when DN A from control strains 
was tested.
To investigate the distribution of pathogenicity markers within the E. coli strains, 
labelled genomic DNA from all 72 strains in the ECOR collection was hybridised to 
the custom made pathogenicity marker array. E. coli Kl 2 DNA was used as a 
negative control. One array was used per hybridisation of every test strain, and all 
hybridisations were performed in duplicate.
To investigate the presence of pathogenicity markers in the ECOR strains, 
fluorescently labelled genomic DNA was hybridised against the first generation 
pathogenicity marker array. Data were analysed further with MS Excel software using 
a macro for normalisation and calling of the presence or absence of each 
pathogenicity marker. All raw data can be found on the enclosed CD-rom under 
Chapter 5/Raw data pathogenicity marker array/ECOR collection.
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5.4.2 
The signal intensities of each probe was corrected for the background, and all data 
were inserted into the macro spreadsheet that automatically took the average of the 
signal intensities of repeated probes, and normalised the mean of the probe 
intensities. All normalised data can be found on the enclosed CD-rom under Chapter 
5/Normalised data pathogenicity marker array/ECOR collection. The MS Excel 
software used a macro to filter out the genes that had a very low signal intensity using 
the previously determined threshold (see section 5.3.2) and returned a list of the genes 
present including the normalised intensity value. Part of the gene list with the 
presence and absence of the genes in the ECOR strains is shown in Table 5.4. In this 
table the positive markers are indicated in black for the strains in which they were 
detected. The complete list for all 72 strains can be found on the enclosed CD-rom 
under Chapter 5/Pathogenicity markers in ECOR and includes all pathogenicity 
markers included on the array.
fimA
spotting 
solution
water
1 Genes are in the same order as Table 5.1 
Black entries indicate the gene was present in the ECOR strain. Gene probe not present in the ECOR strains 
displayed in this table are: aafl, bfpA, cfal, chuA, cnfl, cofA, tftill, eae, slxl, xt\II, eltlA, eltHA, FJCgene, ipaH, 
neuA, neuC, kf'iS, IngA, MyA, ehxA, sfuA, sfaS, stIA, stIB. These gene probes are included on the data tables on the 
CD ram.
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Bionumerics was used to generate a dendogram as previously described in section 
5.3.4 and shown in Figure 5.10.
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Strains carrying pathogenicity markers have the potential to cause disease, but E. coli 
isolated from healthy individuals may carry a variety of pathogenicity markers. This 
was evident form the microarray analysis of the ECOR strains (see table 5.4), and this 
result confirms previous findings of genes involved in pathogenesis in E. coli from 
water and stool samples of healthy individuals (Miihldorfer et al., 1996).
The ECOR collection was representative of different strains of E. coli from different 
sources (Ochman and Selander, 1984). Certain pathogenicity markers (e.g. chuA, F1C 
gene,papA, sfaA, sfaS) appear very frequently within this collection. They are located 
in pathogenicity 'islands' and can often be acquired by horizontal gene transfer (Roy, 
1999). It is likely that these genes have spread throughout the E. coli species. Work 
presented by Vieira and colleagues describes the detection of pathogenicity markers 
in isolates with pathotypes other than expected (Vieira et al., 2001). They report in 
their study the presence of DNA sequences related to pathogenicity in EPEC, EHEC 
and other pathogenic categories in a collection of 59 non-EPEC serogroups. These 59 
E. coli strains carried the eae gene, but lacked other EPEC and EHEC related 
sequences such as EAF or the EHEC related SLT gene probes and were therefore 
defined non-EPEC strains. There was a high rate of LEE associated and hly 
sequences (associated with EPEC and EHEC strains), while other putative 
pathogenicity associated sequences were detected at a lower level. Their findings on 
the combination of pathogenicity markers showed strains that were, for example, 
potential UPEC strains that carried LEE associated sequences not normally associated
_
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with UPEC strains. The work presented in this thesis confirms the results that 
pathogenicity markers are widely distributed in E. coli. Thus, the separation of 
pathotypes might become less distinct as horizontal transfer continues to occur.
The binary results of the presence or absence of pathogenicity markers in the ECOR 
collection were analysed using the categorical clustering algorithm in Bionumerics. 
The result did not show some similarity to previous clustering of these 72 E. coli 
strains in their phenetic groups as determined by Herzer and colleagues (1990), but 
no distinct groups were defined.
In the dendrogram shown in Figure 5.10 a few clusters were observed that included 
one of the reference strains. For example, one large group showed an identical 
hybridisation patterns to the E. coli K12 strain in which no pathogenicity markers 
were detected (Figure 5.10, purple cluster). Two of the ECOR strains in this group 
were originally from Swedish female patients suffering from symptomatic UTI. It 
would have been expected that these isolates would have had a hybridisation pattern 
comparable to that of the UPEC reference strain used in this study. It is most likely 
that the isolates from these patients did not cause the infection, but represent a 
commensal E. coli isolate. As no additional clinical information was available, it was 
not possible to draw any definitive conclusions. There did not seem to be any 
relationship between the isolates of this cluster regarding their group, serotype, host 
or place of isolation. This suggests that horizontal transfer of pathogenicity associated 
sequences might not be localised or specific to certain phenetic groups.
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The second largest group of ECOR strains clustered closely around the UPEC 
reference isolates (Figure 5.10 dark blue cluster). This group mainly contained 
isolates from E. coli group B2, and was a mixture of strains isolated from both 
healthy poeple and UTI patients. It has been reported that isolates belonging to 
groups B and C lacked pathogenic associated sequences (Kuhnert et ai, 1997). In 
contrast, a large group of extraintestinal strains belonging to phylogenetic group B2 
and D contained most of the genes encoding adhesion fimbriae, toxins and iron 
acquisition mechanisms, for which they were tested (Bingen-Bidois etal., 2002). 
Using the pathogenicity marker array most of the strains that clustered around the 
UPEC reference strain were from the B2 group. No other obvious groups were 
detected that were closely related to any particular pathotype. This suggests that there 
was no relationship between the phenetic groups and the pathogenicity marker 
groups. The information from the pathogenicity marker array may be inadequate for 
detecting phenetic relationships, as the number of genes on the array is limited. To 
investigate further whether the pathogenicity marker array was an appropriate tool for 
the identification of these relationships, a group of clinical isolates was tested.
To investigate the distribution of pathogenicity marker genes and to identify clonal 
groups in clinical E. coli isolates obtained from patients with urinary tract infections, 
a collection of strains was screened using the pathogenicity marker array. This 
collection was obtained from the Shrewsbury Public Health Laboratory in a 
collaborative study with Professor R. E. Warren's group. The isolates had been
5. 
previously used for the comparison of the performance of different types of agar for 
the isolation and presumptive identification of organisms from urine (Fallen 
2002). Commercially available biochemical test strips were used for identification of 
the strains (Penna 2002). A total of 373 isolates were identified and 
considered for further investigation using the pathogenicity marker array.
To test for resistance to six first line antimicrobials, the isolates were tested using the 
disc diffusion method standardised by the British Society for Antimicrobial 
Chemotherapy (Andrews, 2001). Bacterial cultures of low cell density (McFarland 
scale 0.5) were tested on Isosensitest agar plates as described in section 2.1. The 
antimicrobial resistance profiles for most of isolates from the Shrewsbury 
collection were identified. The results are summarised in Table 5.5. Three different 
levels of incidence for antimicrobial sensitivity were observed. The occurrence to 
ampicillin sensitivity was low (only 51% of all strains). The occurrence of augmentin 
and trimethoprim sensitivity was comparable, with sensitivity levels of 79% and 77% 
respectively. A large number of isolates (97%) were sensitive to cephalaxin, 
norofloxacin and nitroflurantoin. Multiple resistance against three to five 
antimicrobials were detected in 14 % of the isolates tested.
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5.5.2 
To investigate the distribution of pathogenicity markers and the clonal grouping of 
these isolates, 49 isolates from the Shrewsbury collection were initially used for array 
hybridisation. Data were imported into MS Excel software for further analysis. Raw 
data can be found on the enclosed CD-rom under Chapter 5/Raw data pathogenicity 
marker array/UTI 
5.5.3 
The MS Excel software macro described in section 5.4.2. was used to identify the 
pathogenicity markers present in the Shrewsbury collection of isolates. The 
normalised data of all the tested strains from patients with urinary tract 
infections can be found on the enclosed CD-rom under Chapter 5/Normalised data 
pathogenicity marker array/UTI Some typical results are listed in Table 5.6, 
showing the positive markers as black entries for the strains in which they were 
detected. The complete list for all 49 strains can be found on the enclosed CD-rom 
under Chapter 5/Pathogenicity markers in UTI and includes all pathogenicity 
markers included on the first generation pathogenicity marker array.
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icily marke
1 Genes are in the same order as Table 5.1 
Black entries indicate the gene was present in the Shrewsbury isolates. Gene probe not present in the clinical 
isolates displayed in this table are: 
gene probes are included on the data tables on the CD rom.
The binary data from presence and absence scoring of the pathogenicity markers in 
the UTI strains was stored in the program Bionumerics and used for the generation of 
a dendrogram as previously described in section 5.3.4. The results from the 49 strains 
selected at random did not reveal any novel or significant groupings beyond that 
apparent from the API classification.
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E. coli 
Strains of from the Shrewsbury collection were investigated using the first 
generation pathogenicity marker array containing 29 pathogenicity markers. These 
strains were previously characterised using API strips (Fallon 2002). is 
the most frequently isolated uropathogen, and multiple antimicrobial resistance 
patterns within these isolates are an increasing problem (Threlfall 2000, Fallon 
2002, Farrell 2003). The antimicrobial resistance patterns of strains 
isolated from UTI patients were determined using a disk diffusion test (see section 
5.5.1). The outcome of these tests compared very well to the antimicrobial resistance 
patterns found in isolated from UTIs (Farrell 2003). It could therefore be 
concluded that this collection represented UTI isolates as seen elsewhere. 
Furthermore, the resistance data gave yet another method of placing these strains into 
groups with similar characteristics using the Bionumerics clustering function. Finally, 
the antimicrobial resistance patterns could be used as markers on the array (e.g. 
trimethoprim, ampicillin and cephalexin) and tested along side other pathogenicity 
markers for a more detailed characterisation of 
The most common single antimicrobial resistance in members of the Shrewsbury 
collection was ampicillin resistance, 49% of strains exhibited resistance to this 
antimicrobial (see section 4.5.1). Multiple resistance patterns, seen in 14% of the 
strains, most commonly included a resistance against either ampicillin, trimethoprim 
and/or augmentin. As well as the testing of the antimicrobial resistance patterns, the
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pathogenicity markers of these isolates were identified by the hybridisation of Cy- 
labelled genomic DNA against the pathogenicity marker array.
When results from the pathogenicity testing of the first 49 clinical isolates were 
compared to previous dendrograms from API profiles or antimicrobial resistance 
patterns, obvious similarities were not detected (see Figure 5.11). This could have 
arisen because there were only 29 pathogenicity markers on the array. The grouping 
of these 49 isolates on the basis of just the pathogenicity markers on the first 
generation pathogenicity marker array might not be similar to any previously seen 
patterns. Eleven of these 29 pathogenicity markers were not detected in any of the 49 
clinical isolates. Three out of the 18 probes detected in the isolates were positive 
controls, leaving only 15 genes as markers for detecting relationships among the 
strains and pathotypes. To address this problem a substantial addition of markers onto 
the array is necessary. A group of seven isolates showed high similarity to the J96 
UPEC reference strain, but none of the other isolates tested were very closely related 
to any of the pathotypes. It was expected that more isolates from UTI patients would 
cluster with the UPEC reference strain because of the source of the isolates. Analysis 
of the clinical isolates did not reveal all the pathogenicity markers normally 
associated with the UPEC pathotype. It could be that the isolates investigated were 
not the isolates causing the UTI or that a certain combination of pathogenicity factors 
is essential to produce the clinical features of UTI. For example, over 50% of the 
strains carry the and markers, both these genes are associated with iron 
metabolism. No obvious patterns or groupings were apparent in this group of 49 
strains. Comparison with results obtained through API profiles and resistance testing 
did not show any similarity to grouping of the strains using the array data. It was
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therefore not considered worthwhile investigating any of the other 324 strains. 
Instead, a set of clonal strains with an identical API pattern from a potential outbreak 
of UTIs were investigated, to determine whether an extended array could distinguish 
them on the basis of a wider range of pathogenicity markers.
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After the successful use of the first generation array to detect pathogenicity markers 
in as described in the previous chapter, other genes were considered as 
candidates to be included on the pathogenicity marker array. In collaboration with the 
HPA Laboratory of Enteric Pathogens a second generation array was prepared, 
including potential pathogenicity markers for the EAggEC pathotype identified from 
literature and additionally from sequence information that became available during 
the whole genome sequencing of EAggEC. Fifty-one sequences with high sequence 
similarity to other well known pathogenicity markers as well as a recently identified 
PAI in EAggEC were included.
Although the typical EAggEC phenotype is the adhesion to HEp-2 cells in an 
aggregative "stacked brick" pattern, atypical EAggEC fail to do so. Thus the 
heterogeneous nature of this pathotype makes identification difficult, and no single 
PCR target has been found for the identification of both typical and atypical 
EAggEC. The initial aim of this study was to use microarray technology to determine 
whether any common targets could be identified. The second generation array was 
also used to investigate ten multiple resistant UPEC isolates. These strains were 
isolated from individuals infected during an outbreak of urinary tract infection and 
these isolates could not be distinguished by PFGE. The Shrewsbury Public Health 
Laboratory had confirmed that the API profiles of these strains were identical.
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6.2 Construction of the second generation pathogenicity marker array 
The first generation array was extended with 51 genes for which sequence 
information had been revealed during the EAggEC sequencing project (personal 
communications Dr. E. Dudley, Baltimore). These genes included genes that were 
well characterised as well as others with unknown function, selected on the basis of 
their sequence similarity with genes involved in pathogenicity of the same and 
closely-related species. The selected genes were either chromosomal or plasmid- 
encoded. Many were associated with type III secretion systems, which are present in 
EPEC and EHEC strains and may also be present in EAggEC. The additional genes 
added to the first generation array are listed in Table 6.1. The second generation array 
included a total of 75 putative pathogenicity factors in as well as 3 positive 
control genes: 16S and 3 negative controls: a synthetic 
oligonucleotide, spotting solution and water.
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When the first generation array was expanded, the direct approach of amplifying 
genes from genomic DNA using gene-specific primers was adopted in order to save 
time. The pathogenicity markers listed in Table 6.1 were amplified directly from the 
genomic DNA of two well-described strains of EAggEC, 042 (O44:H18) and 17-2 
(O3: H2), using gene specific primers. The primers, amplification conditions and 
bacterial isolates for the amplification of genes previously described are referenced in 
Table 6.1. Amplification primer sequences for the genes not described elsewhere are 
shown in Appendix III. The amplified PCR products were purified using QIAquick 
PCR columns (see section 2.5.4) and quantified by spectrophotometry. The arrays 
were printed in a similar way as described for the first generation pathogenicity 
marker array.
Validation of the second generation pathogenicity marker array 
The two strains from which the potential pathogenicity markers of EAggEC were 
amplified were used for the validation of the array. Although not all pathogenicity 
markers from these strains were known, the markers added to the first generation 
array could be validated and tested for a positive signal. K12 DNA was used 
as a negative control. Two non-EAggEC strains (EHEC O157:H7 and EPEC 
O127:H7) were also used as controls to detect non-EAggEC specific hybridisation 
signals. Genomic DNA from all these strains was labelled by random amplification
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incorporation of fluorescent Cy labelled dUTPs, as described in section 2.6.4. One 
array was used per hybridisation for each of the tested strains. Arrays were scanned 
and signal intensities were measured using Imagene 4.0 as previously described. All 
raw data can be found on the enclosed CD-rom under Chapter 6/Raw data second 
generation array /Validation. The normalised data can be found on the enclosed CD- 
rom under Chapter 6/Normalised data second generation array/Validation. The 
interpretation of the data as to whether a gene was present in the tested strain was 
adjusted, for two reasons. Firstly, the overall signal intensity had increased as the 
second generation pathogenicity marker array had additional EAggEC potential 
pathogemcity markers. Secondly, Imagene measures signal intensity levels differently 
from Arrayvision leading to lower raw data values. In an identical approach to that 
described in Chapter 5 the threshold was calculated at 0.15 through the analysis of 
strains with a known hybridisation pattern. The distribution of positive and negative 
signals was distinct. The threshold of 0.15 was also estimated in consultation with a 
statistician (CDSC Statistic Unit) to optimise sensitivity and specificity. The binary 
data of present and absent genes for the validation experiment is listed in Table 6.2. 
This table shows the positive markers detected in the control strains as black entries. 
Gene probes on the array that did not hybridise to any of the strains investigated have 
been excluded from the table but are listed in the footnotes.
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A collection of EAggEC strains was used with the second generation array to identify 
markers that would be useful for the identification of typical as well as atypical 
EAggEC. No specific markers were identified in this study. DNA from five control 
strains was also used for hybridisation. These three strains were: EAggEC strains 042 
and 17-2; an EPEC and an EHEC strain, and K12 as a negative control. DNA 
from the EAggEC prototype strain (042), hybridised with all the putative EAggEC 
marker genes, except the fimbrial gene associated with type I and type III fimbriae. 
This was expected as strain 042 has been characterised having type II fimbriae. 
EAggEC 042 DNA also hybridised with two of the iron acquistion genes. DNA from 
the second EAggEC control strain 17-2, hybridised to the genes associated with type I
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and type III fimbriae sequences of which were amplified from this control strain. 
EAggEC 17-2 DNA also hybridised to most of the putative EAggEC genes and to 
two of the iron acquisition genes. Classical strains of EPEC, such as E2348/69, 
harbour the and genes and DNA from the EPEC control strain hybridised 
with these two probes, as well as the gene designated 54f03-02 encoding a flagella 
biosynthesis protein, and a gene of unknown function designated 13-1. DNA 
from the EHEC control strain hybridised with and the gene encoding 
EAST, but failed to hybridise with Like the EPEC strain EHEC DNA also 
hybridised to the gene of unknown function, 13-1 and the flagella biosynthesis 
associated gene 54f03-2, indicating that these genes are not EAggEC-specific, but 
were also distributed among other pathotypes. Some of the chromosomal 
genes identified in EAggEC DNA sequence as putative marker genes, showed a 
sequence homology to EHEC genes associated with the type 111 secretion system. 
These genes were also detected after EHEC O157:H7 DNA hybridisation. After 
hybridisation of DNA from other EAggEC strains specific markers for the 
characterisation of typical as well as atypical EAggEC were not identified. This 
second generation array was then printed for standard use for investigation of other 
isolates and proved to be very useful.
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Ten UPEC isolates, with multiple antimicrobial resistance, from individuals infected 
during an outbreak of urinary tract infections were obtained from the Shrewsbury 
Public Health Laboratory, and were characterised by hybridisation against the second 
generation pathogenicity marker array. These strains were not distinguishable by 
PFGE and had identical API profiles. Genomic DNA was isolated using the 
automated extraction procedure described in section 2.2.2. Extracted DNA was 
fluorescently labelled by the incorporation of Cy5 labelled dUTP by random 
amplification as described in section 2.5.4. The labelled DNA was hybridised 
overnight at 42°C against the second generation pathogenicity marker arrays. Arrays 
were scanned after hybridisation and signal intensities were measured using Imagene 
software. Normalised signal intensities were interpreted using MS Excel software. 
Raw data can be found on the enclosed CD-rom under Chapter 6/Raw data second 
generation array/UTI outbreak and normalised data can be found under Chapter 
6/Normalised data second generation array/UTI outbreak. The binary data of present 
and absent genes for the validation experiment is listed in Table 6.3. This table shows 
the positive markers detected in the UTI outbreak isolates as black entries. Gene 
probes on the array that did not hybridise to any of these strains have been excluded 
from the table but are listed in the footnotes.
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Genes are in the same order as Table 6.1 followed by genes in the same order as Table 
Black entries indicate the gene was present in the UTI outbreak isolates. . Gene probe not present in the control 
strains for the second generation array validation are: 
r/«/, 
The binary data from the analysis of the ten isolates were compared with the results 
of the pathogenic reference strains and a dendrogram generated (Figure 6.1). 
Although the strains were tested on the second generation array, in this dendogram 
only the genes on the first generation array were taken into consideration. This was 
because data from the reference strains (EPEC, IHE3034, EAggEC, EHEC, UPEC, 
ETEC and IMI100) for the additional markers on the second generation array were 
unavailable.
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17715
27807
38179
39166
39350
39636
19675
In Figure 6.1, all but one UTI isolate (19675) showed an identical hybridisation 
pattern. Distinguishing the strains from each other was therefore not possible. After 
including all data obtained in the hybridisation experiment using the second 
generation array, the UTI isolates showed clear differences (see Figure 6.2).
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In the validation of the second generation pathogenicity marker array, all the probes 
gave the expected pattern after hybridisation of 042 EAggEC strain DNA, with the 
exception of the 18-3 probe, which gave a false-negative result. This result suggests 
that the probe could have been wrongly amplified, or that the probe DNA was lost in 
the process of spotting the arrays. The hybridisation pattern of the strain tested for 
type I and type II fimbriae, 17-2, was not as expected. Type I and type II fimbriae 
were amplified from this strain so therefore should have given a positive 
hybridisation signal after hybridisation with 17-2 DNA. Both fimbrial genes were 
detected but the molecules that ensure that the fimbriae arrive at the correct location 
in the cell (usher) were not present. Also one of the type II fimbrial genes gave a 
positive signal. A possible explanation was the high sequence similarity of these
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probes and the resulting cross-hybridisation. Furthermore, in the hybridisation of the 
clonal UTI DNA, only the type II fimbrial genes gave a positive signal and type I or 
III fimbrial genes were not detected. The DNA from the K.12 reference strain 
only hybridised with the positive controls, as previously seen in the first generation 
array. DNA from the other two pathotypes (EPEC and EHEC) used as hybridisation 
targets, identified various markers associated with pathogenicity. Eight of the added 
putative EAggEC pathogenicity markers (i.e. 
and gave a positive hybridisation signal. Six of these probes (i.e. 
and 7-2) were expected as there was a high sequence 
similarity with EHEC genes, as shown in Table 6.1. The other two positive probes 
(i.e. and indicate that that these probes are not specific for EAggEC 
strains and therefore were not suitable as markers for the detection of just typical and 
atypical EAggEC.
To investigate whether this array was an appropriate tool to distinguish between 
closely related isolates from UTI patients, DNA from ten clinical isolates from an 
outbreak of UTI were investigated. With the exception of one strain (i.e. 19675) that 
had an additional capsule antigen gene, the 29 pathogenicity markers present on the 
first generation array failed to distinguish between the ten isolates. All strains 
clustered together and did not show any obvious similarity with any of the reference 
strains. This supports previous findings that relationships between the ECOR and 
other clinical isolates on the basis of the first generation array were difficult to detect. 
When the additional genes from the second generation array were taken into account, 
the strains could be distinguished on the basis of the presence and absence of various 
pathogenicity markers.
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The differences between the hybridisation signals of the ten UTI outbreak strains on 
the second generation arrays were in genes encoding invasion, capsule and fimbriae 
prepared from the EAggEC prototype 042 genomic DNA. These probes added unto 
the second generation pathogenicity marker array were selected to identify markers 
for the detection of EAggEC strains. To see these genes in UTI strains was therefore 
unexpected, but suggests that they were not pathotype-specific for EAggEC. This 
confirms previous results and supports other findings that pathogenicity markers may 
be horizontally transferred between isolates and not associated with just one 
pathotype (Vieira 2001). It also demonstrates that the inclusion of more genes 
on the array increases the likelihood of distinguishing strains not separable on the 
basis of genes included on the first generation array. The separation of the isolates 
into different groups on the basis of the larger second generation array may therefore 
be useful, although it would be advantageous to include more putative markers on the 
array.
Rapid screening systems using many genes on one array may aid or possibly even 
replace other routine diagnostic tests such as, for example serotyping (Bekal 
2003). Gene probes from many pathotypes can be included on one array, which 
makes this technology very powerful. Array hybridisation revealed not only the 
presence or absence of a target gene, as in PCR or single colony hybridisation, but 
also gave an indication of the pathotype. This could speed up the characterisation 
process. Pathotype determination on the basis of just the array results needs to be 
assessed carefully, as not all markers associated with that pathotype will be detected 
in all hybridisations.
199

7. 
Microarray technology has developed rapidly over the past decade (Schena 
1995, Schena, 2003a, Mantripragada 2004). The literature describes various 
applications, from gene expression (Arfin 2000) and drug development 
(reviewed in (Debouck and Goodfellow, 1999)) to genotyping (Anthony 2000, 
Wang 2002a) and comparative genomic hybridisation (Dorrell 2001, 
Anjum 2003). The advantage of array technology in comparison with standard 
molecular techniques is that thousands of genes can be tested in a single experiment 
using a sample volume of just several microlitres. The results obtained from a single 
microarray experiment can be far more informative than the results from the best 
multiplex or real-time PCR reactions currently available. For example, depending on 
the array, information may be obtained on genetic defects and patient profiles. Array 
technology also has the potential to be used in hereditary screening and drug 
treatment of patients (Schena, 2003b).
The availability of whole genome sequences has lead to a rapid expansion in the 
production of chips and arrays, mostly for expression and genotyping experiments 
(Gingeras 1998, Alizadeh 2000, Call 2001, Detweiler 2001). 
Some arrays comprise whole genomes, whilst others carry a subset of genes related to 
specific diseases (Firoved and Deretic, 2003), to cell processes (Nakamura, 2004) or 
to groups of species and subspecies (Wang 2002a).
The main hypothesis of this work was to investigate whether a subset of known 
markers or ORFs could be identified and spotted onto an array in order to assess
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whether or not a strain of carried these genes and whether this information 
may then be used in characterising the strain for epidemiological purposes. A general 
hypothesis was to determine whether DNA arrays could also be used for typing 
organisms without the need for whole genome sequencing. The first step was 
therefore to use the whole genome arrays to determine whether: I) they could 
themselves be used for typing and II) whether specific markers could be identified to 
add to a smaller selection of pathogenicity markers for arraying onto glass slides. The 
second step was to produce and test such a smaller, more specific array, using various 
culture collections.
The two whole genome arrays in this study were commercially available and were 
used for the determining the type of array most suitable for genotyping. The 
differences between the two arrays were their probe composition (oligonucleotides or 
PCR-amplified DNA probes) and their printing substrate (nylon membrane or coated 
glass slide). From a practical perspective the glass slides were practically superior and 
quicker to process. More importantly, the results obtained with the glass slide arrays 
had a narrower distribution and gave more even signal intensity levels.
There are two approaches for the use of DNA arrays in screening bacteria for typing. 
Firstly, isolates may be compared by the presence of similar genes (Dobrindt 
2003). Secondly, genes or regions in the genomic DNA that are absent in one isolate 
but present in another may be compared (Anjum 2003). Thus, either the 
presence of the genes (i.e. similarity) or the absence of the genes (i.e. dissimilarity) 
can form the basis for the typing comparisons. To find appropriate candidate markers 
for characterisation, genomic DNA was extracted from various strains and was
202
7. 
hybridised to the commercial arrays. Probes giving both lower and higher 
hybridisation signals were taken into account when identifying typing markers. A 
large group of putative markers was identified, but the results were not found to be 
reproducible. Statistical analysis showed that the mean and variance of these data 
distributions differed significantly. Due to time constraints and this lack of 
reproducibility further investigation into the genomic regions identified by this 
approach was not carried out. Instead, a small customised array was prepared to 
demonstrate that arrays could be used for the characterisation of isolates.
For further research into using whole genome arrays for fingerprinting, it would 
firstly require to investigate the reproducibility issues. It would be necessary to do 
multiple experiments for each array hybridisation. Also, alterations in the 
hybridisation conditions could affect sensitivity and specificity of the hybridisation 
and produce more reliable data. If a new array was to be created it should contain all 
the genes from sequenced genomes available in the GenBank database 
(Blattnere/fl/., 1997, Hayashi 2001, Perna 2001, Welch 2002, 
Chaudhuri and Fallen, 2004, NIH, 2004). As only genes of known sequence can be 
included on the array, the technology is, at present, limited due to incomplete 
knowledge of the genes carried by the test strains.
Currently different pathotypes of are identified by the disease they cause 
whilst supplemented by serological or molecular tools. Some of these are laborious, 
or have limited potential to distinguish between the different pathotypes (Orskov 
1977, Fallen 2002, Jenkins 2002, Jothikumar and Griffiths, 2002, 
Osek, 2002). For example, testing to distinguish between EAggEC strains is done by
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investigating the attachment of the bacteria to HEp-2 cells (Nataro 1992). 
EAggEC strains show a stacked brick formation when adhering to the cells. This 
method gives no further indication of the pathotype when a stacked brick formation is 
not observed.
Molecular tools used for identification include PCR-based detection methods, a well 
established technique, but which will only provide limited information regarding the 
pathotype (Schmidt 1995b). It is also limited by the number of targets that can 
be detected in one amplification reaction, and by the detection of genes with sequence 
variation. In contrast to the whole genome arrays, small arrays containing a subset of 
genes of interest, including chromosomal and plasmid genes from different strains 
have also been designed. The genes were either identified from whole genome 
hybridisation experiments, (Dobrindt 2003) or from well characterised genes 
described in the literature (Kuhnert 1997, Anthony 2000). Using this 
approach, this work revealed a wide distribution of pathogenicity markers in the 
ECOR strains and clinical isolates. Genes that appeared in more than 20% of the 
ECOR strains were (42%), (24%), (31 %) and, as expected the 
positive control signals. In addition clinical isolates contained pathogenicity markers 
F1C gene, with a frequency of 20% or
more.
Nine clinical isolates from patients with UTI did group with the UPEC reference 
pathotype in the dendrogram, and could therefore be classified as being of this 
pathotype. Because of the source of the isolates, more of the clinical isolates were 
expected to cluster with the UPEC reference strain. None of the strains clustered with
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any other pathotype. This genomic screening for genes is potentially of great value in 
the diagnostic testing of bacterial isolates. In one array hybridisation patterns of many 
genes can be examined. Current developments make it possible to print the arrays in 
single tubes or in a 96-well plate format, which may therefore make the technology 
more accessible to diagnostic laboratories (Perrin 2003). The array developed 
in the presented work will have to be challenged with strains from a wider source to 
cover all pathotypes within the test strains, but the initial experiments have 
demonstrated that indication of the pathotype can be achieved with the array.
After extension of the first generation pathogenicity array with markers for EAggEC, 
this array was challenged with clonal UTI isolates. The results demonstrated that 
these strains could be differentiated. There was an increased level of separation 
compared with the first generation pathogenicity marker array, with which these 
isolates gave identical hybridisation patterns. It would be beneficial to extend this 
relatively small second generation array with other biomarkers from sequenced 
strains and related species, including all relevant pathogenicity markers and 
antimicrobial resistance genes. This would make pathotype investigations more 
precise and also provide additional insights on strain characterisation and horizontal 
transfer of genes, probably even across species borders. As well as many promising 
clinical applications, arrays allow pathogenicity testing of the 'non pathogenic' 
strains that are used in biotechnological applications, and would allow testing for 
food safety purposes (Bekal 2003, Kuhnert 2000).
Although the presence of genes is very useful information for the identification of the 
pathotype, information about the expression of these genes is lacking. It would
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therefore be interesting to examine mRNA expression patterns of the pathogenicity 
markers on the array. The information about expression patterns would be enhanced 
with the inclusion of other probes on the array, with sequences of upstream elements 
of the pathogenicity markers, such as operon and leader sequences. These would act 
as internal controls and provide further information about transcription. Such an array 
is currently being manufactured and validated for the investigation of closely related 
species (personal communication with Dr. M. Anjum, VLA). The 
array will also carry genes used for biochemical speciation (API typing system, see 
section 1.1.2) and antimicrobial resistance markers. Such an array will help provide a 
clearer understanding of pathogenesis and host-pathogen interactions.
Microarray technology has already contributed enormously to the current knowledge 
of genomics. Whole genome arrays, and arrays with specific subsets of genes are now 
produced and validated for many organisms. The arrays described in this thesis were 
constructed, used and validated and thereby gave insight into the potential use of 
array technology in both research and diagnostic laboratories. The arrays and 
methods developed have already been shared with collaborators in other laboratories 
(Dr. Steve Green, HPA Southampton and Dr. Claire Jenkins, HPA Colindale). From 
this and related work, there is no doubt that bacterial diagnostic and typing arrays will 
come to be used widely for diagnosis, surveillance, reference and research.
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APPENDIX I: BUFFERS AND SOLUTIONS
For PCR applications: Promega Nuclease free water
For preparation/dilution of solutions: MilliQ filtered water
(Qiagen, Crawley, UK) 
Buffer ATL resuspension buffer 
Buffer AL lysis buffer, chaotropic salt solution 
Buffer AW1 wash buffer 1, chaotropic salt solution 
Buffer AW2 wash buffer 2, sodium azide solution
(Roche, Lewes, UK)
Wash buffer I wash buffer I, chaotropic salt solution for
removing PCR inhibitors
Wash buffer II wash buffer II for removing salts and proteins 
Lysis/Binding buffer for cell lysis and binding of DNA 
Proteinase K for digestion of proteins 
Magnetic glass particles for binding DNA 
Elution buffer 1 OmM Tris-HCl, pH 8.0 for elution of DNA
PBS (CPHL Media service, London UK)
0.1 M Phosphate buffered saline pH 7.4
80 mM sodium phosphate
15 mM potassium phosphate
27 mM KC1
1.37MNaCl
lOx TBE (Invitrogen, Paisley, UK) 
890 mM Tris 
890 mM boric acid 
20 mM EDTA, pH 8.4
(Severn Biotech, Kidderminster, UK) 
0.25% Orange G 
10% Ficoll in TE
(Roche,
Lewes, UK)
DIG-High Prime labelling mixture containing random
primers, nucleotides, DIG-dUTP and
Klenow enzyme
DIG-labelled Control DNA 5 ^g/ml of HI pBR328 DNA 
DNA Dilution buffer 50 ng/ml herring sperm DNA in 1 OmM
Tris-HCl, ImM EDTA pH 8.0 
Anti-Digoxigenin-AP Conjungate 750U/ml Sheep Fab fragment conjungated
to alkaline phosphatase 
CSPD ready to use chemiluminescent substrate for alkaline
phosphatase 
Blocking solution
DIG Easyhyb granules to be dissolved and used as hybridisation
solution
(Amersham, Amersham, UK) 
Nucleotide mix Fluorescein-11 -dUTP, dATP, dGTP and
dTTP in Tris-HCl pH 7.8, 2-
mercaptoethanol and MgCk
Primers Random nonamers 
Enzyme solution 5U/|al exonuclease free Klenow in buffer
pH6.5
Control unlabelled DNA 1 Ong/ml III lambda DNA 
Control fluorescein-labelled DNA 50pg/ml fluorescein-labelled III
lambda DNA in 5 Ong/ml herring sperm
carrier DNA 
Liquid block Blocking solution
(Amersham, Amersham, UK)
Anti-fluorescein alkaline phosphatase (AP) conjungate
ECF substrate
ECF substrate dilution buffer
(Invitrogen Paisley, UK)
100mMTrispH7.4
lOmMEDTA
(Amersham, Amersham, UK) 
Labelling reaction containing Buffered solution of dATP, dGTP, dTTP
exonuclease free Klenow enzyme
Random primers in a dried and stabilised
form 
Control DNA 300ng of lambda III DNA in a dried
and stabilised form
(Invitrogen, Paisley, UK) 
DNA Polymerase (Klenow fragment) 
2.5 x random prime solution 
(other kit components are not used)
(Qiagen, Crawley, UK) 
Buffer PB chaotropic salt solution 
Buffer PE wash buffer 
Buffer EB elution buffer
Southern blot
20 x SSC (Invitrogen, Paisley, UK)
3.0 M NaCl
0.3 M sodium citrate
pH7.0
10% SDS (Invitrogen, Paisley, UK) 
(Sigma, Poole, UK)
Panorama arrays
(Invitrogen, Paisley, UK)
3.0 M NaCl
0.2 M NaH2PO4
0.02 M EDTA
pH7.4
lOmM Tris, pH 7.5 
ImM EDTA 
1% SDS
Pan Arrays and custom virulence chip
4xSSC 
0.5%SDS 
1% BSA
50% formamide
SxSSC
0.1%SDS
IxSSC 
0.5%SDS
0.06 
Buffer PI 
Buffer P2 
Buffer P3 
Buffer QBT 
Buffer QC 
Buffer QF 
Buffer TE
(AnalR grade, Sigma, Poole, UK) 
(Promega, Southampton, UK).
APPENDIX II: PLASMIDS CARRYING PATHOGENICITY MARKER SEQUENCES AND AMPLIFICATION PRIMER PAIRS FOR PROBE PREPARATION
Name
pJFFECl
pJFFEC2
pJFFEC3
pJFFEC4
pJFFECAAF
pJFFECAER
pJFFECBFP
pJFFECCFA
pJFFECCNF
pJFFECCS3
pJFFECEAE
pJFFECFIC
pJFFECFIM
pJFFECIPA
Gene
F1C 
gene
Position on Ace. No.
3464-3987 on L04539
518-1036 on M21534
159-848 on V00275
107-770 on Ml 7894
53-643 on X81423
1039-2036 on M12486
32-599 on Z12295
1403-2063 on M55661
1321-2229 on X70670
11-556 on M35657
2565-3241 on M581 54
185-704 on Ml 3053
623-1 130 on X00981
991-1676 on M76445
Primers
EC1/2-L 
EC1-R
EC1/2-L 
EC2-R
EC3-L 
EC3-R
EC4-L 
EC4-R
ECAAF-L 
ECAAF-R
ECAER-L 
ECAER-R
ECBFP-L 
ECBFP-R
ECCFA-L 
ECCFA-R
ECCNF-L 
ECCNF-R
ECCS3-L 
ECCS3-R
ECEAE-L 
ECEAE-R
ECF1C-L 
ECF1C-R
ECFIM-L 
ECFIM-R
ECIPA-L 
ECIPA-R
5 ' -GCTCTAGATTGAACGAAATAATTTATATG-3 
5 ' -GCTCTAGATGATGATGACAATTCAGTAT-3'
5 ' -GCTCTAGATTGAACGAAATAATTTATATG-3 
5 ' -GC6GATCCATGATGGCAATTCAGTAT-3 '
5 ' -ACGGATCCTACCGTGCTGACTCTAGACC-3 ' 
5 ' -CGCGAATTCTGTTATATATGTCAAC-3 '
5 ' -TCGAATTCAGCAAACGATTTCTTTAGAG-3 ' 
5 ' -AAGGTACCCCTGCGTTTTAAGAGTTTTT-3'
5 ' -TCTGaVATTCGACACAGACTCTGGCGAAAG-3 
5 ' -TGTGAATTCTGGGATTGCACTCTCAGGA-3'
5' -ATGGAATTCCCGGTTTCCGTGCTTTA-3' 
5 ' -CGGGAATTCCGGCAACGCGGTTAA-3'
5 ' -CCTGAATTCACGGGGGTTTTATAAGGAAA-3 
5 ' -TCAGaATTCTTACATGCAGTTGCCGCTTC-3
5 ' -AATATCGATGATAACTGTGTAAAAA-3 ' 
5 ' -GTTTCCTGCAGTTGGGGCGGTAC-3 '
5 ' -TTTAAGCTTTTACTAAAAAATTATTA-3 ' 
5' -TTTAAGCTTAACGTCTAACAAATT-3'
5 ' -GTAGAATTCCAGGTACGTATACTGTTGG-3' 
5 ' -TATGAATTCACGGTAATTACCTGAAACT-3'
5 ' -GGCGAATTCCGCATGAGCGGCTG-3 ' 
5 ' -ATTGAATTCATAGGCGCGAGCCGTCAC-3 '
5 ' -GCGAATTCATCTCCATGGCTGTA-3 ' 
5 ' -GCGAATTCACTTTAAAGGTGGCGTCG-3 '
5 ' -GGCGAATTCTGTTCTGTCGGCTCTGTC-3 ' 
5 ' -TTGGAATTCAACCTTGAAGGTCGCATC-3 '
5' -TCCGAATTCCTTGACCGCCTTT-3' 
5 ' -TTCSAATTCACGCATCACCTGTGCA-3 '
Length
530
520
680
665
590
1000
570 
650
910
540
680
520
510
690
TA
58
58
58
58
60
58
58
58
50
58
58
58
58
60
Restriction 
enzymes
ft ft





astA
cofA
IngA
chuA
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